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ABSTRACT 
Salmonella enterica is a food-borne pathogen that causes substantial morbidity 
and economic loss worldwide Typhoid fever is the most severe form of salmonellosis 
and kills 600,000 people annually. The emergence and spread of antibiotic resistance 
combined with increased international travel places renewed emphasis on effective 
vaccination strategies. Of the two currently available typhoid fever vaccines, one is 
potentially inappropriate for immuno-compromised individuals while the other could 
be rendered ineffective as the pathogen evolves. This work addresses these 
shortcomings and explores the possibility of identifying novel antigens for use in a 
multiple subunit vaccine. 
S. enterica serovar Typhimurium infection of mice is a well-established 
animal model of human typhoid fever. Phage display is a method of generating 
particles that embody a physical link between a given DNA sequence and the 
polypeptide it encodes. In this work, a phage display library was constructed from 
random fragments of S. Typhimurium genomic DNA. Hyper-immune serum from 
infected CBAICa mice was used for affinity selection of potential antigens from this 
library in a process called biopanning. Individual clones encoding potential antigens 
were subjected to further screening alongside a positive and negative control, and 10 
were consistently positive. Sequences encoding the potential antigens were then sub-
cloned into an expression vector encoding a polyhistidine fusion tag for affinity 
purification. Six of the ten sub-clones could not be induced to express the fusion 
peptide, whilst the other four were induced weakly. These remaining four underwent 
multiple purification steps before being tested by western blot and ELISA alongside 
the same positive control as used in screening for antigenicity. It was found that the 
xii 
positive control in itself was poorly antigenic and the four candidates were not 
antigens, suggesting that other factors interfere with the biopanning and antigen 
detection process. Approaches for modification of the original affinity selection 





A. Salmonella enterica 
1. General background 
Salmonella enterica is a facultative intracellular parasite that is a member of 
the family Enterobacteriaceae and is a close relative of Escherichia co/i. S. enterica 
is divided into subspecies I-VI, but nearly all the strains that cause disease in humans 
and domestic animals belong to subspecies enterica (I). These 6 subspecies are 
composed of over 2000 serotypes (Le Minor, 1988). Serotypes are classified 
according to Kauffmann-White scheme (also used for typing E. co/i and other 
strains) based on antigenic polymorphisms of lipopolysachharide (0) and flagella 
(H) (Fierer and Guiney, 2001). Serotype names are commonly written as if they were 
species names (Darwin and Miller, 1999). In this work, serotype names will not be 
italicised. For example, S. enterica serovar Typhimurium will be termed S. 
Typhimurium. 
Some serotypes are highly adapted to one host species (such as S. Typhi and 
S. Gallinarum in humans and chickens, respectively), while others can cause disease 
in a variety of hosts (such as S. Enteritidis or S. Typhimurium). While infections by 
most serotypes are limited to localised gastrointestinal diseases, some can cause 
systemic infection and septicaemia, with focal infections such as osteomyelitis and 
meningitis. These may be associated with, but not limited to, a number of host 
factors that may predispose the individual to extra-intestinal Salmonella infection 
(Cohen et al., 1987; Wilkins and Roberts, 1988; Darwin and Miller, 1999; Fierer and 
Guiney, 2001). 
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2. Non-typhoid salmonellosis in developed & developing countries 
The most common form of salmonellosis is a self-limiting diarrhoea, with the 
majority of these cases resulting from infection by S. Typhimurium and S. 
Enteritidis. It is estimated that there are 2 to 4 million cases of infection per year in 
the United States alone, primarily following the consumption of contaminated beef, 
poultry, or eggs. Salmonella infections are also responsible for substantial economic 
losses in the livestock industry (Maurice, 1994; Darwin and Miller, 1999). 
In the developed world, antibiotic resistance among Salmonella strains has 
arisen primarily through the systematic use of these drugs in food-producing animals 
for therapeutic, prophylactic, or growth-promoting purposes (Threlfall, 2002). 
Inappropriate use of antibiotics has led to an increase in virulent, multiply antibiotic-
resistant strains of bacteria, such as S. Typhirnurium DTI04. Even more disturbing 
was the discovery that antibiotic resistance in S. Typhimurium DT104 is carried on 
the chromosome rather than on a plasmid (Threlfall etal., 1994). This strain was first 
recognised as a problem in the UK, and it was later isolated in countries throughout 
the world (Glynn et al., 1998; Baggesen et al., 2000; Sameshima et al., 2000). It was 
also found that this strain continued to become resistant to new drugs (Threlfall et 
al., 1996) and spread to a wide range of host species (Baggesen et al., 2000). 
In the developing world, enteritis caused by non-typhoidal serotypes is more 
severe and is more frequently associated with invasive illness than enteritis caused 
by the same or similar serotypes in developed countries. Furthermore, contaminated 
water is the primary source of disease transmission, rather than consumption of 
contaminated animal products. Additionally, the appearance of drug resistance is not 
frequently associated with the use of antimicrobial drugs in livestock, but rather their 
use in humans (Threlfall, 2002). 
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3. Typhoid fever 
The most severe form of salmonellosis is caused by S. Typhi. World wide, it 
is estimated that over 16 million people develop typhoid fever and 600,000 die 
annually (Pang et al., 1998). In developed countries, typhoid fever is relatively 
uncommon, and incidence of this disease is typically associated with travellers who 
have visited areas of the world where typhoid fever is endemic (Mead et al., 1999). 
The majority of typhoid fever cases occur in Africa and Asia, with the highest 
mortality rates in areas where sewage disposal, water purification, and public access 
to medical care is poor (Jones and Falkow, 1996). The occurrence of antibiotic 
resistance is also increasing, as manifested by the numerous outbreaks of typhoid 
fever caused by antibiotic-resistant S. Typhi in Asia in the last 15 years (Threlfall, 
2002). 
Depending on the immune status of the individual and the number of bacteria 
ingested, the incubation time before initial symptoms are manifested ranges from 5 to 
20 days. These symptoms include diarrhoea accompanied by headache, weakness, 
dizziness, chills, muscle pains, anorexia, and/or abdominal cramping. If the disease is 
not resolved at this stage, symptoms progress to the typical fever and abdominal 
pain. Advanced stages of typhoid fever can result in permanent damage to the 
intestines. Untreated typhoid fever usually resolves after about 4 weeks of infection, 
although relapses are not uncommon. If treated with antibiotics, the disease usually 
resolves in 3-5 days. Of those who contract typhoid fever, 1-6% become chronic 
carriers, as do some who have no clinical history of typhoid (Jones and Falkow, 
1996). 
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4. Animal models of infection 
The epidemic of enteritis among humans and livestock caused by Salmonella 
having multiple drug resistance has led to a renewed interest in the study of 
diarrhoeal salmonellosis. Several animal models have been used to study gastro-
enteritis. These include rats, pigs, and rhesus monkeys (Kent et al., 1966; Powell et 
al., 1971; Reed et al., 1986). However, more recent studies have focused on using 
calves as the main animal model for this type of disease because of their importance 
in zoonosis (Tsolis et al., 2000; Santos et al., 2001). 
Studying the pathology of human typhoid fever is slightly more complicated 
than studying enteritis, since S. Typhi, the causative agent, is highly adapted to the 
human host. One animal model of human typhoid fever is the chimpanzee. Oral 
challenge with 10" virulent S. Typhi results in an illness that is similar to, but milder 
than, human typhoid fever. Since this animal is expensive and not in abundant 
supply, it is not an ideal model for extensive investigation into the pathogenesis of 
typhoid fever (Edsall et al., 1960; Pasetti et al., 2003). 
By far the most useful animal model has been the mouse. Murine S. 
Typhimurium infection has been a useful, alternative model for studying the disease 
due to similar pathological characteristics (Carter and Collins, 1974; Jones and 
Falkow, 1996). However, this model cannot be treated as identical to human 
infection with S. Typhi. Although comparison of the mouse and human genomes 
showed remarkable similarity between the species, with only about 300 genes not 
present in both species, it is important to note the differences in size, lifespan, and 
ecological niches occupied by the two species (Mestas and Hughes, 2004). 
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Differences are also observed between the immune systems of each species. 
The difference in size and heart rate between the species substantially affects the rate 
and distance that an antigen-presenting cell must travel in order to reach lymph 
nodes. Thus, it is not surprising that the two species exhibit differences in the 
underlying mechanism and characteristics of the delayed-type hypersensitivity 
(DTH) response, which is thought to be driven by CD4+ T lymphocyte-mediated 
activation of macrophages (Mestas and Hughes, 2004). A longer lifespan in humans 
could be a reason for longer and more diverse T cell memory, as well as the greater 
presence and redundancy of programmed cell death signalling pathways to avoid 
tumorigenesis (Chun et al., 2002; Mestas and Hughes, 2004). In addition, human 
blood contains more neutrophils (50-70%) than lymphocytes (30-50%), compared to 
mouse blood (75-90% lymphocytes, 10-25% neutrophils) (Doeing et al., 2003). 
Nevertheless, research on murine infection with S. Typhimurium has served as an 
excellent model for human typhoid fever and has led to a greater understanding of 
pathogenesis, immunological response, and vaccination against S. Typhi (Pasetti et 
al., 2003). This work will focus on the murine typhoid model, and any 
incontsistencies with human typhoid fever will be highlighted. 
B. S. Typhimurium pathogenesis in mice 
1. Breaching of the intestinal epithelium 
Following oral inoculation of mice with S. Typhimurium, bacteria that 
survive the harsh conditions of the stomach and successfully compete with normal 
rol 
flora of the small intestine initially colonise the Peyer's Patches (PP) (Bohnhoff and 
Miller, 1962; Carter and Collins, 1974; Darwin and Miller, 1999). Attachment to the 
cells of the PP is mediated by long polar fimbriae and enables S. Typhimurium 
colonisation of Peyers Patches (Baumler et al., 1996). Indeed, multiple fimbrial 
adhesins are necessary for full virulence of this pathogen in mice (van der Velden et 
al., 1998). S. Typhimurium then breaches the small intestine within a few hours, 
primarily through the membranous epithelial (M) cells of the PP but also through 
epithelial cells (Makela and Hormaeche, 1997). M cells allow the immune system to 
sample antigens from the intestinal lumen by transporting a broad range of materials 
across the epithelium to underlying lymphocytes and macrophages (Jepson and 
Clark, 2001). 
S. Typhimurium does not passively enter, but rather invades, M cells as well 
as enterocytes. First, the bacteria attach to the intestinal wall with the aid of multiple 
fimbrial adhesins. using effector proteins secreted by the type III secrection system 
(TTSS) of Salmonella pathogenicity island I (SPI-1) (Galan and Collmer, 1999). 
When it comes into contact with M cells, the secreted effector proteins induce 
membrane ruffling and cytoskeletal rearrangements that result in bacterial 
internalisation. Multiple S. Typhimurium-containing vesicles then fuse to form a 
larger compartment. This process has cytotoxic effects that lead to host cell 
destruction, and Salmonella can then spread to adjacent cells and underlying 
phagocytic cells (Jones etal., 1994; Jones and Falkow, 1996). 
Although the major site of intestinal breaching is the M cells of PP, it is not 
surprising that S. Typhimurium has the ability to penetrate the intestine by other 
means, given the fact that M cells comprise about 0.01% of the intestinal 
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epithelium (Jepson and Clark, 2001). Alternative routes of extra-intestinal 
dissemination are likely to have a common requirement for intracellular replication, 
since this is a key determinant of virulence (Leung and Finlay, 1991). One described 
alternative route of dissemination is via internalisation by dendritic cells (DC) that 
penetrate the gut epithelium to sample antigens (Rescigno et al., 2001), with 
subsequent transport to the bloodstream inside CD 18+ phagocytes (Vazquez-Torres 
et al., 1999). 
Like murine S. Typhimurium infection, human S. Typhi infection also 
manifests characteristic intestinal lesions at sites corresponding to PP (Owen, 1994). 
However, experimental data show differences in the mechanism by which S. Typhi 
breaches the intestinal epithelium. S. Typhi induces the surface expression of cystic 
fibrosis transmembrane conductance regulator (CFTR) on human intestinal epithelial 
cells (Lyczak and Pier, 2002). Contact with epithelial cells induces the S. Typhi 
expression of lipopolysaccharide (LPS) core, which is a CFTR ligand (Lyczak et al., 
2001). In addition, type IVb pili that mediate bacterial self-association also bind to 
CFTR and permit host cell invasion mediated by the SPI-1 TTSS (Zhang et al., 
2000b; Lyzak etal., 2001; Morris etal., 2003). 
Furthermore, commensal bacteria have opposite effects on the ability of S. 
Typhimurium to breach the intestinal epithelium compared to S. Typhi. While S. 
Typhimurium must compete with the resident intestinal microflora (Bohnhoff and 
Miller, 1962), invasion by S. Typhi is actually enhanced in their presence. Pre-
treatment of epithelial cells with extracts of commensal bacteria increased the surface 
expression of CFTR by an unknown mechanism. This pre-treatment increased the 
ability of S. Typhi to invade the cells, but had no effect on invasion by S. 
Typhimurium (Lyczak, 2003). 
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2. Initial host response and S. Typhimurium dissemination 
The innate immune response is the fundamental host defence against 
infection that has proven sufficient for the evolutionary survival of most organisms. 
Only vertebrates have an additional, adaptive response that uses immunological 
memory to protect the host from future infections by specific pathogens. Still, 
adaptive immunity cannot protect the host unless the innate immune response 
controls infection during the time required to develop the pathogen-specific response 
(Beutler, 2004). 
Upon invasion of host cells in the intestine by S. Typhimurium, 
polymorphonuclear lymphocytes (PMN) are the first immune cells to accumulate in 
the sub-mucosa, in response to the production of chemokines by the infected 
intestinal cells. The rapid appearance of PMN at sites of infection is an innate 
immune response that is conserved among all host species that have been studied 
(Fierer, 2001). Neutrophils, a type of PMN, are responsible for controlling bacterial 
numbers at the site of intestinal breach (Cheminay et al., 2004). Neutrophils and 
macrophages, which are critical to the survival of Salmonella-infected mice, share a 
common microbicidal role in the innate immune response (Mittrucker and 
Kaufmann, 2000). These phagocytes kill bacteria with the aid of toxic reactive 
oxygen and nitrogen intermediates that are generated by a series of reactions initiated 
by NADPH oxidase (Beutler, 2004). Mouse macrophages also produce inducible 
nitric oxide synthase (NOS), which is central to the elimination of S. Typhimurium 
(Alam et al., 2002). However, whether or not human macrophages make NOS 
remains controversial (Mestas and Hughes, 2004). 
Upon breaching the intestinal epithelium, a proportion of Salmonella gain 
access to the blood. During this brief extracellular state, the pathogen becomes 
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susceptible to attack by the host complement system (See section DIb). Although the 
intracellular state of Salmonella protects it from complement during most of the 
infection, murine complement deficiency increases susceptibility to S. Typhimurium 
infection (Warren et al., 2002). As part of the defence strategy, S. Typhimurium 
produces a 17 kDa outer membrane protein that mediates protection from 
complement by interfering with the formation of a fully polymerised tubular 
membrane attack complex. This protein is encoded by the rck gene carried on the 
pSLT virulence plasmid (Heffernan et al., 1992). On the contrary, S. Typhi is 
shielded from complement killing in non-immune mice by producing an 
exopolysaccharide (Robbins and Robbins, 1984). 
Salmonella that escape rapid clearance from the circulation subsequently 
reach the reticuloendothelial system (RES), where they mainly reside in PMN, 
macrophages, and dendritic cells. At the primary sites of extra-intestinal colonisation, 
S. Typhimuriurn is mainly associated with resident Kupffer cells of the liver, and the 
red pulp macrophages and marginal zone macrophages of the spleen. At these sites, 
bacteria continue to replicate inside macrophages and to infect other macrophages. 
This eventually leads to the formation of a focal lesion. As the infection progresses, 
the number of lesions increases as the host attempts to prevent the uncontrolled 
spread of Salmonella throughout the body (Mastroeni and Sheppard, 2004). At the 
cellular level, many complex interactions between macrophage and S. Typhimurium 
that depend on bacterial and host factors determine the course of the infection. 
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C. Horizontally acquired genes conferring Salmonella virulence 
1. Overview 
Over the last several years, a host of genes that contribute to S. Typhimurium 
pathogenesis have been identified. Many encode proteins involved in basic metabolic 
pathways, gene regulation, stress responses, and defence against host antimicrobial 
factors. Many, but not all, have been shown to be vital for full virulence (Hoiseth and 
Stocker, 1981; Hensel etal., 1995; Bowe etal., 1998; Taylor etal., 1998; Garcia-Del 
Portillo et al., 1999; Humphreys etal., 1999; Lundberg etal., 1999a). 
A significant fraction of virulence genes are the product of horizontal gene 
transfer. These include adhesins, invasins, toxins, and other factors that have been 
added to the chromosome through conjugation, transformation, and transduction. 
This lateral transfer enables Salmonella to expand its host range and is considered the 
most efficient mechanism of bacterial evolution (Ochman et al., 2000). Indeed, the 
level of genetic variability is much less pronounced in host-restricted Salmonella 
serotypes, such as S. Typhi (Selander et al., 1990). 
Clusters of virulence genes that have become integrated in the chromosome 
are called pathogenicity islands (PAl). About 75% of PAl are associated with tRINA 
genes, which are frequently used as integration anchor points by temperate 
bacteriophages (Hou, 1999). This is also true in the case of S. enterica, with all but 
one of the known PAT being flanked by a tRNA gene (Hansen-Wester and Hensel, 
2002). In fact, most of the tRNA-encoding loci have been used as anchor points for 
lateral gene transfer during Salmonella evolution (Porwollik and McClelland, 2003). 
Since many characteristics of Salmonella virulence are the phenotypic result of 
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horizontally acquired genes, the following section will focus on these loci and their 
regulation in pathogenesis. 
2. Salmonella Pathogenicity Islands (SPI) 
The E. coli K12 genorne is approximately colinear with that of S. 
Typhimurium. Salmonella pathogenicity islands (SPI) contain clusters of genes that 
are absent from the corresponding location in the E. coli chromosome (Fierer and 
Guiney, 2001). S. enterica harbours several SPI that enable it to invade its host and 
proliferate. SPI-1 through SPI-5 have been partially characterised in S. 
Typhimurium, although SPI-1 and SPI-2 have been the focus of most studies. SPI-4 
(25 kb) contains a gene required for survival in macrophages as well as putative 
toxin secretion genes. SPI-5 is a 7 kb region with a composite nature and encodes 
effector proteins secreted by the YT'SS of SPI-1 as well as SPI-2 (Schmidt and 
Hensel, 2004). The presence of other SPI has been inferred from the complete 
genomic sequence of S. Typhimurium (McClelland etal., 2001). 
SPI-3 is a 17 kb region that harbours a high-affinity magnesium transport 
system that is important for survival inside macrophages. The mgtC gene, which is 
required for growth in low Mg 2+ concentrations, has no homologue in E. coli. 
However, the macrophage-tropic intracellular pathogen Mycobacterium tuberculosis 
harbours an mgtC homologue that permits growth in low Mg 
2+  concentrations and 
that is required for intracellular proliferation and virulence in mice (Buchmeier etal., 
2000). Since E. coli cannot grow in Mg 2+  concentrations as low as S. Typhimurium, 
the horizontal acquisition of this element may have been an important step in the 
evolution of Salmonella as a pathogen (Blanc-Potard and Groisman, 1997). 
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S. enterica is unusual among bacteria in that it carries two virulence-
associated TTSS. All Salmonellae harbour the SPI-I TTSS, although the repertoire 
of effector proteins secreted by this system is not the same for all serotypes. The SF!-
2 TTSS, which is present in all S. enterica serovars, is absent from S. bongori. S. 
bongori is a commensal organism of cold-blooded vertebrates that is rarely 
associated with human infection. It is believed that the two pathogenicity islands 
were acquired as independent events, and that SPI-2 was acquired after SPI-I. 
Furthermore, SPI acquisition probably also took place in multiple events, since each 
SPI contains a segment of genes with a base composition that differs from the rest of 
the SPI and that is not required for virulence (Reeves et al., 1989; Boyd et al., 1996; 
Ochman and Groisman, 1996; Hansen-Wester and Hensel, 2001). 
SPI-I comprises a region of approximately 40kb on the chromosome. The 
SPI-I TTSS is known to secrete at least 19 polypeptides; however, the genes 
encoding the majority of effector proteins are located elsewhere on the chromosome, 
in association with other pathogenicity islands and mobile genetic elements (Galan, 
2001; Hansen-Wester and Hensel, 2001). SPI-I is critical for S. Typhimurium entry 
into cultured murine M cells and promotes the invasion of M cells in vivo. This is 
achieved by the injection of effector proteins into the host cell through a molecular 
syringe (Kimbrough and Miller, 2002). Orally administered mutant bacteria lacking 
SPI-I maintain a significant ability to colonise PP, to disseminate outside the 
intestine, and to exhibit some virulence, although to a significantly lesser degree. On 
the contrary, SPI-1 deficient bacteria were equally virulent to the wild-type control 
when injected intraperitoneally (Galan and Curtiss, 1989; Penheiter et al., 1997; 
Clark et al., 1998; Jepson and Clark, 1998; Vazquez-Torres et al., 1999). It is not 
surprising that a degree of virulence is retained without functional SPI-i TTSS in 
13 
orally administered bacteria, since it is known that Salmonella can disseminate by 
alternate means (Vazquez-Torres et al., 1999; Rescigno et al., 2001). 
SPI-2 is a 40 kb locus that contains 44 Salmonella-specific open reading 
frames. The total number of effector proteins translocated by SPI-2 is unknown, and 
the functions of those already identified are only partially understood (Hansen-
Wester and Hensel, 2001; Hansen-Wester et al., 2004). In contrast to SPI-1, SPI-2 is 
essential for virulence in mice, regardless of the inoculation route (Ochman et al., 
1996; Shea et al., 1996). This has led to the widely accepted conclusion that SPI-2 is 
required for systemic infection (Hensel, 2000). Expression of the SPI-2 TISS occurs 
only after invasion of host cells and subsequent acidification of the Salmonella-
containing vacuole (SCV) (Cirillo et al., 1998; Beuzon et al., 1999; Pfeifer et al., 
1999; Nikolaus et al., 2001). SPI-2 allows Salmonella replication in non-phagocytic 
cells and survival in macrophages. General vesicular trafficking in host cells and 
maintenance of the SCV are affected by the SPI-2 encoded SpiC and SifA proteins, 
respectively (Uchiya et al., 1999; Beuzon et al., 2000; Guy et al., 2000). SPI-2 also 
interferes with the host cell's antimicrobial defences involving reactive oxygen and 
nitrogen intermediates (Vazquez-Torres et al., 2000; Chakravortty et al., 2002). 
SPI-1 and SPI-2 are activated by different environmental stimuli. In the gut 
lumen, SPI-1 expression is activated by low oxygen levels and high osmolarity. 
Inside host cells, SPI-2 expression is activated by low Mg 2+  levels and phosphate 
starvation (Hansen-Wester and Hensel, 2001). The inability to achieve simultaneous 
induction of both systems indicates the possibility that they may be inversely 
regulated (Deiwick et al., 1999). In addition to environmental components, SPI 
expression depends on the bacterial growth phase. For example, transient expression 
of SPI-1 was responsible for a striking ability to induce rapid apoptosis in cultured 
macrophages. This was triggered by prior growth of the bacteria to a very narrow, 
14 
specific point of growth, at the transition from exponential to stationary phase 
(Lundberg et al., 1999b). SPI-1 and SPI-2 have distinct functions in pathogenesis; 
however, the sequential expression of these two systems raises the possibility that a 
temporal coordination mechanism may exist. Indeed, it has been shown that mutation 
of some SPI-2 genes can influence the expression of SPI-1 genes (Deiwick et al., 
1998). 
A pathogenicity island present in S. Typhi, S. Dublin, and S. Paratyphi C has 
been identified that is not found in other Salmonella strains (Pickard et al., 2003). 
Unlike SPI-1 and SPI-2, SPI-7 (also called Major PAl) is unstable and can excise 
spontaneously from an S. Typhi clinical isolate when grown in the laboratory (Bueno 
ci' al., 2004). Furthermore, clinical S. Typhi isolates missing this region have also 
been characterised (Nair et al., 2004). In S. Typhi, this 134 kb pathogenicity island 
includes the viaB operon for the biosynthesis and export of the Vi exopolysaccharide, 
the pil operon for production of type IVb pili, and sopE, a bacteriophage-associated 
effector protein of the SPI-1 TTSS (Pickard ci' al., 2003). Since Vi-positive S. Typhi 
strains (comprising the majority of clinical isolates) are more virulent than Vi-
negative strains (Hornick ci' al., 1970; Robbins and Robbins, 1984), acquisition of 
SPI-7 is likely to have been an important step in the evolution of this pathogen. 
3. The spy operon 
A third cluster of virulence genes is carried on the frequently self-
transmissable 90 kb pSLT virulence plasmid of S. Typhimurium (Ahmer et al., 
1999). All strains of Salmonella that exhibit virulence in mice carry a virulence 
plasmid encoding the spy operon. This highly conserved operon is the plasmid-borne 
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component responsible for the murine systemic infection phenotype (Guiney et al., 
1995). 
As with proteins secreted by the SPI-2 TTSS, spy proteins are expressed in 
the late logarithmic to stationary phase of bacterial growth, induce morphological 
changes in host cells, and allow intracellular proliferation of Salmonella. Expression 
of spy genes is controlled by the stationary-phase sigma factor RpoS (Chen ci al., 
1995). Within the operon, the product of spvR regulates the expession of the four 
structural components encoded by spvA, spvB, spvC, spvD (Guiney ci al., 1995). 
Mutation of spvR effectively abolishes expression of the other four genes. The spvB 
and spvC genes are sufficient for plasmid-borne virulence and can replace the 
function of the entire spy operon when bacteria are inoculated sub-cutaneously, but 
not orally, into mice (Matsui ci al., 2001). Like SPI-2, spy is essential for 
Salmonella-induced apoptosis of intestinal epithelial cells in tissue culture (Paesold 
ci al., 2002). However, experimental evidence shows that the two sets of genes 
operate by different mechanisms. SpvB, which catalyzes the ADP-ribosylation of 
actin and is essential for murine virulence, is secreted by a non-TTSS pathway into 
host cells and induces apoptosis in eukaryotic cells (Gotoh et al., 2003; Kurita et al., 
2003). Furthermore, in vivo experimental evidence shows that SPI-2 and spy 
contribute independently to murine Salmonella virulence (Shea et al., 1999). 
Epidemiological evidence supports a role for spy in extra-intestinal 
dissemination of S. Typhimurium in humans (Fierer ci al., 1992). In fact, the spy 
locus is found among a wide range of Salmonella serovars, although in many cases it 
has become integrated in the chromosome. However, the absence of spy genes in the 
S. Typhi genome suggests that the basis of typhoid fever pathogenesis is 
fundamentally different from that of systemic infection by non-typhoid Salmonellae 
(Guiney ci al., 1995; Boyd and Hartl, 1998). 
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4. Bacteriophage-associated virulence genes 
Several functional phage genomes are present in Salmonella, with some 
found only in specific strains. For example, S. Typhimurium strain LT2 releases 
Fels-1, Fels-2, Gifsy-1, and Gifsy-2 phage particles in response to DNA stress. Other 
S. Typhimurium strains do not carry Fels-1; however, they are known to carry Gifsy-
3 and SopE. Cryptic prophages and phage remnants are also found throughout the 
Salmonella serovars (Porwollik and McClelland, 2003). Among these bacteriophage-
associated sequences lie genes encoding key factors that affect pathogenesis. 
The Salmonella-specific P22 phage is known to carry genes that modify its 
surface receptor, LPS. Since a considerable proportion of anti-Salmonella antibodies 
are directed against LPS, 0-antigen modification is one of the most important means 
of immune escape by Salmonella. LPS modification may be a P22 mechanism of 
preventing super-infection by other phages, but changes in the 0-antigen also render 
host antibodies to the previous, unmodified form useless. However, other 
chromosomal genes are also responsible for 0-antigen variation (Fierer and Guiney, 
2001). Furthermore, there is no evidence that LPS modification is required for 
virulence, although there is an example of increased murine S. Choleraesuis 
virulence associated with phage 14 lysogeny- induced 0-antigen modification 
(Nnalue et al., 1990). 
The Gifsy-2 phage carries several genes that are directly involved in the 
pathogenesis process. The ssel gene encodes a TTSS effector protein involved in 
Salmonella-induced actin polymerisation in host cells (Miao et al., 2003). 
Interestingly, Gifsy-2 also carries an antivirulence component whose mechanistic 
role in infection has yet to be elucidated (Ho and Slauch, 2001). However, the most 
relevant Gifsy-2 genes in pathogenesis are gtgE and sodCl. These two genes are 
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responsible for the observed 100-fold attenuation of S. Typhimurium when it is cured 
of Gifsy-2. GtgE is a protein of unknown function that is produced in laboratory 
conditions as well as in vivo (Ho et at., 2002). 
SodCI is a well-characterised periplasmic Cu21, Zn2 superoxide dismutase 
with one of the highest catalytic rates ever observed for a superoxide dismutase 
(Pesce et at., 2000). This enzyme catalyses the conversion of two superoxide anions 
to one molecule of hydrogen peroxide and one molecule of oxygen. Its periplasmic 
location helps to protect the cell against exogenous superoxide, thus enhancing the 
ability to survive the effects of NADPH oxidase inside phagocytes (Fang et at., 
1999). SodCI is only present in some of the most pathogenic serotypes, with the 
notable exceptions of S. Paratyphi and S. Typhi (Fang et at., 1999). Although the 
contribution of sodClto virulence is well established, its exact role in the context of 
grvA, the Fels-1 encoded sodCIIJ, or the chromosomally encoded sodCJI remains 
unclear (Boyd and Brussow, 2002; Janssen et at., 2003). 
The Gifsy-1 phage carries a gene giA that is specifically induced in S. 
Typhimurium when it reaches the small intestine of mice. This protein is important 
for growth and colonisation in the PP (Stanley et at., 2000). Gifsy-1 also carries a 
leucine rich TTSS effector protein encoded by gogB. Although Gifsy-1 is less 
important to S. Typhimurium virulence than Gifsy-2, its contribution becomes 
apparent when all Gifsy-2 elements except sodCl are removed. It has been suggested 
that Gifsy-1 contains one or more virulence determinants whose function(s) overlap 
with element(s) encoded by Gifsy-2 (Figueroa-Bossi and Bossi, 1999). 
Gifsy-3 was identified as a novel phage present in S. Typhimurium strain 
ATCC14O28 that carries two genes (pagf and sspHl) associated with pathogenesis 
(Figueroa-Bossi et at., 2001). Inactivation of the PhoP/PhoQ-activated pagJ locus is 
known to reduce virulence 1000 fold (Belden and Miller, 1994). The leucine rich 
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SPI-1 YI['SS effector protein encoded by sspHl is translocated to the mammalian 
nucleus and interferes with gene expression, which ultimately leads to a down-
regulation of the inflammatory response (Haraga and Miller, 2003). Still, curing 
ATCC 14028 of Gifsy-3 had no detectable effect on virulence in mice (Figueroa-
Bossi et al., 2001). This may have been due to a redundancy of these genes in 
Salmonella (Miao et al., 1999; Amavisit et al., 2003). 
The SopE bacteriophage was originally identified in S. Typhimurium 
SL1344 when a gene encoding a SPI-1 TTSS effector protein, sopE, was found to be 
located within its genome (Hardt et al., 1998b). SopE is an activator of host cell Rho 
GTPases, and translocation into the cell leads to the membrane ruffling that induces 
macropinocytosis of Salmonella (Hardt et al., 1998a). A homologue of SopE (known 
as SopE2) that activates a different set of host cell Rho GTPases is well conserved 
among Salmonella serotypes (Prager et al., 2000; Ehrbar et al., 2002). The SopE4-
encoded sopE gene, however, is found in only a few serotypes associated with 
epidemics (Mirold et al., 1999). Further evidence to support a role for sopE in 
virulence is its characteristic presence in S. Paratyphi B isolates from systemic 
infections and absence in isolates from enteric infections (Prager et al., 2003). 
When analysing the transfer of many phage-encoded virulence genes between 
strains, a common theme emerges. Many of these genes, including ssel, gogB, pagf, 
sspHl, and sopE, are located within the tail-fibre region of the bacteriophage 
genomes (Boyd and Brussow, 2002). Selective pressure apparently leads to more 
rapid evolution of tail fibre genes than other phage genes (Haggard-Ljungquist et al., 
1992). Thus, there appears to be an inherent genetic flexibility in this region. Since 
phage attach to host receptors via tail fibres or tailspike proteins, variability in the 
genes that encode them can enable phage to modify their host specificity. This can 
create a new niche or a possible selective advantage for future generations of phage 
as they evolve. Furthermore, if the variation takes the form of accessory genes 
(called morons) such as those listed above, the evolutionary fitness of the host is 
potentially enhanced. This would provide the host with a disincentive for removing 
the lysogenised phage, which in turn would give an evolutionary advantage to phage 
that carry morons (Hendrix et al., 2003). Finally, stresses experienced by a bacterial 
pathogen during the course of infection may induce otherwise dormant prophages. 
Indeed, live phage particles are known to be produced in the course of some bacterial 
infections. Furthermore, structural components of phage particles can be directly 
pathogenic (Waldor, 1998). The revelation that exposure of S. Typhimurium to H202 
induces the release of fully functional Gifsy-1 and Gifsy-2 prophages raises the 
possibility that in vivo prophage induction plays a role in virulence (Figueroa-Bossi 
and Bossi, 1999). 
D. Regulation of Salmonella gene expression in the host 
1. Overview 
Virulence genes are undoubtedly crucial to pathogenesis; however, they must 
be expressed at the appropriate stage of infection in order to function properly. A 
recent study identifying candidate antigens for subunit vaccination against 
Salmonella highlighted the importance of gene regulation in vivo for the selection of 
appropriate antigens (Rollenhagen et al., 2004). Salmonella, like other organisms, 
senses and adapts to environmental conditions by regulating the expression of its 
genes at many levels. Such conditions include temperature, osmolarity, nutrient 
availability, pH, gravity, growth phase, and the concentration of oxygen, specific 
ions, peptides, and other small molecules. Regulation may occur at the level of 
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transcription, mRNA stability, translation, or post-translational modification. 
Disruption of the ability to regulate this expression can interfere with pathogenesis. 
Indeed, numerous regulatory components are known to be essential for virulence 
(Clements et al., 2001). 
2. Control of sequential events during the course of invasion 
a. S. Typhimurium 
S. Typhimurium has a type III flagellar protein export apparatus which 
secretes peritrichous flagella providing motility. While the expression of flagella 
during the course of infection is proven by the production of host antibodies to H 
antigen, the precise role of flagella in virulence remains unclear. For example, 
interfering with the ability of S. Typhimurium to switch between phase I and phase II 
flagellin at the level of regulation resulted in decreased virulence in the murine 
typhoid model, but had no effect on bovine gastroenteritis (Ikeda et al., 2001). On 
the other hand, abrogation of the ability to produce flagella in the first place did not 
diminish S. Typhimurium virulence in mice but had a negative effect on its capacity 
to invade intestinal epithelial cells and to cause fluid accumulation in the ligated calf 
intestine (Lockman and Curtiss, 1990; Ikeda etal., 2001; Schmitt etal., 2001). 
Nearly 50 genes encoding the proteins responsible for flagellar biosynthesis 
and function are located in 17 operons on the S. Typhimurium chromosome 
(Kutsukake et al., 1988). Production of flagella is influenced by environmental 
stimuli that include oxygen and nutrient availability, pH, temperature, and 
osmolarity. Since motility is energetically expensive to the cell, it is not surprising 
that the synthesis of flagella is regulated by a complex network. This network 
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includes a hierarchical organisation of flagellar genes into three classes: 1) genes 
encoding FIhD and FIhC, which form a heterotetramer that activates class 2) genes 
encoding hook-basal body complexes and an alternative sigma factor FliA (RpoF) 
that activates transcription of class 3) genes encoding the filament protein as well as 
the hook-associated, motor, and chemotaxis proteins. Additionally, the expression of 
these genes is influenced by other transcriptional activators and repressors, and by 
mRNA stability through binding of the CsrA global regulator (Lawhon et al., 2003; 
Soutourina and Bertin, 2003; Teplitski et al., 2003). 
New regulators continue to be discovered in Salmonella, such as RtsA and 
RtsB. Interestingly, these are absent in E. coli and appear to be part of a horizontal 
acquisition event. RtsB binds to the flhDC promoter and represses the production of 
flagella; RtsA activates the transcription of hilA, which in turn up-regulates the 
expression of SPI-1 genes (Ellermeier and Slauch, 2003). Together with BarA/SirA 
and csrB/CsrA, RtsB and RtsA are involved in the coordinated regulation of motility 
and invasion as Salmonella passes from the extracellular to the intracellular state. 
Further experimentation will reveal how these and perhaps other components work 
together during the early stages of infection. 
b. S. Typhi 
In contrast to S. Typhimurium, S. Typhi invasion of epithelial cells requires 
intrinsic, intact motility, and most strains produce only one phase of flagellin (Liu et 
al., 1988; Arricau et al., 1998). Differences in the mechanism of invasion between 
the two serotypes may be related to the response to environmental stimuli. For 
example, environmental osmolarity seems to have a stronger effect on SPI-1 protein 
secretion in S. Typhi than in S. Typhimurium. Additionally, serotype-unique 
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elements may also play a role, since production of flagella and secretion of SPI-1 
proteins in S. Typhi is in part post-translationally controlled by the presence of the Vi 
polysaccharide capsule (Arricau et al., 1998). 
As described at the end of section BI, S. Typhi attachment to host cells is 
mediated by interaction of LPS core and type IV pili with surface-expressed CFTR. 
S. Typhi produces type IV pili that mediate bacterial self-association, as well as type 
V pili that inhibit self-association. At the end of the pil operon is a segment of DNA 
flanked by a pair of 19-bp inverted repeats (a simple shufflon), followed by the rd 
gene encoding a shufflon-specific recombinase. Due to DNA inversion mediated by 
Rci, the pilV gene encodes two products with different C-terminal amino acid 
sequences. However, Rci activity physically interferes with transcription of the pilV 
gene, which indicates that Rci activity and pilV expression are inversely correlated. 
Since Rci activity is influenced by the extent of DNA supercoiling, environmental 
conditions that promote supercoiling (such as low levels of oxygen in the gut) may 
lead to decreased expression of pilV (Morris et al., 2003). Under these 
circumstances, the formation of bacterial aggregates may enhance uptake by host 
cells and may help protect individual cells from host defences. Strains of S. Paratyphi 
C (which can cause typhoid fever in humans) that are Vi also carry the equivalent 
phi operon, but with an important difference: the shufflon is rendered inactive and 
hence the bacteria do not self-associate. Since S. Paratyphi C does not cause large-
scale persistent epidemics of typhoid fever, this observation supports the possible 
importance of type IV pili-mediated bacterial self-association to typhoid fever (Tam 
et al., 2004). 
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3. Sensing environmental Mg': the PhoP-PhoQ system 
The PhoP-PhoQ regulatory system is one of the best-characterised regulons 
present in enteric bacteria, with the majority of studies having been performed in 
Salmonella. This two-component regulatory system affects the expression of at least 
40 proteins (Miller and Mekalanos, 1990). It consists of a sensor anchored in the 
cytoplasmic membrane (PhoQ) that governs the phosphorylation state of a 
cytoplasmic gene regulator (PhoP). The periplasmic domain of PhoQ, when bound to 
Mg2 , promotes the ability of its cytoplasmic domain to dephosphorylate PhoP. Thus, 
low Mg 2+  leads to increased levels of phosphorylated PhoP, which subsequently 
influences the transcription of a host of other genes (Groisman, 2001). 
The phoPQ operon is regulated in a positive autogenous fashion that 
amplifies the ability of PhoQ to sense the extracellular concentration of Mg 2+ 
(Soncini et al., 1995; Groisman, 2001). Recent work has shown that PhoP activation 
can occur through self-association of over-expressed PhoP, and this abolishes the 
need for phosphorylation, and therefore the need for regulation by PhoQ in these 
conditions (Lejona et al., 2004). In the context of pathogenesis, precise regulation of 
gene expression by PhoP is crucial. Indeed, S. Typhimurium phoP-constitutive 
mutants that exhibit excessive induction and repression of the corresponding PhoP-
induced and —repressed genes are as attenuated for virulence in mice as phoP-null 
mutants (Miller and Mekalanos, 1990). 
Several PhoP-activated genes (pag) as well as PhoP-repressed genes (prg) 
have been identified. Many pag genes encode proteins that are involved in 
remodelling of the outer membrane and in conferring resistance to bile and cationic 
antimicrobial peptides (Gunn et al., 1998; van Velkinburgh and Gunn, 1999). A 
number of prg genes, on the other hand, are responsible for the formation of the 
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supramolecular type 3 secretion needle complex for invasion of host cells 
(Kimbrough and Miller, 2000). Disruption of pag or prg genes often results in 
attenuation of virulence (Belden and Miller, 1994). Additionally, the PhoP-PhoQ 
system regulates the transcription of mgtC, a SPI-3 locus that is associated with Mg 2+  
acquisition and is required for virulence (see section C2 of this chapter) (Blanc-
Potard and Groisman, 1997). Since a low concentration of Mg 2+  is indicative of an 
intracellular environment, it is logical that Salmonella should express TTSS genes 
encoding factors responsible for entry into host cells when Mg2+  is not low 
(Groisman, 2001). 
While PhoP-PhoQ is responsible for the regulation of several loci associated 
with virulence, the majority of PhoP-regulated genes do not play a role in virulence. 
This is not surprising, given the fact that the PhoP-PhoQ regulatory system is also 
present in non-pathogenic bacteria (Garcia Vescovi et al., 1994). However, it is 
interesting that the presence of all PhoP-regulated genes affecting Salmonella 
virulence appear to be the result of horizontal acquisition events. Groisman (2001) 
hypothesised that evolutionary pressures led to PhoP-PhoQ control of these genes in 
order to ensure that they would be induced only at the appropriate time and place 
during the course of infection. 
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E. Features of host resistance 
1. Innate immunity 
a. Cells 
As described in section B2, PMNs and macrophages are important effectors 
of the innate immune response. Administration of a monoclonal antibody to Ly6G (a 
protein found on the surface of PMNs and a small percentage of B cells) rendered 
mice neutropenic and more susceptible to Salmonella infection (Fierer, 2001). 
Although Salmonella preferentially reside in macrophages, these phagocytes play a 
crucial role in its elimination. Notably, a major difference between innately resistant 
and susceptible mice is in the ability of their macrophages to kill Salmonella (Lissner 
et al., 1983). This trait has been attributed to a specific locus, Slcllal, which is 
discussed in section Eld. Although natural killer (NK) cells are considered to be part 
of the innate immune response, they were shown to modulate the effector function of 
the adaptive immune response upon challenge in mice previously immunised with 
attenuated Salmonella (Schafer and Eisenstein, 1992). In addition to inducing 
apoptosis of infected cells, NK cells produce proinflammatory cytokines, including 
IFN-y, which activates macrophages and the acquired immune response in the 
presence of LPS (Kim et al., 2000). 
Another type of cell at the interface of innate and adaptive immunity is the 
DC, which samples antigens at the portals of pathogen entry. Upon exposure to a 
pathogen (e.g. through stimulation of Toll-like receptors), DCs produce cytokines 
and chemokines to recruit phagocytes to the site of infection. As DCs mature in 
response to inflammation, the antigen sampling capacity is down-regulated, the 
antigen presenting capacity is up-regulated, and the expression of co-stimulatory 
molecules is induced (Boss and Jensen, 2003). The DCs then migrate to the lymph 
nodes to activate the proliferation of antigen-specific T cells. These T cells migrate 
back to the site of infection, participate in its clearance, and give rise to memory 
(Mazzoni and Segal, 2004). Indeed, experimental evidence supports a role for DCs in 
priming naïve T cells (particularly CD4 T cells) in response to Salmonella infection 
(Yrlid et al., 2001). 
b. Toll-like receptors 
Central to the innate immune response is the ability to recognise pathogen-
associated molecular patterns (PAMPs) such as flagellin, peptidoglycan, LPS, and 
unmethylated CpG motifs. Recognition of these PAMPs by Toll-like receptors 
(TLRs) triggers maturation of DCs and the secretion of several cytokines and 
chemokines (Gordon, 2002). TLRs are integral membrane glycoproteins having an 
extracellular domain with leucine-rich repeats and a cytoplasmic domain bearing 
similarity to the signalling domains of IL-I receptor family proteins (Akira, 2003). 
Binding of PAMPs to TLRs triggers a signalling cascade that leads to activation of 
Nuclear Factor-K13 (NF-KJ3), which translocates to the nucleus and activates the 
transcription of a large number of genes involved in immune regulation (Akira and 
Hemmi, 2003). In addition to inducing the TLR-triggered inflammatory response, 
NF-43 is required to induce the expression of co-stimulatory molecules on DCs that 
allow for complete activation of T lymphocytes (Miyake, 2004). 
Bacterial lipoproteins and peptidoglycan are recognised by TLR2 in 
conjunction with another TLR. Flagellin stimulates the inflammatory response when 
it binds to TLR5, which is located on the basolateral (but not apical) surface of the 
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intestinal epithelium (Akira, 2003). Bacterial DNA, which is exposed upon 
internalisation and degradation, contains unmethylated CpG motifs that are 
recognised by TLR9, which is found in intracellular compartments (Mazzoni and 
Segal, 2004). LPS binds to LPS binding protein (LBP) when encountered in the 
bloodstream. Subsequent to forming a complex with CDI4, MD2, and TLR4 on the 
mammalian cell surface, a potent inflammatory response is initiated. It is worth 
noting that some mammalian cells discriminate between different LPS structures, and 
this varies according to the species in question. For example, the anticancer agent 
taxol binds to TLR4 and mimics the action of LPS in mice, but not in humans. The 
reverse is true for penta-acylated LPS. Furthermore, human and mouse TLR9 
recognise different unmethylated CpG motifs. Such differences are attributed to 
differences in the structure of the TLRs that bind to these ligands (Akira, 2003). 
c. Complement 
The complement system is composed of a set of plasma proteins that react 
with one another to aid in the opsonization and lysis of invading pathogens, as well 
as to promote the inflammatory response. Many of the components are proteases that 
become activated upon cleavage. A cascade of reactions is triggered upon interaction 
of specific complement components with antigen: antibody complexes or surface 
molecules of pathogens. These initiation events lead to activation of the complement 
system via the classical pathway, mannan-binding lectin pathway, or alternative 
pathway. The classical pathway begins with the binding of Clq to antibody 
complexed with antigen, or direct binding to the pathogen surface. The mannan-
binding lectin pathway begins with the binding of mannan-binding lectin to 
mannose-containing carbohydrates on pathogens. The alternative pathway begins 
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with spontaneous hydrolysis of C3 and subsequent binding of C3b to the pathogen 
surface. All three pathways can lead to the formation of the membrane attack 
complex, which forms holes on the surface of invading pathogens and leads to cell 
lysis. Additionally, phagocytes possess complement receptors that activate the uptake 
of pathogens, thus increasing the rate of clearance. Finally, activated complement 
components, such as C5a, are potent mediators of inflammation that are released into 
the surrounding area during the chain reaction (Janeway et al., 2001). 
Salmonella infection includes a brief stage of bacteremia during which the 
organism is cleared from the bloodstream before it begins to multiply in the liver and 
spleen. The 0-polysaccharide chain of Salmonella prevents insertion of the 
membrane attack complex; for this reason, the lytic function of complement is 
thought to be not very important to combating infection by this organism (Mastroeni, 
2002). Since activated C3 binds to the terminal sugar of Salmonella LPS, 
opsonisation could play a role in its clearance. Indeed, changes in the terminal sugar 
structure that affect C3b binding also affect virulence in mice (Fierer and Guiney, 
2001). Clearance of Salmonella from the bloodstream is greatly delayed in mice 
whose complement has been depleted by pre-treatment with cobra venom. 
Furthermore, C1qa mice were found to be significantly more susceptible to 
Salmonella infection compared to C1qa mice. However, the mechanism of 
protection in this study remains elusive, since it used a Salmonella strain that was 
resistant to opsonisation and lysis by complement (Warren et al., 2002). 
d. Siclial 
The most extensively studied factor of murine innate resistance was 
originally associated with S. Typhimurium, Leishmania donovani, and 
Mycobacterium bovis BCG infection. This Ity/Lsh/Bcg locus was later shown to 
encode a macrophage protein conferring resistance to all three pathogens and re-
named Nrampl (for natural resistance associated macrophage protein). After the 
protein was characterised as a divalent cation transporter localised to the phagosomal 
membrane, its gene was re-named Sicila] (for solute carrier family 11 member al) 
(Wyllie et al., 2002). Although this protein is expressed in PMN as well as 
macrophages, earlier studies using X-irradiated mice have provided evidence that 
macrophages rather than PMN are the likely mediators of Slcl lal-associated natural 
resistance (Hormaeche, 1979; Hormaeche et al., 1990; Mastroeni and Sheppard, 
2004). This protein is not detected in early endosomal compartments, but in the late 
endosomal and lysosomal compartments (Gruenheid et al., 1997), suggesting that 
Nrampl is not involved in the process of phagocytosis, but that it is directly targeted 
to the endosomal compartment from the trans-golgi network (Blackwell et al., 2000). 
Disruption of the Nrampl gene has pleiotropic effects that eventually drive the 
polarity of the T-helper cell response (discussed in section E2b) (Soo et al., 1998). 
The mechanism by which Slcl lal confers resistance has been investigated by 
focussing on the direction of ion transport into or out of the phagosome, with 
evidence in support of transport in both directions. These observations gave rise to 
several hypotheses, among them: 1. Slcl lal transports iron into the phagosome to 
serve as a catalyst for the Fenton reaction to generate the extremely reactive hydroxyl 
radical for bactericidal activity. 2. Slcl lal salvages iron from the phagosome as part 
of an iron-recycling pathway. 3. SIcI lal transports divalent cations out of the 
phagosome to deprive bacteria of enzyme cofactors necessary for bacterial defence, 
(Gomes and Appelberg, 1998; Atkinson and Barton, 1999; Kuhn et al., 1999; Mulero 
et al., 2002). 
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With so much seemingly contradictory evidence, it would appear that 
Slcl lal function is more complex than previously thought. Studies not focussed on 
the direction of transport have revealed an indirect role for SIcilal in the increased 
expression of inducible nitric oxide synthase (NOS) and in controlling the 
maturation of the Salmonella-containing vacuole (SCV) (Fritsche et al., 2003; 
Jabado et al., 2003). Siclial thus affects macrophage function at the level of 
bactericidal activity, cytokine production, and antigen presentation (Blackwell, 
1996). Interestingly, S/dial was shown to up-regulate the expression of SPI-2 
genes. This highlights the dynamic interaction between the defence and counter-
defence mechanisms that have come into play as pathogen and host have co-evolved 
(Zaharik et al., 2002). 
2. Adaptive immunity 
a. Antigen processing and presentation 
Survival of the mammalian organism requires an immune surveillance that 
can detect the presence of molecules that have been produced by abnormal host cells 
or by pathogens. In addition to the recognition of PAMPs by TLRs, the mammalian 
immune system responds to specific antigens. 
All nucleated cells bear major histocompatibility complex (MHC) class I 
molecules on the cell surface. Phagocytic cells also bear MHC class II molecules. 
Both types of molecules bind to short peptides and present them as possible antigens 
for immune surveillance by T lymphocytes. MHC I molecules generally display 
peptides that originate in the cytosol, such as viral antigens. MHC II molecules 
generally display peptides of exogenous origin, such as bacterial antigens that have 
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been phagocytosed (Kaufmann, 1997). Additionally, the CD! family of molecules 
can display lipid antigens. Group 1 CDI molecules display both endogenous and 
exogenous lipid antigens, while group 2 molecules predominantly display 
endogenous lipid antigens (Joyce and Van Kaer, 2003). 
Cytosolic proteins and antigens are degraded in the proteasome into peptides 
that are subsequently transported to the lumen of the endoplasmic reticulum (ER) by 
the heterodimeric transporter associated with antigen processing (TAP). In the ER, 
peptides are loaded onto MCH I heterodiniers within the class I-loading complex, 
after which MHC I is transported to the cell surface (Joyce and Van Kaer, 2003). 
Presentation of exogenous antigen by MHC I is known to occur during infections 
(including Salmonella infections) by mechanisms that are not yet clearly defined 
(Pfeifer et al., 1993; Brode and Macary, 2004). 
Group 1 CDI molecules are assembled in the ER and subsequently targeted 
to the cell surface through the secretory pathway. Subsequently, they may be 
recycled between the surface and intracellular compartments multiple times to 
sample lipid antigens. Group 2 CDI molecules follow an additional pathway in 
antigen-presenting cells. Like the MHC II molecule (see below), CDI associates with 
Ii in the ER and is transported to the late endosomal/lysosomal compartment. There, 
Ii dissociates from CDI in a cathespin-dependent manner and is replaced with lipid 
antigen, after which CD  is transported to the surface (Joyce and Van Kaer, 2003). 
Exogenous antigens are degraded in the endosome/lysosome. In the ER, 
newly synthesised MHC II heterodimers associate with Ii chain, which acts as a 
chaperone to stabilise the molecule, to prevent premature peptide loading, and to 
direct the molecule to the late endosomal compartment. Ti contains a class II-
associated invariant chain peptide (CLIP) that occupies the antigen binding groove 
after the rest of Ii has been removed by a series of cathespin-catalysed proteolytic 
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cleavage events. CLIP is then replaced with exogenous peptide by the exchange 
factor DM, which is targeted independently to the late endosomal compartment. 
MHC II is then transported to the cell surface (Boss and Jensen, 2003). The phoP 
locus of Salmonella (discussed in section D4) influences the efficiency of antigen 
processing in phagocytes. Macrophages process mutants lacking this locus more 
efficiently than wild-type Salmonella. Furthermore, over-expression of PhoP-
activated genes results in poor antigenic presentation (Wick et al., 1995). Since 
Salmonella is known to influence vesicular trafficking, it is not surprising that 
antigenic processing is also affected (Hernandez et al., 2004). 
The MHC genes are the most highly polymorphic genes known; some human 
MHC I and II genes have as many as 200 alleles. These alleles each occur at a high 
frequency, such that a given individual is almost certain to be heterozygous. The 
combination of MHC alleles on a chromosome is referred to as the MHC haplotype. 
Specific MHC haplotypes have been associated with susceptibility and resistance to 
Salmonella infection in mice (Hormaeche et al., 1985). Similarly, specific MHC 
haplotypes have been associated with susceptibility and resistance to typhoid fever in 
humans (Dunstan et al., 2001 b). 
The amino acid sequence of an MHC II heterodimer in the peptide-binding 
groove affects its affinity for a given peptide antigen. Thus, MHC heterozygosity is 
expected to enhance resistance to infectious diseases by increasing the diversity of 
antigens presented to T lymphocytes. Experiments in mice have indicated that MHC 
heterozygosity generally confers a selective advantage against infection, although 
heterozygous offspring are not more resistant to a given pathogen than the resistant 
parental homozygote (Penn et al., 2002). A recent study assessed heterozygote 
superiority in the context of murine co-infection with two pathogens associated with 
opposite MHC haplotype susceptibility profiles. It was revealed that when resistance 
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associated with a given haplotype is dominant, heterozygotes are more resistant to 
co-infection than either parental homozygote (McClelland et al., 2003). This 
mechanism of resistance may help explain the highly diverse nature of MHC loci 
from an evolutionary standpoint. 
b. B lymphocytes and antibodies 
B lymphocytes, which originate in the bone marrow, produce antibodies and 
also act as antigen-presenting cells. These cells internalise antigen that binds to 
surface Ig, process it, and present it to T lymphocytes in the context of MHC II. Once 
activated, B cells can proliferate and differentiate into memory and antibody-
secreting cells (O'Rourke et al., 1997). Antibody molecules have immense potential 
diversity that is generated by rearrangements in the genes encoding the light and 
heavy chains of the antibody molecule (Weigert et al., 1980). Thus, an antibody can 
be produced to bind nearly any antigen. Cytokines trigger B cells to produce 
different isotypes of antibody, which differ in their constant region (Davies and 
Metzger, 1983). 1gM is the primary isotype produced in a primary response, whereas 
and IgG and IgA are predominant later in the response. Furthermore, specific 
isotypes are associated with TH1  versus  TH2  responses (Abbas et al., 1996; cYGarra, 
1998). Antibodies have multiple roles in host defence: activating complement via the 
classical pathway, opsonising microoganisms for enhanced uptake by phagocytes, 
binding and neutralising toxins by blocking their ability to bind receptors, and 
similarly blocking the ability of pathogens to dock onto host receptors. 
The importance of B lymphocytes to protection from Salmonella infection 
has been revealed by experiments with B cell-deficient mice. Igh-6 mice 
(Slc11a1'S) were not protected by challenge with virulent S. Typhimurium 
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subsequent to administration of an attenuated (aroA) strain that would otherwise 
generate a protective acquired immune response. Administration of immune serum 
could not compensate for the deficiency of protection, indicating that a simple lack 
of antibody production could not generate this phenotype. Furthermore, the T 
lymphocytes from these B cell-deficient mice exhibited a reduced ability to secrete 
THI cytokines compared to control mice subsequent to infection with the attenuated 
S. Typhimurium strain. Thus, B cells may play a role in the activation of T cells 
during the immune response to Salmonella (Mastroeni et al., 2000; Ugrinovic et al., 
2003). 
c. Cell-mediated (T111) and antibody-mediated (TH2) responses 
In general, T lymphocytes bearing CD4 molecules recognise MHC 11-antigen 
complexes, while those bearing CD8 molecules recognise MHC I-antigen 
complexes. Depending on the biochemical signal that is triggered in the T cell, CD4 
and CD8 T lymphocytes can produce various cytokines. These cytokines can induce 
or repress the production of other cytokines, as well as induce or repress the activity 
of other immune cells. This affects the overall immune response. Cytokine-
producing CD4 cells are known as T-helper (TH) cells. CD8 cells are primarily 
responsible for inducing programmed cell death in "altered-self' cells (such as virally 
infected cells) and these cells are known as cytotoxic T cells (Kaufmann, 1997). 
According to which cytokines are produced by the T-helper cells, the 
outcome can be a TH1  or  TH2  response. The TH2  response mainly results in antibody 
production by B cells, whereas the TH1  response results in activation of phagocytes 
and cytotoxic T cells (Kaufmann, 1997). In general, antibodies are effective against 
extracellular pathogens, while cell-mediated immunity is effective against 
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intracellular pathogens. Additionally, cytokines that promote a TH1  response inhibit 
the TH2  response, and vice versa (Abbas et al., 1996). 
After clearing a Salmonella infection, humoral immunity sufficiently protects 
Slc]1a1 mice, but not Slcllal"s mice, against subsequent challenge (Eisenstein et 
al., 1984). In Slc11a1 mice, cell-mediated immunity (CMI) is thought to be more 
important than humoral immunity with respect to limiting systemic infections by S. 
Typhimuriurn. Cytokines characteristic of a TH1  response are produced in genetically 
susceptible mice infected with S. Typhimurium, and it has been shown that the 
presence or lack of these cytokines determines how well these mice can combat the 
infection (Nauciel and Espinasse-Maes, 1992; Mastroeni et al., 1996). This 
observation is in agreement with the fact that a THI  response results in activation of 
macrophages, which reduces intracellular survival of bacteria, and so, is particularly 
important for combating such infections (Moulder, 1985; Finlay and Falkow, 1989; 
Kaufmann, 1993). Furthermore, artificial induction of a TH2 response has been 
shown to lead to poorer clearance of S. Typhimurium in Sic] 1a1&  mice (Denich et 
al., 1993). Interestingly, although Salmonella do not enter the cytosol of the cells 
they inhabit, cytotoxic T cells play a major role in combating S. typhimurium 
infection in mice (Lo et al., 1999). 
Although CMI has been shown to be the major effector of immunity to S. 
Typhimurium in Slc]]a]'s  mice, a study in murine passive immunity showed that 
both T cells and antibodies are required for resistance to infection (Mastroeni et al., 
1993). One study, which found that antibody is required for protection against 
virulent but not attenuated S. Typhimurium, suggested that antibodies delay the rapid 
accumulation of virulent bacteria before activation of the TH1  response (McSorley 
and Jenkins, 2000). It is important to note that the mutation in Slc]lal that renders 
mice genetically susceptible to Salmonella infection has not been found in humans 
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and may be an artefact of mouse inbreeding. Although some alleles of the human 
Sicilal homologue have been associated with development of an immune response 
to mycobacteria, no association with typhoid fever has been established (Alcais et 
al., 2000; Dunstan et al., 2001a). 
F. Vaccination 
1. Overview 
Now more than ever before, humans travel more frequently and to 
geographically more diverse and remote areas of the world. In addition, individuals 
visit more places in a shorter time than ever before. These factors favour the spread 
of infectious diseases (Wilson, 1995). Furthermore, the increase in frequency and 
spectrum of antibiotic resistance among bacteria places extra emphasis on 
prophylactic measures for control of infectious diseases (Graham, 2002). 
In addition to the composition of the vaccine, the degree and type of 
protection induced by vaccination varies according to route of administration and 
dosage. The route by which an individual is immunised affects which phagocytes 
will encounter and display the antigen, and ultimately affects the nature of the 
immune response (Thatte et al., 1995). For Salmonella, mucosal administration 
would be most favourable because it is the natural route by which infection occurs 
(Holmgren et al., 1992). Additionally, low doses of antigen generally induce a T111 
response, whereas high doses induce a TH2  response (Abbas et al., 1996). 
Some vaccines are used in conjunction with adjuvants, whose function is to 
enhance and/or bias the immune response. Adjuvants are especially important for 
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administration of subunit vaccines, since purified antigens are often poorly 
immunogenic (Greenwood et al., 1991). Currently, the only adjuvants approved for 
use in humans are aluminium compounds, none of which induce CMI (O'Hagan, 
1998). This is partially attributed to the fact that some CMI-inducing adjuvants 
traditionally used in animals, such as Freund's adjuvant, cause unacceptable side 
effects (Leenaars et al., 1998). Consequently, candidates for new adjuvants are being 
tested for CMI efficacy and side effects. These include lipids such as dimethyl 
dioctadecyl ammonium bromide (DDA) (Lindblad et al., 1997) and monophosphoryl 
lipid A (Baldridge et al., 2000), as well as the element beryllium, which is known to 
induce autoimmune THI  responses (Lee et al., 2000). Particulate forms, such as 
liposomes and microparticles, also have promising features as adjuvants. This is not 
surprising, since the immune system has evolved to respond to particulate matter, 
such as bacteria and viruses. Microparticles can be administered mucosally and can 
release antigen over an extended period of time, which abrogates the need for 
multiple doses. This feature could improve vaccination rates in underdeveloped 
countries (O'Hagan, 1998). 
2. Typhoid fever vaccines 
The first vaccines developed against typhoid fever were based on whole S. 
Typhi cells inactivated by heat, acetone, or phenol, but these vaccines caused malaise 
and fever in many cases (Ivanoff et al., 1994). The moderate protection these 
vaccines offered lasted for a relatively short period of time (Collins, 1974; Ivanoffet 
al., 1994). 
The first live attenuated S. Typhi vaccine was a Ty2 I a galE mutant generated 
by nitrosoguanidine mutagenesis (Germanier and Furer, 1971). This type of DNA 
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disruption undoubtedly caused multiple mutations in Ty2la, and it was later found 
that the attenuating factor was not due to its galE mutation, but possibly to its rpoS 
mutation (Hone et al., 1988; Robbe-Saule et al., 1995). Subsequently, it was 
discovered that the same rpoS mutation is present in the parent strain, Ty2 (Robbe-
Saule and Norel, 1999). Currently, the Ty2la mutant is the most widely used S. 
Typhi vaccine, It offers protection for up to 7 years in 60% of subjects and causes 
very little adverse reaction (Ivanoffet al., 1994). However, it requires multiple doses 
and is ineffective in some cases (Plotkin and Bouveret-Le Cam, 1995). 
Another attenuated S. Typhi vaccine (CVD908) was subsequently constructed 
by defined aroC and aroD deletions in the same parent strain Ty2. These deletions 
render the strain auxotrophic for aromatic amino acids, which are not present in 
human tissues at sufficient levels for infection. CVD908 is 100 times more 
immunogenic than Ty2la, and it can provide good protection with just one dose. 
However, it caused silent, self-limited vaccinemias when taken in the highest doses 
(Tacket et al., 1992a; Tacket et al., 1992b). A further deletion in a stress shock 
protein produced CVD908-htrA. This strain generates similar levels of protection and 
limited side effects, without causing vaccinemia (Tacket et al., 1997b; Tacket et al., 
2000). Further trials of CVD908-htrA in children in typhoid endemic areas are 
currently underway. Other promising attenuated Ty2 derivatives are Ty800 and 
x4073. Ty800 is disrupted at phoP/phoQ (described in section 133), while x4073 
harbours deletions in cya (adenylate cyclase), crp (global regulator), and cdt 
(involved in systemic dissemination). Both were immunogenic and well tolerated in 
volunteers after a single dose, but Ty800 was more immunogenic than X4073 
(Hohmann etal., 1996; Tacket etal., 1997a). 
Attenuated bacteria are able to express in viva induced antigens and persist in 
the host long enough to induce CMI. Thus, most research into new typhoid fever 
vaccines has concentrated on live attenuated strains. However, live bacteria may be 
unsuitable for young children, immunocompromised individuals, or patients taking 
antibiotics. Furthermore, Ty2la is less immunogenic when administered 
simultaneously with anti-malarial drugs (Plotkin and Bouveret-Le Cam, 1995; 
Garmory etal., 2002; Parry etal., 2002). 
The currently used S. Typhi Vi polysaccharide vaccine is effective with only 
a single dose, can be administered to children as young as 2 years old, and has mild 
and infrequent side effects (Plotkin and Bouveret-Le Cam, 1995). This vaccine elicits 
protection that is mediated by high levels of serum Vi antibody (Robbins and 
Robbins, 1984; Hessel et at., 1999). Since this vaccine relies solely on humoral 
immunity and is effective for most people, it is apparent that the majority of the 
population bears more similarity to genetically resistant (Slc11a1r'r)  mice than to the 
susceptible (Sic] ]a1S)  mice. Indeed, although most research has been performed in 
susceptible mice, some investigators argue that resistant mice might be more 
appropriate (Eisenstein and Sultzer, 1983). Furthermore, the fact that polysaccharide 
is a T lymphocyte independent antigen (Weintraub, 2003) suggests that a typhoid 
fever vaccine need not elicit a TH1  response to confer protection. However, chronic 
carriers of S. Typhi display high levels of serum Vi antibody, whereas only a fraction 
of acute patients show elevated levels of this antibody (Lanata et at., 1983). This 
underscores a need to understand the correlates of protection by the human immune 
system against typoid fever infection. Nevertheless, the current satisfactory 
protection elicited by the Vi polysaccharide subunit vaccine may not endure in the 
face of S. Typhi evolution. The genetic instability of the chromosomal region that 
produces this antigen (Bueno et at., 2004; Nair et at., 2004) highlights the need for 
identifying additional protective antigens in the next generation of vaccines. 
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3. Candidate antigens for subunit vaccines 
Although the whole-cell killed S. Typhi vaccine causes unacceptable side 
effects, it provides a level of protection that is higher than either the live attenuated 
or Vi subunit vaccine (Engels et al., 1998). Thus, a mixture of antigens can provide 
good protection. The ideal typhoid fever vaccine should contain a variety of antigens 
and should stimulate CMI as well as humoral immunity for a genetically diverse 
human population. Choosing specific antigens that elicit protection with minimal 
side effects, and subsequently combining them with an adjuvant that induces a THI 
as well as TH2  response is a strategy that has been tested for another gastrointestinal 
pathogen, Helicobacterpylori (Sanchez et al., 2001). 
Since most of the emphasis on new Salmonella vaccine development has 
been on live attenuated strains, relatively few antigens have been investigated for use 
in subunit vaccines. Known antigens in the mouse model include LPS, flagellin, 
fimbriae, porins, outer membrane proteins, heat shock proteins, stress-induced 
catalase, and AhpC (Kagaya et al., 1992; Taylor et al., 1998; Mastroeni et al., 2001). 
However, only low-level protection could be induced by immunisation with fractions 
containing porins, flagella, or polysachharide fraction of LPS (Mastroeni et al., 
2001). The main challenge, therefore, is the identification of protective antigens. 
A recent study has suggested that proteins with increased in vivo expression 
are ideal candidates for multiple subunit vaccination (Rollenhagen et al., 2004). This 
is based on the idea that T cells respond to antigens in a dose-dependent manner. 
Several candidate antigens were identified by quantifying in vivo GFP expression 
from single-copy transcriptional fusions to Salmonella chromosomal promoters. 
Subsequent immunisation of mice with two antigens in Freund's complete and 
incomplete adjuvant in the first and second injection, respectively, resulted in a level 
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of protection comparable to a killed whole cell vaccine. The two protective antigens 
were Mig-14 and SseB, a putative transcription factor and a SPI-2 secreted protein, 
respectively (Rollenhagen et al., 2004). The cytocolic localisation implied by the 
putative function of Mig- 14 suggests that protective antigens need not be surface-
exposed components. This is consistent with an earlier study indicating that most 
antigenic Salmonella proteins are located in the cytosolic fraction (Brown and 
Hormaeche, 1989). 
4. Strategies for antigen selection 
The first vaccine generated through the use of modern recombinant DNA 
technology was the hepatitis B vaccine, containing highly purified capsid protein. 
Since the advent of genomic technology, several new approaches have provided 
tremendous insight into microbial pathogenesis and have revolutionised vaccine 
design. These include genome sequencing, signature-tagged mutagenesis (STM), 
proteomics, DNA microarrays, in silico analysis, and in vivo expression technology 
(IVET). These have led to the identification of candidate antigens for subunit 
vaccines against Neisseria meningitidis group B, Streptococcus pneumoniae, 
Porphyromonas gingivalis, Chlamydia pneumoniae, and Staphylococcus aureus 
(Adu-Bobie et al., 2003). 
While conventional vaccinology relied on the identification of the most 
abundant antigens during the course of infection, new approaches have enabled the 
identification of all immunogenic antigens. This is significant because the most 
abundant proteins are often not suitable vaccine candidates (Adu-Bobie et al., 2003). 
Another method of identifying antigens is through the use of phage display. As 
discussed in the following sections, phage display can be a powerful tool for this 
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purpose. Significantly, it allows the selection of any antigen, including those that are 
only produced during the course of infection. No studies have been published 
assessing the use of phage display for novel Salmonella antigen identification. The 
many successful applications of phage display for antigen identification justify 
further investigation in the context of Salmonella vaccine development. 
G. Phage display 
1. Overview 
Phage display is a simple and powerful tool for identification and 
optimisation of ligands that bind to molecules such as antibodies, proteins, 
carbohydrates, plastic polymer, or nucleic acids (Messmer et al., 2000). Essentially, 
phage are engineered to express foreign peptides or proteins as integral parts of the 
capsid. To achieve this, foreign DNA is cloned into the phage gene that encodes the 
capsid protein. The displayed peptide or protein provides a means for selection, 
while the DNA that encodes it provides the means for further analysis. The fact that 
both the gene and its translation product are physically linked in a unit that can 
propagate itself makes this a powerful tool for identification and characterisation of 
ligands (Wilson and Finlay, 1998). The useful properties of phage display 
continually lead to new applications, such as directed evolution of proteins, targeted 
gene delivery to mammalian cells and in-vivo screening of peptide libraries (Rajotte 
et al., 1998; Wilson and Finlay, 1998; Poul and Marks, 1999). 
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2. Biopanning 
Biopanning is a form of artificial evolution that is used for identifying protein 
ligands. It is achieved by successive rounds of affinity selection from a phage 
population followed by propagation. Like chromatography, a substrate of choice is 
used as the solid phase, while a suspension containing a phage library constitutes the 
mobile, liquid phase. After allowing constituents of the liquid phase to bind 
according to affinity, the solid support is washed to remove residual unbound 
particles. Finally, elution of the bound particles results in an enriched population of 
phage that are subsequently propagated to form a new population for the next round 
of affinity selection. 
Many variables affect the successful panning of phage libraries against 
antibodies. The antibody titre and the copy number of peptide or protein being 
displayed by individual phage should be properly balanced. In addition, using phage 
with a lower display copy number would more likely result in binding due to affinity 
rather than avidity (Wilson and Finlay, 1998). Additionally, it is important to use a 
method that minimises non-specific or undesirable binding during biopanning. For 
example, sequences rich in tyrosine and tryptophan have a tendency to bind to 
plastic. Furthermore, an approach must be used that minimises the tendency for non-
recombinant phage to out-compete recombinant clones during enrichment (Wilson 
and Finlay, 1998). 
Affinity selection enriches for ligands that bind with high specificity, but it 
does not eliminate all non-specific ligands (Christian et al., 1992). For this reason, 
biopanning is normally followed by other tests that confirm the binding specificity of 
an isolated phage clone. These are often various forms of enzyme-linked 
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immunosorbent assay (ELISA) and/or plaque lifts. After these tests, the clone can be 
sequenced to reveal the identity of the ligand. 
There are several methods for biopanning. Depending on the circumstances, 
one or more rounds of selection may be used. Typically, Fc-biotinylated antibodies 
are bound to a streptavidin-coated solid support, which is subsequently incubated 
with phage in solution. Most often, the solid supports used during biopanning are 
magnetic beads or polystyrene plates (Folgori et al., 1994; Germaschewski and 
Murray, 1996). One group first mixed the phage with biotinylated antibody, then 
captured the antibody-bound phage by incubating the mixture in streptavidin-coated 
petri dishes (Fack et al., 1997). Christian et al. (1992) used magnetic beads in the 
first round of biopanning, and polystyrene plates in the second round. Another study 
assessed the merits of using magnetic beads versus polystyrene plates (McConnell et 
al., 1999). It concluded that panning with antibody-coated magnetic beads captured a 
higher proportion of phage that bound specifically to the antibodies. It also 
emphasised the importance of capturing the target phage during the first round of 
panning. 
Using polyclonal sera in biopanning adds another level of complexity, since 
the concentration and repertoire of antibodies are not defined. Additionally, high 
levels of reactivity with related bacterial proteins of the phage host can complicate 
detection of phage fusion proteins (Folgori et al., 1994). Furthermore, polyclonal 
sera often contains antibodies that cross-react with multiple ligands, especially those 
rich in proline (Tchernychev etal., 1997). 
When trying to isolate disease-specific epitopes, it may become necessary to 
use sera from healthy individuals as a negative control, or as a means of negative 
selection (Germaschewski and Murray, 1996; Sioud et al., 1996). Folgori et al. 
(1994) found that repeated attempts at negative selection did not significantly deplete 
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their library of unwanted ligands, so they used the sera from healthy individuals to 
screen selected phage in plaque lifts and in ELISA tests before sequencing. They also 
panned with healthy sera in parallel and compared the number of phage recovered. 
Panning and enrichment usually results in one clone dominating the final pool 
of phage. Messmer et al. (2000) devised a method called iterative panning and 
blocking (IPAB) by which the same original library can be panned repeatedly against 
the same polyclonal antisera to obtain multiple positive clones. Once a clone has 
been identified, a blocking ligand is constructed, based on the characteristics of that 
clone. Next, the original library can be panned again in the presence of the blocking 
ligand so that the clone with the next highest binding affinity can be isolated, and so 
on. This is important because an antigen that is recognised by sera may not elicit a 
protective immune response (Wood and Gallagher, 2000, unpublished results). 
3. Random peptide libraries and gene fragment libraries 
To identify ligands that bind to antibodies, two types of recombinant phage 
libraries can be used. These are libraries displaying random, synthetically designed 
peptides, and gene-fragment libraries. There are several benefits of using random 
sequences of short peptides. Firstly, continuous epitopes are often six amino acids in 
length (Fack et al., 1997), so libraries consisting of short peptides should be 
sufficient to identify this type of epitope. Secondly, the diversity of all possible 
sequences is better represented in a library of shorter peptides, making it a more 
complete library. This is important, since there is a practical limit to the number of 
independent clones which can be generated to make a single library (Wilson and 
Finlay, 1998). 
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Perhaps the most interesting feature of synthetically designed peptide 
libraries is in the ability of the peptides to mimic other types of molecules, such as 
carbohydrates. One study successfully induced anti-carbohydrate antibodies using 
phage-displayed peptide mimics (Phalipon et al., 1997). However, displayed peptides 
that mimic an antigen do not always elicit antibodies against the original antigen. For 
example, another study panned a random peptide library against a protective 
monoclonal antibody, originally selected from BALBIc mice, that recognised an 
undefined, discontinuous, conformational epitope of Bordetella pertussis toxin 
(Felici et al., 1993). After biopanning, binding specificity was confirmed by 
competition experiments with the original antigen. Three different clones of high-
copy recombinant phage displaying the epitope-mimicking peptides were chosen for 
immunisation of BALB/c mice. However, the mice were not immunised with 
peptides. A specific response against the displayed peptides was observed for one of 
the phage clones, but none of the recombinant phage elicited a detectable production 
of antibody against the original antigen. 
If the aim of biopanning is to select phage for the purpose of developing a 
vaccine against an infectious disease, a library containing gene fragments of the 
causative agent may be more appropriate, since it will have the capacity to display 
the original epitopes rather than epitope mimics (Pack et al., 1997). If larger 
fragments are used in a gene fragment library, it is also possible to generate the 
conformational and discontinuous epitopes recognised originally by the antibodies. 
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4. Filamentous phage 
Most work on phage display has been done using filamentous phage, as it 
was the archetype. Later, systems using lambda, T4, and T7 bacteriophages were 
developed (Rosenberg et al., 1997; Wilson and Finlay, 1998). A drawback of using 
filamentous phage is that the proteins or peptides being displayed must be 
compatible with the coupled assembly/export process. Furthermore, a requirement 
for the host to stay alive precludes the production of filamentous phage displaying 
products that are toxic to the cell. The lambda, T4, and T7 phage have the advantage 
of lytic propagation, but these phage display systems are not as well-developed as 
that of filamentous phage (Wilson and Finlay, 1998). A greater wealth of literature 
and collective experience may improve the likelihood of success in a biopanning 
experiment, whose outcome is clearly affected by many different parameters. 
The filamentous phages are a large group of viruses that infect Gram-negative 
bacteria. The majority of phage display studies have used the Ff group, which 
includes the nearly identical M13, fd, and fl strains. Filamentous phages infect E. 
coli through the F pilus and are secreted continuously, without killing the host. The 
single-stranded circular genome of approximately 6400 nucleotides is converted by 
host enzymes to a double-stranded form upon entry into the cell. Phage genes then 
can be transcribed and translated, and new copies of the genome are produced by 
rolling-circle replication. The genome encodes 11 proteins, five of which are 
structural, three of which are required for DNA replication, and three of which are 
responsible for directing the assembly and export of new particles. The signals for 
initiation of DNA replication, termination of RNA synthesis, and packaging are 
located in a non-coding intergenic region (Russel, 1995; Russel et al., 1997). 
The major coat protein, pVIII, encloses the particle with about 2700 
molecules of about 50 amino acids each (Figure 1.1). Each of the minor coat proteins 
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is present at about five copies or less. Proteins pVII and pIX are located at the tip that 
is extruded first from the host cell, while pIll and pVI are located on the end that 
attaches to the F pilus. The particle is a tubular structure of approximately 10 x 900 
nm whose variable length gives it the flexibility to accommodate a variety 
recombinant polypeptides (Russel, 1995; Russel et al., 1997). 
SSUNA 
Q pVll 	 Z=:: pVlll 	 4W pVl 
pIX 	 - pill 
Figure I.I. Schematic representation of a filamentous phage particle 
Although all five structural proteins have been used in phage display, the 
proteins most commonly used are pill and pVIII. in both cases, the protein is 
synthesised with an N-terminal signal peptide that directs it to the periplasm, where it 
is cleaved before assembly into the new phage particle. Therefore, the introduced 
polypeptide must be compatible with the assembly and secretion process if it is to be 
incorporated into the phage particle. The amino terminal residue of both pill and 
pVllI are exposed on the phage surface, while their carboxy termini are directed 
inward. Thus, fusion of foreign DNA to the beginning of the gene results in 
displayed polypeptide. In addition, the larger size of pill allows for the display of 
fusions in the middle region. The smaller pVIIl cannot accommodate middle-region 
fusions. Using pVIII for phage display allows a larger number of recombinant 
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molecules to be displayed on the surface, increasing the likelihood that binding will 
occur during biopanning. On the other hand, the low copy number associated with 
pill phage display enables discrimination between weak and strong binding affinities 
in biopanning (Smith and Petrenko, 1997). 
Several different systems can be used for pill and pVIII phage display. Very 
short peptides, fused to all pill or pVIII molecules, can be accommodated by the 
phage particle (Figure 1.2A). Longer peptide- and polypeptide-fusions can be 
displayed on the phage surface without compromising stability if the respective wild-
type protein molecules are also incorporated into the phage particle to achieve a 
mosaic. This can be accomplished by supplementing a copy of the wild-type gene on 
the phage genome (Figure 1.2B). Alternatively, mosaic particles can be produced 
also by using phagemids in combination with helper phage (Figure 1.3) (Smith and 
Petrenko, 1997). 
Phagemids are plasmids that contain the non-coding region of the phage 
genome as well as the plasmid origin of replication. They can contain a selection 
marker, such as antibiotic resistance, and a hybrid gene encoding the desired 
polypeptide-coat protein fusion. Helper phage contain all genes necessary for the 
infection cycle, typically with mutations that suppress the packaging of helper phage 
DNA into particles so as to favour packaging of the phagemid instead. When in the 
host, phagemids can be grown as plasmids. When a helper phage infects this host 
cell, the phagemid is converted to single-stranded form and is incorporated into a 
proportion of phage particles. All particles are mosaics on the surface, containing 
either helper phage ssDNA or phagemid ssDNA (Bass et al., 1990; Smith and 
Petrenko, 1997). 
Typically one or two copies of pill fusion protein are displayed in the mosaic 
system, while the number of pVIII fusion proteins on the surface varies greatly. The 
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proportion of fusion protein molecules incorporated into the particle depends on the 
size of the insert and the ability of the signal peptidase to process the fusion protein 





Figure 1.2. Filamentous phage display systems using pVIlI and pill. (A) When foreign DNA is 
fused to the only copy of the relevant gene, all copies of the resulting protein are identical. (B) When a 





phagemid 	[ C) 
1' 
Figure 1.3. Schematic representation of progeny resulting from infection of a phagemid-
carrying host by helper phage. All particles are mosaics on the surface, containing either helper 
phage ssDNA or phagemid ssDNA. 
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5. Phagernid pG8SAET 
A variety of phagemid vectors have been developed and tested by a group 
studying interactions of Staphylococcus aureus proteins with host components 
(Jacobsson and Frykberg, 2001). Initially, a pIll-based vector was tested by panning 
a library displaying random fragments of S. aureus proteins against IgG and 
fibronectin. Sequencing the insert DNA from individual clones after selection and 
enrichment revealed fusions of S. aureus genes encoding known IgG- and 
fibronectin-binding proteins. All were in the correct orientation but in the wrong 
reading frame. Confrimation that particles bearing these sequences were able to bind 
specifically to the target led to the conclusion that ribosomal slippage had corrected 
the reading frame, thus allowing expression of the protein fragment. This led to the 
hypothesis that phage having correct fusions were somehow less favoured in the 
selection process, and that ribosomal slippage could be a mechanism of down-
regulating the expression of fusion protein. Since multiple rounds of biopanning 
could not increase the proportion of IgG- and fibronectin-binding clones to more 
than 40% of the phage population, it was concluded that the level of display may be 
too low for selection by biopanning. Using a pVffl-based vector, a higher proportion 
of clones encoding IgG- and fibronectin-binding fragments was obtained. Once 
again, however, clones with inserts in the wrong reading frame out-competed those 
with correct fusions (Jacobsson and Frykberg, 2001). 
Another group experienced similar problems when biopanning with a library 
displaying peptides of 40 amino acids in length. Isolation of clones with stop codons 
and/or frameshifts in the display sequence occurred after panning against some 
ligands, but not others (Carcamo et al., 1998). Jacobsson and Frykberg thus 
concluded that decreased expression levels may be advantageous to the display of 
some polypeptides. To reduce the reliance of the phage on ribosomal slippage as a 
means of lowering display levels, the promoter and signal sequence (believed to 
promote slippage) were replaced, and amber stop codons were introduced 
downstream of the insert. In the host strain TG1, a proportion of amber stop codons 
are translated as tryptophan. Thus, 0-3 amber stop codons were added downstream of 
the insert site in the two vectors containing the old and the new promoter and signal 
sequence. A stoichiometric mixture of an S. aureus library made in each of the 8 
vectors was panned against lgG. Three out of four clones isolated subsequently were 
in pG8SPAI, which was the vector containing one stop codon and the new promoter 
and signal sequence (Jacobsson and Frykberg, 2001). 
The phagemid vector pG8SAET is a derivative of pG8SPAI, with an added 
sequence encoding an E-tag downstream of the insert. This tag allows screening, 
using a commercially available antibody, for the expression of fusions in the correct 
reading frame. Since biopanning with this vector against some ligands resulted in 
nearly 100% correct clones, the tendency for ribosornal slippage was apparently 
reduced (Jacobsson and Frykberg, 2001). Thus, the phagemid pG8SAET was 
selected for use in this study. 
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AIMS OF THE PROJECT 
Phage display has been used successfully in the identification of antigenic 
components of Toxoplasma gondii, Brugia malayi, Plasmodium faiciparum, and a 
host of other bacterial and viral pathogens (Theisen et al., 2000; Robben et al., 2002; 
Gnanasekar et al., 2004). Several Salmonella antigens have been identified 
empirically and through screening processes (Brown and Hormaeche, 1989; Huang 
et al., 2004; Rollenhagen et al., 2004). Only in one recent case has good protection 
against Salmonella infection in the mouse model been demonstrated as a result of the 
administration of antigenic Salmonella subunits (Rollenhagen et al., 2004). This 
study emphasized the importance of antigen selection based on in vivo expressed 
levels. However, only two protective antigens were identified in this study. A larger 
number of protective antigens may need to be used for the formulation of a vaccine 
suitable for a genetically heterogeneous population. No studies employing phage 
display for the identification of Salmonella antigens have been published yet. Phage 
display is advantageous over other methods of antigen discovery because it is 
inexpensive and allows the identification of antigens whose expression is restricted 
to the host environment. The main aim of this project was to identify novel 
Salmonella antigens, using phage display technology, for use in a multiple subunit 
vaccine. Secondary aims were to identify improved strategies for antigen selection. 
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CHAPTER 2 
Materials and Methods 
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A. Materials 
1. Growth media and solutions 
. LB: 1% Difco bacto-tryptone, 0.5% Difco yeast extract, 1% NaCl 
. LB agar: LB with 1.5% agar 
. 	ffl: LB agar with 50 ig/ml kanarnycin 
. 	LBA50: LB agar with 50 g/ml ampicillin 
. 	LBAIOO: LB agar with 100 tg/rnl ampicillin 
Top agar: 1% Difco bacto-tryptone, 0.5% Difco yeast extract, 0.5% NaCl, 0.7% 
agar 
. 	Anion Exchange Buffer 1: 20 mM Tris-Cl (pH 8.0); filter sterilised, de-gassed, 
and stored at 4°C 
. 	Anion Exchange Buffer 2: same as Anion Exchange Buffer 1, with 1 M NaCl 
. 	Cation Exchange Buffer 1: 50 mM Na2HPO4 and 50 mM NaH2PO4 combined to 
pH 7.0; filter-sterilised, de-gassed, and stored at 4°C 
. 	Cation Exchange Buffer 2: same as Cation Exchange Buffer 1, with 1 M NaCl 
Coating Buffer 1: 17.5 mMNaHCO3, 7.5 mMNaCO, 0.01% NaN3 (pH 9.5) 
Coating Buffer 2: 50 mM NaHCO3 combined with 50 mM Na2CO3 to pH 9.7 
Coomassie Destain: 5% methanol, 7% acetic acid 
. 	Coomassie Stain: 45% methanol, 10% acetic acid, 0.1% Coomassie Brilliant 
Blue  
Denaturing Lysis Buffer: 0.1 M NaH2PO4, 10 mM Tris-CI, 8 M Urea (pH 8.0) 
Denaturing Wash Buffer: same as Denaturing Lysis Buffer, with pH 6.3 
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. Dilution Buffer: 0.25% skimmed milk in PBS-T 
6x DNA Loading Buffer: 25% sucrose, 0.25% bromophenol blue 
5 mM dNTPs: 5 mM dATP, 5 mM dCTP, 5 mM dGTP, 5 mM d'flTP 
. Elution Buffer 1: 50 mM sodium citrate, 150 mM NaCl (pH 2.0) 
. 	Elution Buffer 2: 20 mM Tris-Cl (pH 8.0), 0.3 M NaCl, 10% glycerol, 0.1-0.25 
M imidazole, 0.5 mM AEBSF, 5 g/ml leupeptin, 5 jig/ml pepstatin 
2>< LDS Sample Buffer: 0.5 M Tris-CI (pH 8.5), 20% glycerol, 1 mM EDTA, 
4% LDS, 0.04% Serva Blue G 
. 	Lysis Buffer: 20 mM Tris-CI (pH 8.0), 0.3 M NaCI, 10% glycerol, 0.1% NP-40, 
1 mM imidazole, 0.5 mM AEBSF, 5 jig/ml leupeptin, 5 pg/ml pepstatin 
. 	Lysozyme Solution 1: 10 mg/ml chicken egg white lysozyme in 0.25 M Tris-CI 
(pH 8.0) 
. MES Buffer: 50 mM MES, 50 mM Tris, 1 mM EDTA, 0.1 % SDS (pH 7.3) 
. MOPS Buffer: 50 mM MOPS, 50 mM Tris, 1 mM EDTA, 0.1 % SDS (pH 7.7) 
NBT Developing Solution: freshly prepared by combining I ml of 0.1% nitroblue 
tetrazolium in 10 mM Tris-CI (pH 8.8) with 40jJ I M M902, 100 j.tl of 5 mg/ml 
BCIP in dimethyl formamide, and 9 ml of 0.5 M Tris-CI (pH 8.8) 
. NuPAGE Transfer Buffer: 25 mM bicine, 25 mM Bis-tris (free base), 1 mM 
EDTA, 20% v/v methanol 
OPD Developing Solution: freshly prepared to a final concentration of 24mM 
citric acid, 50mM Na2HPO4, 0.012% H202, and 0.4 mg/ml 0-Phenylenediamine 
. 	PBS: 0.15 M NaCI, 16.3 mM Na2HPO4, 1.9 mM NaH2PO4 (pH 7.0) 
. 	PBS-T: PBS with 0.05% Tween 20 
. Refolding Buffer: 0.1 M KC1, 20% gylcerol, 20 mM Hepes (pH 7.9) 
Resolving Gel Buffer: 0.75 M Tris-CI (pH 8.9), 0.4% SDS 
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Running Buffer 1: 1% SDS, 25 mM Tris, 0.25 M glycine (pH 7.5) 
Running Buffer 2:50 mM Tris, 50 mM Tricine, 0.1 % SDS (pH 8.24) 
Running Buffer 3:50 mM MOPS, 50 mM Tris, 1 mM EDTA, 0.1 % SDS 
(pH 7.7) 
SDS Sample Buffer: 80 mM Tris-CI (pH 6.8),2% SDS, 0.1 M DTT, 10% 
glycerol, 0.002% Brornophenol Blue 
Stacking Gel Buffer: 0.25 M Tris-CI (pH 6.7), 0.4% SDS 
. STEP solution: 0.5 % SDS, 50 mM Tris-HC1, pH 7.5, 0.4 M EDTA, 1 mg/ml 
Proteinase K 
. 	0.5x TBE: 5 mM Tris, 44.5 mM boric acid, 1 mM EDTA (pH 8.3) 
TBSI: 0.15 MNaC1, 10mM Tris-Cl (pH 7.4) 
. TBS1-T:TBS1 with 0.05%Tween 20 
. 	TBS2-T: 0.15 M NaC1, 10 mM Tris-CI (pH 8.8) with 0.05% Tween 20 
TE: 10 mM Tris-CI, 1 mM EDTA (pH 8.0) 
TFBI: 30 mM KC2H302, 0.1 M RbCI, 10 mM CaCl2, 50 mM MnC12, 15% 
glycerol (adjusted to pH 5.8 with acetic acid) 
TFB2: 10 mM PIPES, 75 mM CaCl2, 10 mM RbCl, 15% glycerol (adjusted to 
pH 6.5 with KOH) 
. 	Transfer Buffer: 25 mM Tris, 0.15 M glycine (pH 8.3), 0.0375% SDS, 20% 
methanol 
. 	Tris Acetate Buffer: 50 mM Tris, 50 mM Tricine, 0.1 % SDS (pH 8.24) 
. Tris Buffer 1: 50 mM Tris-CI (pH 8.0), 50mM EDTA 
. 	Tris Buffer 2: 50 mM Tris-Cl (pH 7.5), 1 mM EDTA, and 200 jg/ml RNase A 
. Tris Buffer 3: 50 mM Tris-Cl (pH 7.5), 1 mM EDTA 
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Tris-eguilitrated phenol: Phenol having been extracted once with an equal 
volume of 0.5 M Tris-Cl, pH 8.0, followed by several additional extractions with 
an equal volume of 0.1 M Tris-Cl, pH 8.0, until the phenol pH>7.8 
. 	Wash Buffer: 20 mM Tris-Ci (pH 8.0), 0.3 M NaCI, 10% glycerol, 20 mM 
imidazole, 0.5 mM 4-(2-aminoethyl)benzenesulfonyl chloride HC1, 5 jxg/ml 
leupeptin, 5 g/ml pepstatin 
AEBSF and IPTG were purchased from Melford. Unless otherwise stated, all 
reagents were purchased from Sigma. 
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2. Protein and DNA molecular weight standards 
Protein Standard Approximate 
Molecular Weight (Da) 
albumin (bovine) 66,000 




carbonic anhydrase 29,000 
trysinogen 24,000 
trypsin inhibitor 20,100 
ct-lactalbumin 14,200 
Table 2.1a Protein molecular weight standards for SDS-PAGE (MW-SDS-70L, Sigma) 
Standards were prepared and combined according to manufacturer's instructions 
Protein Standard Approximate 
Molecular Weight (Da) 




insulin chain B, oxidised 3,496 
bradykinin 1,060 
Table 2.1b Molecular weight marker for SDS-PAGE, ultra low-range (M 3546, Sigma). 
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Figure 2.1. DNA molecular weight markers used in this thesis. Cohesive ends of the 12 nt cos site 
of bacteriophage lambda from fragments 21226 bp and 3530 bp (indicated*)  may anneal and form an 
additional band at 24756 bp. These fragments can be separated by heating at 65°C for 5min and then 
cooling on ice for 3mm. 
2. Bacterial strains, plasmids, and primers 
Bacterial Strain Genotype Source/Reference 
E. coli BL2 I (DE3) hsdS gal (Xc1ts857 iridl Sam7 Studier et al. (1990) 
nin5_lacUV5-T7_genel)  
E. coli TG I supE hsd A5 thi A(lac-proAB) L. Frykberg and K. 
F'(traD36proAB lacF lacZ Jacobsson 
AMI5)  
E. coli TOP 10 F mrcA A(mrr-hdsRMS-mrcBC) Invitrogen 
4801acZtM15 AlacX 74 deoR 
recAl araDl39 A(ara-leu)7697 
gal UgalK rpsL endAl nupG  
S. Typhimurium his Hoiseth and Stocker 
SL1344  (1981) 
S. Typhimurium his aroA Hoiseth and Stocker 
SL3261  (1981) 
Table 2.2 Bacterial strains used in this study 
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Plasmid/*Phage Relevant Features Source! 
Reference 
*M13 R408 defective packaging ability, resulting in Promega 
preference for plasmid ssDNA over phage 
ssDNA  
pG8SAET AmpR,  pUC19 derivative, with lacZcz Jacobsson and 
removed and the following additions: M13 Frykberg (2001) 
on, protein A promoter and signal 
sequence from Staphylococcus aureus in 
+1 frame, followed by E-tag sequence in 
+2 frame, followed by I TAG, followed by 
gpVIII_ofMl3_in_+2_frame  
pG8SAET-L7/L12 pG8SAET encoding S. Typhimurium rplL this thesis 
gene fused, in the correct reading frame, to 
the signal sequence and E-tag  
pENTR!SD/D- pUC ori, covalently bound topoisomerase I Invitrogen 
TOPO from Vaccinia virus at directional cloning 
site with flanking attLi and attL2 
sequences, KanR 
pET-DEST 42 pBR322 on; Cml' and ccdB flanked by Invitrogen 
attRl and attR2; T7 promoter, lacO, lad, 
encodes C-terminal V5 epitope followed 
by 6x His tag, Amp'  
pET-DEST42 cysA pET-DEST 42 derivative with Cm1R  and this thesis 
frag ccdB replaced with fragment of cysA  
pET-DEST42 pET-DEST 42 derivative with Cm]" and this thesis 
STM3 167 frag ccdB replaced with fragment of STM3 167  
pET-DEST42 ytfE pET-DEST 42 derivative with Cm1R  and this thesis 
frag ccdB replaced with fragment ofyE 
pET-DEST42 ptsN pET-DEST 42 derivative with Cml
1 
 and this thesis 
frag ccdB replaced with fragment ofptsN  
pET-DEST42 oat pET-DEST 42 derivative with Cml' and this thesis 
frag ccdB replaced with fragment of oat  
pET-DEST42 yhjJ pET-DEST 42 derivative with Cm1R  and this thesis 
frag ccdB replaced with fragment of yhjJ  
pET-DEST42 gpl6 pET-DEST 42 derivative with Cm1R  and this thesis 
frag ccdB replaced with fragment of g16 
pET-DEST42 yijO pET-DEST 42 derivative with Cml and this thesis 
frag ccdB replaced with fragment of yi/O  
pET-DEST42 ydiY pET-DEST 42 derivative with Cmlk  and this thesis 
frag ccdB replaced with fragment ofydiY  
pET-DEST42 pET-DEST 42 derivative with Cm!' and this thesis 
STM2235 frag ccdB replaced with fragment ofSTM2235  
pVCN2 pCDNA3 -derived, Amp', IPTG-inducible V. North, Univ. 
T7 promoter encoding eGFP-6xHis of Edinburgh 
pMOG3 pET-DEST 42 derivative with Cm1R  and M. Mogensen, 
ccdB replaced with S. Typhimurium rplL Univ. of 
Edinburgh 
Table 2.3 Plasmids used in this study 
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Primer Primer Sequence Comments and Usage 
Name 
cysAfor 5'- CACCATGGATT PCR of the cysA gene fragment 
CTCCTCTACC -3' encoding antigen for cloning into 
pENTR/SD/D-TOPO (5'-3) 
cysArev 5'- CAGCGGATCG PCR of the cysA gene fragment 
TGATACCAC -3' encoding antigen for cloning into 
pENTR/SD/D-TOPO (3-5') 
STM3167for 5'- CACCATGCCG PCR of the STM3 167 gene fragment 
GATGTCAGTC -3' encoding antigen for cloning into 
pENTR/SD/D-TOPO (5'-3') 
STM3167rev 5'- CGACAGATATC PCR of the STM3 167 gene fragment 
CTTCATACTGTTC -3' encoding antigen for cloning into 
pENTR/SD/D-TOPO (3-5') 
ytfEfor 5'- CACCATGACCA PCR of the ytfE gene fragment 
AAGTGGAAC -3' encoding antigen for cloning into 
pENTR/SD/D-TOPO (5-3') 
ytfErev 5'- CATACCCTGTT PCR of the ytfE gene fragment 
TGATCATGGG -3' encoding antigen for cloning into 
pENTR/SD/D-TOPO (3-5') 
ptsNfor 5'- CACCATGTTC PCR of the ptsN gene fragment 
GACGCCATC -3' encoding antigen for cloning into 
pENTR/SD/D-TOPO (5-3') 
ptsNrev 5'- CAGCGACAG PCR of the ptsN gene fragment 
CGTGTGCAG -3' encoding antigen for cloning into 
pENTR/SD/D-TOPO (3'-5') 
oatfor 5'- CACCATGCCTG PCR of the oat gene fragment 
TTGTGGTATC -3' encoding antigen for cloning into 
pENTR/SD/D-TOPO (5-3') 
oatrev 5'- GCTGTACTTG PCR of the oat gene fragment 
AGTTTCCCCG -3' encoding antigen for cloning into 
pENTR/SD/D-TOPO (3'-5') 
gpl6for 5'- CACCATGTTC PCR of the gpl6 gene fragment 
CCAAATCAGG -3' encoding antigen for cloning into 
pENTR/SD/D-TOPO (5-3') 
gpl6rev 5'- GCGCT'TTATAT PCR of the gpl6 gene fragment 
CTGACGGTTTG -3' encoding antigen for cloning into 
pENTR/SD/D-TOPO (3'-5') 
yijOfor 5'- CACCATGTATA PCR of the yijO gene fragment 
TTGATGAACGC -3' encoding antigen for cloning into 
pENTR/SD/D-TOPO (5'-3') 
Table 2.4 Primers used in this study. The required 5' CACC for cloning into pENTR/SD/D-TOPO 
and the introduced start codon have been underlined. 
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Primer Primer Sequence Comments and Usage 
Name 
yijOrev 5'- GATGGCCC PCR of the yijO gene 
CCGTTTTCTG -3' fragment encoding antigen 
for cloning into 
pENTRISD/D-TOPO (3-5') 
STM2235for 5'- CACCATGCTTG PCR of the STM2235 gene 
AAAAAAATCAG -3' fragment encoding antigen 
for cloning into 
pENTR/SD/D-TOPO (5'-3') 
STM2235rev 5'- ACAGCCTGT PCR of the STM2235 gene 
AGCCGCACG -3' fragment encoding antigen 
for cloning into 
pENTR/SD/D-TOPO (3'-5') 
ydiYfracs 5'- CACCATGAAT PCR of the ydiY gene 
GCGGGCTAC -3' fragment encoding antigen 
for cloning into 
pENTR/SD/D-TOPO (5-3') 
ydiYfrac3 5'- GGTACGTTGT PCR of the ydiY gene 
CCATACCAGG -3' fragment encoding antigen 
for cloning into 
pENTRISD/D-TOPO_(3'-5') 
yhjJfrac5 5'- CACCATGAAAGT PCR of the yhjJ gene 
ACGCGACAAAG -3' fragment encoding antigen 
for cloning into 
pENTR/SD/D-TOPO (5'-3') 
yhjJfrac3 5'- AGTCAAAATG PCR of the yhjJ gene 
TCAGTATCGG -3' fragment encoding antigen 
for cloning into 
pENTR/SD/D-TOPO (3-5') 
ribfor 5'- GTCTATCACTAAAG PCR of rp IL for cloning into 
ATCAAATCATTGAAG -3' pG8SAET (5-3') 
ribrev 5'- AACTTCAACT PCR of rpIL for cloning into 
TCAGCGCCAG -3' pG8SAET (3'-5') 
sasekv 5'- TATCTGGTGGC Colony PCR 
GTAACACCTGCT —3'  
etseq 5'- CGTAAACTAGGTGTA Sequencing of pG8SAET 
GGTATTGCATCTGTAAC -3' clones (5'-3') 
etag 5'- GATCGTCACCCT Colony PCR; Sequencing of 
CGGATCCCTAGG -3' pG8SAET clones (3'-5') 
oligol 5'- CGACTCACTATAG Sequencing of pET-DEST42 
GGGAATTGTGA -3' clones (5-3') 
Table 2.4 (continued) Primers used in this study. The required 5' CACC for 
cloning into pENTR/SD/D-TOPO and the introduced start codon have been 
underlined. 
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B. Manipulations of bacteria and phage 
Manipulations of bacteria 
Statonary-phase liquid cultures of bacteria were produced by inoculation of a 
single colony into 5 ml of LB medium with added antibiotic, if required, and 
incubated for 16 hours at 37°C with agitation. Larger cultures were produced in the 
same way, but with an inoculum consisting of a 100-fold dilution of stationary-phase 
culture. Long-term bacterial stocks were made by combining I ml of stationary-phase 
culture with 70 t1 of DMSO and immediately storing at -80°C. Bacteria from a 
liquid culture or freezer stock were propagated on LB agar plates containing 
antibiotic, if required, by streaking onto the plate and subsequently incubating it at 
37°C for 16 hours. Such plates were stored at 4°C for no more than 4 weeks. 
Manipulations of phage 
Helper phage stock was made by the addition of 10" plaque-forming units 
(PFUs) of M13 R408 helper phage to 108  stationary-phase E. coli TGI host cells in 
100 pi of LB. The mixture was incubated at 37°C for 20 min or at RT for 30 min to 
allow infection, then combined with 5 ml of 42°C top agar, mixed, and poured onto 
an LB agar plate. After the top agar was allowed to solidify at RT, the plate was 
incubated at 37°C for 16 hours. The top agar was then removed with a spoon and 
vigorously mixed with 5 ml of LB, after which the mixture was incubated for 4 hrs at 
37°C with agitation. The mixture was then centrifuged at 27,000 x g for 10 mm, and 
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the supernatant was filtered through a membrane with a pore size of 0.45 im using a 
syringe. PFUs were estimated by infecting host cells with serial dilutions of the 
lysate in LB and subsequently plating out with top agar as described above. 
Alternatively, 10 l of serial dilutions was spotted onto top agar freshly solidified 
with 108  host cells on an LB plate. Plaques were counted after the plates had been 
incubated at 37°C for 16 hours, and the number was multiplied by the dilution factor 
of the lysate. Helper phage stock was stored at 4°C for up to two months, or at -80°C 
in 0.5 ml aliquots. 
The number of M13 particles containing pG8SAET was determined by 
infecting 50 il (approximately 108  cells) of stationary-phase E. coli TG1 with serial 
dilutions of lysate in 100 pA LB as described above, incubating for 30 min at RT, and 
spreading over individual LBA50 plates. The plates were incubated at 37°C for 16 
hours, after which colonies were counted. 
C. Preparation for library construction 
1. Purification of DNA from S. Typhimurium SL1344 
Cells from a 100 ml stationary-phase S. Typhimurium SL1344 culture were 
collected by centrifugation at 2,000 x g for 20 mm, and the resulting cell pellet was 
resuspended in 5 ml of Tris Buffer 1 and frozen at -20°C. Freshly prepared 
Lysozyme Solution 1 (0.5 ml) was added to the frozen cells, which were 
subsequently allowed to thaw, with gentle agitation, in a RT water bath. As soon as 
the cells thawed, they were placed on ice for 45 mm, after which 1 ml of freshly 
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prepared STEP solution was added and mixed. The mixture was then heated to 50°C 
for 1 hr with occasional, gentle mixing, after which 6 ml of Tris-equilibrated phenol 
was added and gently mixed for 5 min to form an emulsion. The mixture was then 
centrifuged at 1,000 x g for 15 min and the upper, aqueous layer was transferred to a 
clean tube, while the material at the interface of the two layers was carefully 
excluded. An amount of 3 M sodium acetate (pH 5.4), equivalent to 0.1 of the 
volume of transferred aqueous layer, was added and gently mixed. Two volumes of 
ethanol were then added and mixed by inversion. The resulting precipitate, which 
contained DNA and RNA, was spooled out with a small glass rod. The precipitate 
was gently rotated against the side of the tube and subsequently allowed to air-dry on 
the rod. The rod was then transferred to a clean tube containing 5 ml of Tris Buffer 2, 
and rocked gently overnight at 4°C. After complete dissolution of the pellet, an equal 
volume of chloroform was added. After inverting several times to mix, the layers 
were separated by 15 min of centrifugation at 1,000 x g. The aqueous upper layer 
was transferred to a clean tube, after which the DNA was precipitated as above with 
sodium acetate and ethanol. Once again, the DNA was spooled out using a glass rod. 
After the residual ethanol had evaporated, the pellet was allowed to completely 
dissolve in 2 ml of Tris Buffer 3 by overnight incubation at 4°C with gentle mixing. 
2. Quantitation of SL1344 DNA 
DNA concentration was determined by agarose gel electrophoresis. Briefly, 
various dilutions were made in sterile dH20 and subsequently combined with 6 x 
DNA Loading Buffer. These samples were then loaded onto a 110 mm x 150 mm 
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horizontal gel (1% w/v agarose in 0.5 x TBE) containing 0.5 tg/ml ethidium 
bromide. The samples, along with a control sample containing a known quantity of 
DNA, were electrophoresed through the gel in 0.5 x TBE at 100 V for 1.5 hr. The gel 
was then exposed to UV light ().=313) and imaged using an Epi Chemi III Darkroom 
(UVP Laboratory Products). The intensity of a band of SL1344 DNA was compared 
to the intensity of a known quantity of DNA in the control sample. 
3. Preparation of electrocompetent host cells 
Two 5 ml cultures of stationary-phase E. co/i TG  cells were added to 100 ml 
LB and incubated at 37°C with agitation until the OD (2600) reached 0.6, after 
which the culture was distributed among four centrifuge pots and incubated for 30 
min on ice. The cells were then centrifuged 2,500 x g for 15 min at 4°C, and the 
supernatant was discarded. The cells were then gently resuspended in I L of cold 
10% glycerol, and centrifuged again. The cycle of gentle resuspension in fresh, cold 
10% glycerol and subsequent centrifugation was repeated two more times. After the 
final centrifugation, cells were gently resuspended in a volume of cold 10% glycerol 
equal to the pellet, and 50 iii portions were distributed into pre-chilled 1.5 ml tubes. 
The tubes were snap-frozen in liquid nitrogen before immediate storage at -80°C. 
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D. Construction of S. Typhimurium pG8SAET library 
1. Preparation of vector and insert DNA 
Stationary-phase E. coli TG  cells containing the vector pG8SAET in 100 ml 
of LB + 50 tg/ml ampicillin were distributed evenly among 10 sterile tubes, and the 
plasmid DNA was isolated using Qiagen's QiAprep Spin Miniprep Kit according to 
manufacturer's instructions. DNA from the 10 plasmid preparations was combined 
into a single tube. Fifty micrograms of this DNA was digested with 100 units of 
SnaBI (Fermentas) for 2 hrs at 37°C, after which 60 units of calf intestine 
phosphatase were added, and the mixture was incubated a further 1 hr at 37°C. The 
digested, dephosphorylated DNA was then extracted 3 times with an equal volume of 
Tris-equilibrated phenol and twice with chloroform. The aqueous phase containing 
DNA was then passed through 200 il of CL 6B sepharose (Amersham Biosciences). 
S. Typhimurium SL1344 DNA (100 tg) in 300 p.1 of dH20 was sonicated at 
RT for 10 s, with pulse on 1 s and pulse off 1 s (e.g. 20 seconds total), at 39% 
amplitude (Sonics & Materials Inc. Vibrason). The DNA was incubated with 0.1 mM 
dNTPs, 1 mM ATP, 1 x T4 DNA Polymerase Buffer, 25 units of T4 DNA 
Polymerase and 50 units of T4 Polynucleotide Kinase (Fermentas) at 37°C for 30 
mm. The mix was extracted 3 times with an equal volume of Tris-equilibrated phenol 
and 2 times with chloroform, and passaged through 400 p.1 of CL 6B sepharose 
(Amersham Biosciences). 
2. Ligation and transformation 
Five tubes of Ready-To-Go T4 DNA Ligase (Amersham Biosciences), each 
containing 1-2 jig of cut, dephosphorylated pG8SAET and 3-6 jig of sheared, blunt-
ended, phosphorylated insert DNA were incubated for 16 hrs at 16°C. The five 
ligations were pooled together and combined with 400 jil sterile dH20, 4 jil of 10 
mg/mi tRNA, and 16 jil of 5 M NaCl. One millilitre of ethanol was added, and the 
mixture was subsequently inverted several times to mix. After 15 min incubation at 
RT, the precipitate was pelleted in a microcentrifuge at top speed for 10 mm. The 
supernatant was removed, and the pellet was resuspended once more in 400 jil sterile 
dH20 and precipitated again in the same manner. The supernatant was removed, and 
the pellet was allowed to dry, after which it was resuspended in 11 jil sterile dH20. 
One microlitre was then added to each of 11 tubes containing 50 jil aliquots of 
electrocompetent host cells having been freshly defrosted on ice. The DNA/ host cell 
mixture of each tube was then transferred to a pre-chilled cuvette and electroporated 
at 2.5 V constant, after which the cells of all electroporations were immediately 
combined in 100 ml of LB. This combined culture was incubated at 37°C for 1 hr 
with agitation. A small aliquot was then removed for dilution plating, and ampicillin 
was added to a final concentration of 50 jig/ml. The culture was incubated for 16 hrs 
at 37°C. 
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3. Colony PCR and production of phage 
Primers "sasekv" and "etag" were used to amplify the flanking regions of the 
pG8SAET SnaBl restriction site along with any inserted sequence. Ten PuReTaq 
Ready-To-Go PCR Beads (Amersham Biosciences) were resuspended in 250 1 of 
dH20 containing 50 pmol of each primer. Portions of 10 il were aliquotted into 0.2 
ml tubes, and a toothpick was used to transfer cells from a colony to the tube. Cells 
were resuspended in the mixture well. In a PCR Sprint machine (Hybaid), the tubes 
were incubated at 94°C for 1 mm, followed by 25 cycles of 94°C for I mm, 50°C for 
1 mm, and 72°C for 5 mm. An incubation at 72°C for 5 min followed the last cycle. 
A 5 il portion of the reaction was then subjected to electrophoresis on a 1% agarose 
gel alongside a Lambda DNA/EcoRI+HindIII Marker (Fermentas) following the 
method in section C2. 
To produce recombinant phage particles, 1.5 ml, 3 ml, and 10 ml portions of 
the 100 ml culture prepared in section D2 was incubated with 1 x 1011, 1 x 	and 
7 x 10" helper phage, respectively, for 20 min at 37°C with agitation. This 
host/phage mixture was then added to 50 ml, 50 ml, and 75 ml, respectively, of 
molten top agar (45°C), mixed, and poured over 15 plates of LBA50. Once the top 
agar solidified, the plates were incubated for 16 hrs at 37°C, after which the top agar 
was scraped off and mixed with an equal volume of LB containing 50 tg/m1 
ampicillin, vortexed, and incubated for 4 hrs at 37°C with agitation. The mixture was 
centrifuged at 27,000 x g for 10 mm, and the supernatant was filtered through a 
membrane with a pore size of 0.45 tm. Aliquots of 0.5 ml were stored at -80°C. 
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E. Production and testing of serum 
1. Production of serum 
Twenty 8-12 week old female CBA/Ca mice (Division of Bilogy, University 
of Edinburgh) were injected intraperitoneally (i.p.) each with 2 x 106  stationary-
phase S. Typhimurium SL3261 in 100 1 of PBS. After 28 days had passed, the same 
mice were injected i.p. each with 6.5 x 105 stationary-phase S. Typhirnurium SL1344 
in 100 pi of PBS. Twenty-one days after the first challenge with S1,1344, the same 
mice were injected in the same manner with 1.2 x 106  SL1344. Thirty-five days after 
the second challenge with SL1344, the mice received a final injection of 1x106 
5L1344. Mice were bled on days 0, 28, 10 post-challenge I (pci), 17 pcI, 10 pc2, 
and 14 pc3. A final bleed was collected 17 days after the third challenge with 
SL1344, after which the mice were sacrificed. Blood was allowed to clot in 0.2 ml 
tubes for 3 hrs at RT, after which the tubes were centrifuged for 10 min at 1,000 x g. 
The supernatants were combined to form pooled serum samples from each day of 
collection. Injections were administered by Dr. Maurice Gallagher and serum 
collection was performed by Dr. Chris Inchley. 
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2. SDS-polyacrylamide gel electrophoresis, transfer, and immunoblot 
a. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE was performed essentially as described by Laemmli (1970). 
Sample preparation was as follows: 10-12 tl of SDS Sample Buffer containing 
approximately 6.7 x 107 cells of S. Typhirnuriurn SL1344 were boiled for 5 min in 
1.5 ml tubes, then placed on ice. Polyacrylamide gel preparation was as follows: a 
12.5% resolving gel was prepared by combining 2.5 ml of 30% w/v stock solution 
having an acry lam ide/bis-acrylarnide ratio of 37.5:1 (Severn Biotech) with 1.5 ml of 
Resolving Gel Buffer, 2.5 ml of dH20, 50 il of freshly prepared 10% APS, and 
finally adding 2.5 pA of TEMED. The mixture was poured into a 5.5 cm x 8.2 cm x 
1.0 mm area between two glass plates and overlaid with dH20-saturated sec-butyl 
alcohol. After the resolving gel had polymerised, the overlay was poured off. A 5% 
stacking gel was then prepared by combining I ml of the same 30% 
acrylamide/bisacrylarnide solution with 1.5 ml of Stacking Gel Buffer, 3.5 ml of 
dH20, 50 tl of freshly prepared 10% APS, and finally adding 2.5 pA of TEMED. The 
mixture was poured on top of the resolving gel until it completely filled the 
remaining area, and a comb was placed into the mixture so that 0.5 cm separated the 
bottom of the comb from the top of the resolving gel. After the stacking gel 
polymerised, the comb was removed and the wells were washed with Running Buffer 
several times until unpolymerised acrylamide had been washed away. The sample 
and molecular weight marker (MW-SDS-70L, Sigma) were loaded onto a gel, which 
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was electrophoresed in Running Buffer in a BioRad Mini Protean II cell at 15 mA 
and 200Vfor 1-1.5 hratRT. 
b. Transfer and immunoblot 
Three pieces of 6 x 9 cm filter paper, pre-soaked for 5 min in Transfer Buffer, 
were stacked on top of one another and placed onto the anode of a BioRad TransBlot 
SD Semi-Dry Transfer Cell. A 6 x 9 cm piece of Protran nitrocellulose membrane 
with a pore size of 0.45 .tm (Schleicher & Schuell), pre-soaked for 5 min in Transfer 
Buffer, was placed on top of the three soaked filter papers. A gel was then removed 
from the cell and glass plates, and subsequently carefully placed on top of the 
nitrocellulose, such that no air bubbles were trapped between the gel and membrane. 
Three more 6 x 9 cm soaked filter papers were placed on top of the gel, after which 
an identical stack was prepared adjacent to the first stack using the other gel. The 
cathode lid was placed firmly on top of the stacks, and proteins were transferred at 
500 mA, 15 V for 40 min at 4°C. Membranes were incubated in 0.2% Ponceau S in 
1% acetic acid for 5 mm, then rinsed with dH20 several times until protein bands 
were clearly visible. The bands of the molecular weight marker were traced over 
with a pen, after which the membrane was cut into three parts. From this point 
forward, each part of the divided membrane was treated separately. They were 
further rinsed multiple times with TBS1 until the Ponceau S stain disappeared. 
Membranes were then incubated overnight at 4°C in 5% skimmed milk in TBSI. 
Subsequently, they were rinsed twice more with TBS 1 -T and then incubated for 1 hr 
at RT in 5 ml of a dilution of mouse serum prepared in 0.5% skimmed milk in TBS1- 
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T. The membranes were then washed with TBS1-T 3 times for 5 mm, after which 
they were incubated in 5 ml of the same buffer containing 0.5% skimmed milk and a 
1:1,000 dilution of alkaline phosphatase-conjugated rabbit anti-mouse antibody for 1 
hr at RT. Following this treatment, the membranes were washed 3 times for 5 min in 
TBS2-T. During this time, the NBT Developing Solution was prepared. Each piece 
of membrane was then incubated in developing solution for exactly 2 mm, after 
which they were rinsed immediately with tap water to stop the reaction. Membranes 
were allowed to dry, after which a PowerLook III scanner (UMAX) was used to save 
the images electronically. 
3. Enzyme-linked immunosorbent assay (ELISA) 
Cytosolic proteins were isolated from stationary-phase S. Typhimurium 
SL1344 by Z. Carpenter. Briefly, cells from a 500 ml culture were pelleted at 4°C for 
15 min at 2,500 x g and subsequently resuspended in 20 ml cold Lysis Buffer, after 
which they were lysed using a French press. The lysate was then ultracentrifuged at 
100,000 x g for 1 hr at 4°C, after which the supernatant was transferred to a fresh 
tube for a second, identical centrifugation. The supernatant, containing cytosolic 
proteins, was stored in 0.5 ml aliquots at -20°C. Protein content was quantified using 
Coomassie Plus Protein Assay Reagent (Pierce) according to manufacturer's 
instructions. 
In each of 96 wells of an Immulon-2 plate, 100 jJ of Coating Buffer I 
containing 3.33 jg cytosolic proteins from stationary-phase S. Typhimurium SL1344 
was incubated overnight at 4°C. Wells were then washed 3 times with 230 ptl PBS-T 
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using an MRW (AM60) plate washer (Dynex Technologies, Inc.). To each well was 
then added 200 pA Coating Buffer I containing 1% skimmed milk, and the plate was 
kept humid as it was incubated at 37°C for 1 hr. Serial dilutions of serum in Dilution 
Buffer were then added in 100 pd portions to each well, and the plate was kept humid 
as it was incubated for 4 hrs at RT. Wells were then washed again 3 times with 230 
il PBS-T. To each well was then added 100 tl of Dilution Buffer containing 1:500 
HRP-conjugated anti-mouse IgG antibody (Diagnostics Scotland), and the plate was 
kept humid as it was incubated at 37°C for 30 mm. Wells were then washed again 3 
times with 230 tl PBS-T. To each well was then added 100 tl of freshly prepared 
OPD Developing Solution. The plate was incubated in the dark for 15 min at RT, 
after which 25 pd of 2 M H2SO4  was added to each well to stop the reaction. The 
absorbance (2492) of the wells was then measured using an Anthos 2010 
microplate reader and Stingray software. 
F. Enrichment of library and screening of selected clones 
1. Biopanning conditions 
a. Original biopanning conditions 
Human plasma (Sigma) (10 pA in 200 t1 Coating Buffer 2) was added to a 
single well of an 8-well Maxisorp Nunc-Immuno Module, which was then wrapped 
in parafllm and incubated at RT for 1 hr. The well was then washed 8-10 times with 
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PBS-T over the course of 10 mm. To the well was then added either 200 pi of a 
freshly defrosted aliquot of phage prepared in section D3, or 200 jil of a freshly 
defrosted aliquot of a S. aureus pG8SAET library of phage particles (Jacobsson and 
Frykberg, 2001). The well was then incubated for 4 hrs at RT with agitation, after 
which it was washed 30 times over 10 min with PBS-T. Subsequently, 200 pi of 
Elution Buffer 1 was added to the well and incubated at RT for 3-5 mm, after which 
the elution was transferred to a 1.5 ml tube containing 35 .tl of 1 M Tris-Cl, pH 9.0 
and mixed. Dilutions of this mixture were made immediately in LB, and a 5-100 j.il 
portion of each dilution was added to a fresh tube containing 100 p1 of LB and 50 p1 
of stationary-phase TG1 host cells. Each tube was incubated for 30 min at RT, after 
which the contents were spread over individual LBA50 plates. The plates were 
incubated at 37°C for 16 hours, after which colonies were counted. Colonies were 
then scraped off in I ml of LB, to which 1010 R408 particles were added. The 
mixture was then incubated, combined with top agar, and plated onto LBA50 as in 
section B2. Phage were subsequently recovered from top agar as in section B2 using 
LB with 50 tg/ml added ampicillin, after which they were used in a second round of 
biopanning. The second round was identical to the first, with the exception that 
phage were incubated in the well for 1 hr and more dilute quantities of elution were 
used to infect host cells for more convenient quantitation. 
b. Modified biopanning conditions 
For test biopannings with anti-mouse antibody, wells were coated with 2 jil of 
goat anti-mouse IgG, Fc-specific (Sigma) in 200 p1 Coating Buffer 2 for 16 firs at 
4°C. The wells were washed 3 times with PBS, after which 5 pJ of anti-S. 
Typhimurium mouse serum in 200 tl PBS was added. Wells were incubated at RT 
for 1 hr, after which wells were washed 3 times again with PBS. From this point 
onward, wells were treated as in section Fla and remaining particles were recovered 
from wells after elution according to the procedure below. For pre-absorption, 4 or 
12 wells were coated with 2 p.t of pre-immune CBA/Ca serum in Coating Buffer 2 
for 16 hrs at 4°C. Library phage were added to each well consecutively and 
incubated for 10 mm (12 wells) or 15 mm (4 wells) prior to incubation in a well 
having been coated with immune serum. Alternatively, non-immune serum (from 
CBA/Ca mice not used in the production of hyperimmune serum) was added to 
library phage prior to biopanning. Serum was incubated at 56°C for 30 min to 
inactivate complement, or was left untreated, prior to addition to library phage. The 
phage library (200 p.1) was combined with 10 p.! or 20 p.l of serum and incubated at 
RT for 15 mm. prior to addition of this mixture to wells. 
For testing the binding capacity of wells, varying amounts of anti-S. 
Typhimurium serum were added to 200 p.1 of Coating Buffer 2 and incubated for 16 
hrs at 4°C. A single round of biopanning was then performed as in section Fla, using 
phage generated from pG8SAET having no insert instead of the library phage. For 
testing different blocking solutions, wells were incubated for 1 hr at 37°C in 1% 
skimmed milk in PBS-T, 1% gelatin from cold water fish skin (Sigma) in PBS-T, or 
PBS-T alone. Wells were washed 5 times with PBS-T over 5 mm, after which freshly 
defrosted phage prepared in section D3 were added to wells, which were treated from 
this point onward as in section Fla. In addition, any phage remaining in the well after 
treatment with Elution Buffer were harvested by direct addition of host cells to the 
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well. Upon removal of Elution Buffer, 150 .jl of LB and 50 l of stationary-phase 
TG1 cells were added to the well, followed by a 30 min incubation at RT. Dilutions 
were then made in LB, which were immediately plated out on LBA50. Plates were 
incubated for 16 hrs at 37°C and the resulting colonies were counted. 
Immunoglobulin G was partially purified from serum collected in section El 
according to the protocol for purification of rabbit lgG from serum, using saturated 
ammonium sulfate (SAS), as outlined in Barbas et al. (2001). Briefly, SAS was 
added in 3 41 portions to 0.5 ml of serum stirring on ice to achieve a 45% cut. The 
precipitate was collected by centrifugation and resuspended in 0.5 ml of PBS. This 
was subsequently dialysed against 200 nil of PBS 4 times in 20 hrs at 4°C, as was the 
supernatant fraction. Protein concentrations of the IgG-enriched fraction and of the 
supernatant were determined using the Coornassie Plus Protein Assay Reagent 
(Pierce) according to manufacturer's instructions. 
After all biopanning modifications had been completed, approximately 0.2 
mg of IgG-enriched fraction was used to coat a single well for 16 hrs at 4°C. The 
well was then washed as in section Fla, and 200 p.1 of 1% skimmed milk in PBS-T 
was added. It was then wrapped in parafilm and incubated at 37°C for 30 mm, after 
which it was washed again, eluted, neutralised, incubated with host cells, and plated 
out as in section Fla. Phage remaining in the well after elution were collected as 
described in section Fib. Resulting colonies were screened for E-tag expression 
according to section F2. Stationary-phase liquid cultures were prepared from each 
chosen clone and combined with equal volumes of other clones to form a mixed 
culture of stationary phase cells. This culture was subsequently used for propagation 
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of phage particles in top agar, followed by extraction according to section B2 for a 
second round of biopanning. 
2. E-tag detection 
Colonies were patched onto a fresh plate of LBA50 in a grid pattern and 
incubated at 37°C for 5 hrs. A circular Protran membrane with a diameter of 82 mm 
and pore size of 0.45 Jtm (Scleicher & Schuell) was then placed onto the gridded 
colonies, then carefully peeled away with sterile forceps from one point at the edge 
of the plate. The membrane was then placed on a fresh plate of LBA50 such that the 
sterile side was in direct contact with the agar, without air bubbles. The plate was 
covered and placed at 37°C for overnight growth. The membrane was then removed 
from the plate with forceps and transferred, colony side up, onto three metal caps 
inside a covered glass petri dish with chloroform in the bottom, as shown (Figure 
2.2). The membrane was exposed for 5 min to chloroform vapour, then placed into 
TBS1-T and incubated at 37°C for 20 min with vigorous shaking. A Pasteur pipette 
was used to wash off remaining colony debris, and the membrane was washed 
several times with fresh TBSI-T. The membrane was then incubated with gentle 
agitation at RT for 1 hr in 5 ml of 5% skimmed milk in TBSI-T, after which 5 jJ of 
mouse anti E-tag antibody (Amersham Biosciences) was added. The membrane was 
incubated a further 1 hr at RT with gentle agitation, and then washed 3 times for 10 
min with PBS-T. It was then incubated in 5 ml 1% skimmed milk in TBS-T 
containing 2 .tl of HRP-conjugated anti-mouse IgG antibody (Diagnostics Scotland) 
for 1 hr at RT. After the membrane was again washed 3 times for 10 min with TBSI-
T, it was washed once more with TBSI. The membrane was developed using the 
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ECL Plus Western Blotting Detection System (Amersham Biosciences) according to 
manufacturer's instructions, and imaged in an Epi Chemi III Darkroom (UVP 
Laboratory Products) or exposed to Super R)( Fuji medical X-ray film (Fujifilm). 
Chiorofo nbrane 
Metal supports 
Figure 2.2 Schematic representation of colony lysis for E-tag detection 
3. Plasmid purification and sequencing 
Small-scale plasmid purification was performed on 5 ml stationary-phase 
cultures using a Wizard Miniprep Kit (Promega) according to manufacturer's 
instructions. To sequence the inserts, 20 pmol of primer "etseq" was combined with 
0.4 tg of purified plasmid DNA, 2 jil of Sequencing Buffer, and 2 pJ of BigDye 
Terminator v3.1 Cycle Sequencing reaction mix in a final volume of 10 i1. In a PCR 
Sprint machine (Hybaid), the mixture was incubated at 94°C for 1 mm, followed by 
30 cycles of 94°C for I min and 60°C for 4 mm, after which the reaction was stored 
at -20°C until it was delivered to the Institute of Cell and Population Biology 
Sequencing Service (University of Edinburgh) for purification using Performa DTR 
96-Well Short Plates (Edge BioSystems) and electrophoresis using a 3730 DNA 
analyzer (Applied Biosystems). 
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4. Screening of selected clones 
a. Positive control clone 
Primers "ribfor" and "ribrev" were used to amplify the rplL gene from S. 
Typhimurium SL1344 chromosomal DNA prepared in section Cl. A 50 p.1 mixture 
was prepared, containing 25 ng template DNA, 10 pmol of each primer, 5 p.1 of the 
supplied 10 x reaction buffer for Pfu, 2 units of Pfu DNA polymerase (Promega) and 
2 p.1 of 5 mM dNTPs. The mixture was subjected to thermal cycling according to 
section D3. A 5 p.1 portion of the reaction was then subjected to electrophoresis on a 
1.2% agarose gel alongside a 100 bp DNA Ladder (New England Biolabs) following 
the method in section C2. The remaining reaction mixture was then purified using a 
QlAquick PCR Purification Kit (Qiagen). In a final volume of 50 p.1, the purified 
PCR product was then incubated with 10 units of T4 Polynucleotide Kinase (New 
England Biolabs) in 1 x reaction buffer supplemented with 1 mM ATP at 37°C for 
30 mm. The mixture was then incubated at 65°C for 20 min to inactivate the enzyme. 
A tube of Ready-To-Go T4 DNA Ligase (Amersham Biosciences), containing 1 jig 
of phosphorylated PCR product and 2 jig of SnaBI-digested, dephosphorylated 
pG8SAET prepared in section Dl, was incubated for 3 hrs at RT. The ligation mix (1 
p.1) was then transformed, according to section D2, into TGI host cells prepared in 
section C3. LB (800 p.l) was added to the cells and the tube was incubated at 37°C 
for 1 hr with agitation. Cells were then plated out onto LBA50 and incubated at 37°C 
for 16 hrs. Resulting colonies were used for PCR according to section D3 and 
82 
screened for E-tag expression according to section F2. Finally, a chosen clone was 
sequenced according to section F3. 
b. Dot blots 
Stationary-phase cultures were made of each clone to be screened, of which 
10 	1 was combined with lO 
9  PFUs of M13 R408 helper phage in a final volume of 
0.5 ml LB+50 tg/ml ampicillin in a 1.5 ml tube. Tubes were incubated for 5 hrs at 
37°C with agitation, after which they were centrifuged at maximum speed for 5 mm 
to pellet the host cells. Three hundred microlitres of supernatant were removed and 
placed into a fresh tube. From this tube, I .il was removed and spotted onto Protran 
nitrocellulose membrane (Schleicher & Schuell). The membrane was then placed in 
5% skimmed milk in TBSI-T and incubated for 16 hrs at 4°C with gentle agitation. It 
was then incubated with agitation at RT for a further 1 hr in either the same solution, 
the same solution with 10% bovine serum added, or the same solution with 20% 
foetal bovine serum added. The membrane was then washed 3 times for 10 min with 
PBS-T, after which it was placed in 5% skimmed milk in TBSI-T containing either a 
1:1,000 dilution of mouse anti E-tag antibody (Amersham Biosciences), or a 1:4,000 
dilution of mouse anti-SL1344 serum from the final bleed. From this point onward, 
the membranes were treated identically to the membranes in section F2. 
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G. Cloning, purification, and assessment of candidate antigens 
1. Cloning of selected gene fragments 
Preparation of heat-shock competent E. co/i TOP 10 cells 
Stationary phase E. co/i TOPIO cells (5 ml) were used to inoculate 500 ml of 
LB+20 mM MgSO4. Cells were incubated at 37°C with agitation until the OD 
(X=600) reached 0.6, after which it was chilled and centrifuged as in section C3. 
Only two centrifugations were required. The pellet was gently resuspended the first 
time in 200 ml of cold TFBI and the second time in 20 ml of cold TFB2. Aliquots of 
100 VLl in 1.5 ml tubes were snap-frozen and stored as in section C3. 
Entry vector cloning 
PCR was performed using the appropriate pairs of primers from Table 2.3 
according to section 174A. Cloning into pENTRISD/D-TOPO (Invitrogen) was 
performed essentially according to manufacturer's instructions. Briefly, 1 tl of PCR 
product was combined with 0.5 tI of Salt Solution (1.2 M NaCl, 60 MM  MgC12), 0.5 
pJ of TOPO vector, and 0.5 d of sterile dH20. This mixture was incubated at RT for 
5 min and subsequently added to a 100 j.il aliquot of heat-shock competent E. co/i 
TOP1O cells prepared in section Gla, freshly defrosted on ice. The DNA/competent 
cell mix was incubated on ice for 5 mm, after which it was transferred to a 42°C 
water bath, incubated for exactly 45 seconds, and transferred back to ice for 2 mm. 
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LB (800 jtl) was added to the tube, and it was incubated at 37°C for 1 hr with 
agitation. Cells were then plated out onto LBK and incubated at 37°C for 16 hrs. 
Resulting colonies were used to inoculate 5 ml cultures for small-scale plasmid 
purification. Purified plasmid DNA (0.5 tg) was then digested with 5 units of BsrGI 
(New England Biolabs) in a final volume of 20 jl for 1 hr at 37°C. Half of this 
reaction was then electrophoresed on a 1.2% agarose gel alongside a 2-Log DNA 
Ladder (New England Biolabs), essentially according to section C2. 
c. Destination vector clonin 
Cloning into the pET-DEST42 Gateway Vector (Invitrogen) was performed 
essentially according to manufacturer's instructions. Briefly, 0.5 tl containing 50 ng 
of entry vector, I jil containing 150 ng of destination vector, 1 pi of 5 x LR Clonase 
Reaction Buffer, and 1.5 pJ of TE were combined in a 1.5 ml tube. After I tl of LR 
Clonase enzyme mix was added, the tube was incubated at 25°C for 1 hr. The 
reaction was terminated by the addition of 0.5 tl of 10 mg/mI Proteinase K and 
subsequent incubation for 10 min at 37°C. One microlitre was then transformed, 
according to section D2, into electrocompetent E. coli BL21 (DE3) cells having been 
prepared according to section C3. After electroporation, 800 jJ of LB was added and 
the tube was incubated at 37°C for 1 hr with agitation. Cells were then plated out 
onto LBA100 and incubated at 37°C for 16 hrs. Resulting colonies were used to 
inoculate 5 ml cultures for small-scale plasmid purification according to section F3. 
Digestion of plasmid DNA was performed according to section Gib. Sequencing 
was performed using primer "oligol" according to section F3. 
85 
2. Overexpression and detection of His-tagged protein 
Overexpression 
A 0.1 ml portion of stationary phase E. coli BL2I(DE3) cells harbouring 
destination vector constructs was used to inoculate 10 ml of LB+100 1g/ml 
ampicillin. Cells were incubated at 37°C with agitation until they reached an OD 
(?=600) of 0.5. IPTG was then added to a 1 mM final concentration, and the cells 
were incubated with agitation at 37°C for 2 or 4 hrs, 30°C for 3 or 6 hrs, or at 18°C 
for 18 hrs. Alternatively, a culture was incubated in identical conditions without the 
addition of IPTG. 
Detection 
The 10 ml cultures in section G2a were centrifuged at 6,000 x g for 10 mm. 
The supernatant was decanted and the cell pellet was resuspended in 0.5 ml of Lysis 
Buffer. The cells were subsequently placed on ice and sonicated (Sonics & Materials 
Inc. Vibrason) at 20% amplitude in 3 pulses of 5 s each, with a 1 s gap between 
pulses. The resulting lysates were centifuged at top speed for 2 min at 4°C in a 
microfuge. A 0.4 ml portion of the supernatant was transferred to a fresh 1.5 ml tube. 
The protein content of this supernatant was quantified using the Coomassie Plus 
Protein Assay Reagent (Pierce) according to manufacturer's instructions. Fifteen 
micrograms of each sample were combined with dH20 in a final volume of 5 jtl, to 
which 5 il of 2 x LDS Sample Buffer were then added, after which the samples were 
incubated for 10 min at 70°C. Alongside 5 j.il of an Ultra Low Range Molecular 
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Weight Marker (Sigma) in I x LDS Sample Buffer, each sample was then 
electrophoresed in an X Cell II Module (Invitrogen) on a 1.0 mm 12% NuPAGE 
Novex Bis-Tris Gel (Invitrogen) at 200 V constant for 35 min in MES Buffer. The 
gel was then fixed by placing it in 100 ml of 40% methanol, 10% acetic acid and 
incubated for 15 mm. Following this, it was washed 2 times for 10 min with dH20, 
and subsequently incubated for 1 hr in 20 ml of GelCode Blue Stain Reagent 
(Pierce). To destain, it was then incubated in 100 ml dH20 for 20 mm. The gel was 
incubated at RT with gentle agitation during fixing, washing, staining, and 
destaining. Finally, it was imaged using an Epi Chemi III Darkroom (UVP 
Laboratory Products). 
3. Purification of expressed His-tagged protein 
a. Affinity purification in native conditions 
A 500 ml culture of cells were induced according to the conditions in section 
G2a used to establish the ideal for individual constructs. The entire culture was then 
centrifuged at 3,000 x g for 10 min at 4°C, and the pellet was frozen at -20°C. It was 
subsequently resuspended in 20 ml of ice-cold Lysis Buffer. Cells were lysed using a 
French press at 4,000 psi, and the suspension was centrifuged at 4°C for 30 min at 
10,000 x g. In the meantime, 0.1 ml of Ni-NTA agarose beads (Qiagen) was washed 
twice with 0.5 ml of Lysis Buffer. DNase I was added to the supernatant to a final 
concentration of 10 .1g/ml, after which the mixture was then added to the beads and 
mixed for 3 hrs at 4°C. The liquid was then allowed to drain away from the beads. 
The beads were washed 4 times with 1 ml of ice-cold Wash Buffer and sequentially 
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eluted with I ml of ice-cold Elution Buffer 2 containing 0.1 M, 0.15 M, 0.2 M, and 
0.25 M imidazole. The protein content in 5 VLI portions of each elution was then 
assessed by electrophoresis and detection according to section D2b. 
Affinity purification in denaturing conditions 
A cell pellet obtained from 500 ml of culture (see section G3a) was 
resuspended in 20 ml of Denaturing Lysis Buffer and added to 100 W  of Ni-NTA 
resin. The lysate was allowed to mix with the resin for 3 hrs and was subsequently 
drained away. The resin was then washed 3 times with 5 ml of Denaturing Wash 
Buffer, after which it was washed 3 times with 5 ml of Refolding Buffer. Following 
these washes, bound protein was eluted from the resin with 2 x 0.5 ml of Refolding 
Buffer containing 0.2 M imidazole. Protein content of the elution was then assessed 
by electrophoresis and detection according to section D2b. 
Ion exchange chromatography 
The 4 elutions of each protein purified in section D3a were combined, after 
which the buffer was exchanged for Cation Exchange Buffer 1 or Anion Exchange 
Buffer 1. Except in the case of the smallest two proteins, this buffer exchange was 
achieved by dialysis against 3 x 200 ml at 4°C over 20 hrs using Spectra/Por 
Membrane (Spectrum Laboratories) with a molecular weight cutoff of 3.5 kDa. 
When necessary, protein solutions were concentrated by sealing the solution within 
the dialysis membrane and sprinkling polyethylene glycol (PEG, MW = 8,000, 
Sigma) on top of the membrane to draw out liquid over a period of hours until the 
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desired volume was achieved. The buffer of the smallest two proteins was exchanged 
using a Microsep microconcentrator (Filtron Technology) with a molecular weight 
cutoff of 1 kDa according to manufacturer's instructions. Protein samples were then 
passed through a Millex-GV 0.22 tm filter (Millipore) to remove debris. Cation or 
anion exchange chromatography was performed using a Mono S HR 5/5 or Mono Q 
HR 5/5 column (Amersham), respectively. Samples were loaded in 2 x 5 ml 
volumes, and the column was washed with 10 ml of the same buffer. Following this, 
a gradient of increasing salt concentration was passed through the column over 10-30 
mIs beginning with 100% (Cation or Anion) Exchange Buffer 1 and ending with 
100% (Cation or Anion) Exchange Buffer 2. At the end of the gradient, an additional 
10 ml of (Cation or Anion) Exchange Buffer 2 was passed through the column. The 
absorbance (X=260) of eluate collected in 0.5 ml fractions was used to detect the 
presence of protein. The protein content in 5 jl portions of selected fractions was 
then assessed by electrophoresis and detection according to section 132b. 
Concentration of CysA was achieved by freeze-drying followed by resuspension in a 
smaller volume. 
4. Immunoblot and ELISA of candidate antigens 
Purified proteins in 100-200 ng quantities, or 30 tg of cell lysate from section 
G2b, were subjected to electrophoresis on a WAGE gel according to section G2b. 
At the end of electrophoresis, the gel was not fixed. Instead, it was transferred to a 7 
x 8.4 cm Immun-Blot PVDF membrane with a pore size of 0.2 m (BioRad) using 
an X Cell II Blot Module (Invitrogen). The membrane was immersed in methanol 
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and subsequently in Transfer Buffer for 5 min prior to transfer. The same 
arrangement of filter paper-membrane-gel-filter paper was set up as in section E2b, 
but NuPAGE Transfer Buffer was used instead of Transfer Buffer. In addition, three 
blotting pads, soaked in NuPAGE Transfer Buffer, separated the 'sandwich' from the 
cathode on one side and the anode on the other side, with the membrane closer to the 
anode than to the cathode. The upper chamber was then filled with NuPAGE 
Transfer Buffer and the lower chamber with dH20. Proteins were transferred at 30 V 
constant for 30 rnin at RT, after which the membrane was stained with Ponceau 5, 
marked, and destained as in section G2b. The membrane was then incubated in a 
1:4,000 dilution of mouse anti-SL1344 serum from the final bleed in 1% skimmed 
milk in TBSI-T for 1 hr at RT. Alternatively, the membrane was incubated in a 
1:1000 dilution of HRP-conjugated His-probe H-3 mouse monoclonal antibody 
(Santa Cruz Biotechnology). From this point onward, the membranes were treated 
identically to the membranes in section F2. Since the His-probe antibody was HRP-
conjugated, no secondary antibody was necessary. ELISA was performed according 
to section E3, except that the wells were coated with 0.1 j.ig of purified protein. 
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CHAPTER 3 
Construction of a Phage Display Library from 
S. Typhimurium DNA and Production of 
High-Titre 
S. Typhimurium-Reactive Serum 
A. Introduction 
The merits of multiple subunit vaccination have been discussed with respect 
to Salmonella infection. In order to formulate a new multiple subunit vaccine, 
suitable antigenic components need to be identified. Phage display can be a powerful 
tool for the identification of new antigens when used as part of a selection scheme 
using immune serum. In this chapter, a phagemid library is constructed from S. 
Typhimurium DNA and evaluated for use in subsequent experimental antigen 
selection. Additionally, hyperimmune S. Typhirnurium-reactive serum is raised in 
two different strains of mice. The serum from both groups is assessed for suitability 
as a ligand for biopanning the library with the goal of obtaining candidate antigens. 
To achieve the goal of identifying S. Typhimurium antigens, the phagemid 
vector pG8SAET was used to construct a library from genomic DNA. This vector 
was specifically developed for the construction of an M13 phage display library from 
bacterial genomic DNA (final section of Chapterl details its development) 
(Jacobsson and Frykberg, 2001). The vector contains a CoIEI origin for replication 
of double-stranded plasmid DNA in E. coli, an M13 origin for the replication of 
single-stranded DNA for incorporation into phage particles, and a selectable marker 
conferring resistance to ampicillin (Figure 3.1). Additionally, it contains the 
bacteriophage M13 gene encoding the major coat protein, gene VIII, as well as a 
signal sequence allowing the transport of the coat protein to the periplasm for 
assembly into phage particles. The promoter and signal sequence are derived from 
the spa gene of S. aureus encoding protein A (see final section of chapter 1). The 
cloning site is located at the 3' end of the signal sequence, at the restriction site for 
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SnaBI. When digested with this enzyme, pG8SAET becomes linear and blunt-ended. 
The vector also encodes a tag (E-tag) that is 5' to gene VIII and in the same reading 
frame (Figure 3.2). Furthermore, the vector is designed such that the signal peptide is 
in a different reading frame from the E-tag and gene VIII sequences. The E-tag will 
be expressed when the frameshift is corrected by inserted DNA, thereby allowing for 
screening of individual clones whose sequences are in-frame at both the 3' and 5' 
ends of the inserted DNA. Finally, an amber stop codon located immediately 3' to 
the E tag is suppressed in the host strain TG  to allow low-level expression of fusion. 
SapI (1) 
Protein A promoter 
Protein A signal peptide 
NcoI (299) 
SnaBI (3 10) 




pG8SAET 	 \\ \gpVlll II 	EcoRI (527) 
3395 bp 1) 
M13 replication origin 
Ampicillin resistance 
Figure 3.1 General features of pG8SAET, including selected restriction sites. 
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Vcol (299) 
SnaBI (3 10) 
E-tag 
Protein A promoter 	 Amber Stop 
Sapl (1) 	 Protein A signal peptide 	 BainHI (362) gpVlll 	EcoRl (527 
II 	 I 
Figure 3.2 Region of pG8SAET designed specifically for phage display library construction. 
B. Results 
1. Construction of phage display library 
a. Preparation of vector and insert DNA 
Genomic DNA was purified from S. Typhimurium SL1344 by enzymatic 
lysis and ethanol precipitation. It was then sheared by sonication, made blunt-ended 
with T4 DNA polymerase, and phosphorylated with T4 polyneucleotide kinase. The 
vector DNA was digested with SnaBI and dephsphorylated with calf intestine 
phosphatase. After inactivation and removal of enzymes, genomic and vector DNA 
were subjected to agarose gel electrophoresis (Figure 3.3). The majority (>90%) of 
genomic DNA fragments ranged between 0.5 and 2.0 kilobase pairs in length. 
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Figure 3.3 Vector and insert DNA 21 
used to make the library. The size 51 
(in base pairs) of theLambda 49 
DNA/EcoRI+HindIlI molecular 42 
weight maker in lane 1 is indicated to 35 
the left. Lane 2: 1 itl  of digested 20 
pG8SAET. Lane 3: 5 tl  of digested 19 
pG8SAET. Lane 4: 5 pd of sheared S. 15 




b. Optimisation of ligations for library construction 
Five test ligations were performed with the combinations of vector and insert 
DNA indicated in Table 3.1, after which the ligations were precipitated and 
resuspended in a total of 10 .xl. Five microlitres of each were then subjected to 
agarose gel electrophoresis (Figure 3.4), and 1 .tl of each was transformed into 
competent TG1 E. coli host cells. The number of colonies produced by each 
transformation, as calculated by dilution plating, are indicated in Table 3.1. 
Table 3.1 DNA 
composition of trial 
ligations and colonies 
generated from the 
transformation of 1/10 





dH20 Colonies from 
 1/10 of Ligation 
1 2 jJ 8 p.1 10 p.1 
— 
3.5 x 106 
2 2 p.! 16 p.! 2 p.1 4.3 x 106 
3 4 p.1 8 p.! 8 p.1 4.2 x 106 
4 4 p.1 16 p.1 --- 7.2 x 106 




Figure 3.4 Trial ligations for 
Library construction, 
precipitated with tRNA. Half of 
each ligation was subjected to 
agarose gel electrophoresis. Lanes 
1-5 correspond to ligations 1-5. 
Lane 6: 8 p.1 of insert DNA. 
To assess the proportion and size of pG8SAET DNA inserts, colony PCR was 
performed on 12 colonies produced from the transformation of ligations 3 and 4. The 
forward primer "sasekv" anneals at approximately 50 bases to the 5' side of the 
SnaBI site, while the reverse primer "etag" anneals approximately 80 bases to the 3' 
side of it. These reactions were then analysed by agarose gel electrophoresis (Figure 
3.5). For colony PCRs, from both sets of ligations, a DNA band was apparent in 11 
out of 12 reactions. Additionally, for both sets of PCRs, 9 of the reactions produced a 
band of larger size than would be produced by a colony with no insert (128 bp). 
Overall, the average band size of the 9 amplified inserts from ligation 4 was larger 
than those from ligation 3. 
12345678 	910111213 1 2 3 4 5 6 7 8 9 10 11 12 13 
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Figure 3.5 A and B. Agarose gel electrophoresis of colony PCRs for transformants from 
ligations 3 and 4, respectively. Lane 7 is the same molecular weight ladder used in Figure 3.3. 
Arrowheads represent the position of bands produced by colonies without an insert in pG8SAET. 
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Finally, colonies from these two ligations were screened for the expression of 
E-tag by colony lysis on nitrocellulose followed by immunodetection using 
monoclonal anti E-tag antibody. Two out of 46 colonies from ligation 3 and four out 
of 80 colonies from ligation 4 were E-tag positive (data not shown). 
c. Library construction and analysis 
After reviewing the data for ligations 3 and 4, new ligations were prepared as 
a combination of the two to construct a library for further use. Five ligations were 
prepared, with two having an identical composition to ligation 3, and the other three 
having an identical composition to ligation 4. The five ligations were then combined, 
precipitated twice with ethanol, and the DNA was transformed into electrocompetent 
E. coli TGI host cells. Dilution plating of the 100 ml culture at one hour after 
transformation indicated that the culture contained 8 x 108  unique transformants in 
total. Colony PCR was carried out on 24 of the transformants, and these were 
analysed by agarose gel electrophoresis (Figure 3.6). Of the 22 reactions that 
produced a band, 19 were greater in size than the size expected for a colony 
containing pG8SAET without an insert. E-tag expression was also evaluated for 160 
colonies at this stage, of which 7 were positive. 
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Figure 3.6 Agarose gel electrophoresis of colony PCR performed on randomly 
selected unique clones from the pG8SAET/S. Typhimurium library. Lanes 7 and 
G contain the same DNA ladder used in Figure 3.3. All other lanes contain colony 
PCR reactions. Arrowheads represent the position of bands produced by colonies 
without an insert in pG8SAET. 
d. Propagation of pG8SAET library as phage particles 
After ampicillin had been added and the 100 ml culture had reached 
stationary phase, 1.5 ml, 3 ml, and 10 ml portions of the culture were then infected 
with helper phage at different ratios. The infected library portions were grown in soft 
agar on antibiotic-containing agar plates, from which phage particles were 
subsequently extracted and filter-sterilised (see section D3 of Chapter 2 for details). 
Aliquots of 0.5 ml were stored at -80°C for future use. An aliquot from each of the 
three infections was then defrosted, serially diluted in LB, and incubated with TG1 
host cells. Ampicillin-resistant colonies resulting from the infection represented 
individual transfers of pG8SAET from a phage particle to a host cell. Phage stocks 
made from the 1.5 ml, 3 ml, and 10 ml infections were found to contain 1.4 x 1010, 
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1.7 x lOb,  and 1.0 x 1010  pG8SAET-harbouring particles per ml of frozen stock, 
respectively. Titration of plaque-forming units (PFUs) from the 10 ml infection 
indicated that it contained an equal number of particles harbouring helper phage 
DNA compared to phagemid. E-tag detection performed on 1000-2000 colonies from 
each of the three infections indicated that 0.2%, 0.3%, and 0.4%, respectively, were 
positive. 
2. Production of high-titre S. Typhimurium reactive serum 
On day 1, BALB/c (Slc11a1's)  and CBA/Ca (Sicliath)  mice were injected 
intraperitoneally (i.p.) with SL3261, an attenuated S. Typhimurium that is known to 
confer protection against virulent strains (Hoiseth and Stocker, 1981). The same mice 
were then injected i.p. with virulent S. Typhimurium SL1344 on day 28 and twice 
again with SL1344 over the course of the subsequent 38 days. Serum from 
individuals of each mouse strain was collected and pooled together throughout the 
course of the experiment. Immune sera in different dilutions were used in western 
blots to probe whole-cell lysates of SL1344, 10 jig cytosolic SL1344 fraction 
preparation, 0.1 jig purified S. Typhimurium GroEL, and 0.6 jig purified S. 
Typhimurium LPS (Sigma) (Figures 3.7-3.9). Immunoblotted membranes were 
developed with a substrate that stained the membranes directly (see Chapter2 for 
details). Figure 3.7 and 3.8 compare the BALBIc and CBA/Ca pooled sera, and 
Figure 3.9 shows the difference in antigen recognition at day28 and dayl7pc3 of the 
CBA/Ca antibody response. Figure 3.10 shows the changing CBA/Ca antibody 








Figure 3.7. Comparison of BALB/c 
and CBAICa sera for LPS and GroEL 
antibody responses. Final bleeds 
(dayl7pc3), at 1:5000 dilution. 
Lane 1: whole cell lysate; Lane 2: 
LPS; Lane 3: GroEL; Lane 4: 
Molecular weight marker, with 
corresponding sizes (in kDa) on 
the right. 
BALB/c C BA/Ca 
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Figure 3.8. Comparison of BALB/c 
and CBAICa sera for strength and 
diversity of response against proteins. 
Final bleeds (day 17pc3), at 1:10,000 
dilution. Lane 1: whole cell lysate; 
Lane 2: cytosolic proteins preparation; 
Lane 3: LPS; Lane 4: Molecular weight 
marker, with corresponding sizes (in kDa) 
on ther right. 
1:1000 1:10,000 
day28 dayl7pc3 
Figure 3.9. Comparison of CBAICa 
1 	2 3 4 1 	2 3 4 sera from different time points during 
development of the antibody response. - . .._ —175 Day28 serum was collected 28 days after 
immunisation with live attenuated SL3261; - - * 
83 day 17pc3 was the final bleed which was 
62 
collected 17 days after the third challenge  
with virulent SL1344. The right panel of this 
figure is the identical image used in the right 
_33 panel of Figure 3.8. Lane 1: whole cell lysate; - 	- 25 Lane 2: cytosolic proteins preparation; Lane 3: LPS; Lane 4: Molecular weight maker, with 
*7 Corresponding sizes (in kDa) on the right. 
Serum dilutions are indicated above each panel. 
immunoblotted membranes visualised by ECL. The CBA/Ca response was further 
investigated by ELISA (Figure 3.10), using the cytosolic preparation as ligand. 
Endpoints of dilutions were used to determine the strength of anti-S. Typhimurium 
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positive reading, where a positive reading is interpreted as an OD (492 nm) value 
higher than the average of the secondary antibody control wells plus a constant, 
which was set at 0.2 OD units (Kemeny, 1991). 
Figure 3.10. Western blots of CBA/Ca sera 
performed on cytosolic proteins, with 
corresponding Coomassie-stained gel. A single gel 
was used for electrophoresis of S. Typhimurium 
SL 1344 cytosolic proteins (10 jig/lane), after which it 
was divided along the pre-stain molecular weight 
marker (Lane 10; sizes in kDa on the right) for 
subsequent Coomassie staining (Lanes 9-10) or 
transfer to nitrocellulose (Lanes 1-8), after which the 
membrane was cut into strips for Western blot with 
CBA/Ca sera. Lane 1: day 0; Lane 2: day 28; Lane 3: 
day l0pcl; Lane 4: day l7pcl; Lane 5: day lOpc2; 
Lane 6: day 17pc2; Lane 7: day 14pc3; Lane 8: day 
I 7pc3. All sera were used at 1:4000, with the 
exception of day 0, which was used at 1:200 and 
exposed with the maximum possible time and setting 
of the Epi Chemi III Darkroom (UVP Laboratory 
Products) 
Figure 3.11. ELISA titres from diluted CBA/Ca sera collected on different days after 
immunisation and challenge with S. Typhimurium SL3261 and SL1344, respectively. Each well 
was coated with 3.33 jig cytosolic fraction of SL1344 and probed with antibody from CBA/Ca mice. 
dO: pre-immune serum; d28: serum collected 28 days after immunisation with SL3261; dlOpcl: serum 
collected 10 days after challenge I with SL1344; dl7pcl: day 17 post-challenge 1; dlOpc2: day 10 
post-challenge 2, etc. Titres represent the serum dilution factor. 
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Clearly, a strong antibody response was produced in both BALB/c and 
CBA/Ca mice as indicated by the very dilute level of serum needed for the 
immunoblot (1:10,000 for the final bleed, dayl7pc3) and the >25,000-fold increase 
in the concentration of antibody able to bind to a cytosolic preparation of S. 
Typhimurium proteins (Figure 3.10). Additionally, the difference between BALB/c 
and CBA/Ca serum is strikingly clear in western blots. These results will be 
discussed in detail in the following section. 
C. Discussion 
1. Construction of phage display library 
Since pG8SAET was designed specifically as a vector for making 
filamentous phage libraries from bacterial genomic DNA, it was the most appropriate 
vector for this study. The library was made using randomly sheared DNA from the 
virulent S. Typhimurium strain SL1344 following the protocol established for 
pG8SAET (Jacobsson and Frykberg, 2001). Digestion of pG8SAET with SnaBI 
linearised the vector and produced blunt-ended DNA at the digestion site. 
Subsequent dephosphorylation of the digested vector effectively hindered re-ligation 
of pG8SAET without an insert (compare ligation 5 to ligations 3 and 4 in Table 3.1). 
However, complete digestion and/or dephosphorylation of pG8SAET was not 
achieved, since colonies were indeed obtained from ligation 5. This could be due to 
random mutation at the restriction site for SnaBI or incomplete dephosphorylation by 
calf intestine phosphatase. 
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Because shearing is completely random, it is superior to digestion with 
restriction endonucleases for the purpose of generating genornic DNA fragments for 
making a library. Shearing SL1344 DNA produced fragments with the majority 
ranging in length between 0.5 and 2.0 kilobase pairs, which is ideal considering that 
the average coding sequence in the S. Typhimurium genome is approximately 1 
kilobase in length (McClelland et al., 2001). Because shearing does not perfectly cut 
DNA without leaving stretches of single-stranded sequence, mending and 
phosphorylation of sheared DNA by treatment with T4 polymerase and T4 
polynucleotide kinase was necessary. This treatment produced high-quality insert 
DNA for the purpose of making a library, as evidenced by the large number of 
transformants produced from ligations 3 and 4 in comparison to ligation 5 (Table 
3.1) and the high frequency of pG8SAET clones harbouring an insert as produced 
from ligations 3 and 4 (Figure 3.5). 
Clones produced from ligation 3 have, on average, larger DNA inserts than 
clones produced from ligation 4 (Figure 3.5). However, the lack of remaining insert 
DNA in ligation 3 compared to 4 (Figure 3.4) and the higher number of clones 
produced by ligation 4 (Table 3.1) indicated that ligation 3 had incorporated all the 
insert DNA without exhausting the availability of digested, dephosphorylated vector. 
In order to increase the efficiency of ligation and maintain an insert size closer to I 
kb, five ligations were prepared comprising a combination of ligations 3 and 4. 
After the library was transformed into electrocompetent E. coli TG1 host 
cells, the total number of individuals contained in the library was determined by 
serial dilution plating. The library consisted of 8 x 108  individuals with 19 / 22 = 
86% (Figure 3.6) containing an insert. Thus, the library contained 6.9 x 108  unique 
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clones in total. The S. Typhirnurium genome consists of 4.8 x 106  base pairs. The 
library contained clones with an average insert size of 500 bp (average size of colony 
PCR products) - 150 (approximate size of colony PCR product from a colony 
containing pG8SAET with no insert) = 350 base pairs. The minimum number of 
clones required for 99% coverage of the genome was calculated using the following 
formula (Jacobsson et al., 2003): In (1-0.99) / In [1-(350 / 4.8 x 106)] = 6.3154x 10'  
However, this formula does not account for the fact that a DNA fragment 
must be in the correct orientation, as well as the correct reading frame at both the 5' 
and 3' ends, for proper expression of the gene fragment in pG8SAET. For this 
reason, the final number required must be multiplied accordingly: 
6.3154x104 x 2 (orientation) x 3 (correct frame at 5') x 3 (correct frame at 3') 
= 1.136772 x 106 
The library of 6.9 x 108  unique clones is significantly larger than theoretically 
required, which is appropriate given the fact that genomic DNA is not a continuous 
open reading frame. Nevertheless, the above calculation predicting that I in 18 
clones will express the E-tag is a good estimation. This is reflected by the fact that 
the number of clones expressing an E-tag from ligations 3, 4, and the library are I in 
23, 1 in 20, and 1 in 23, respectively. Interestingly, the proportion of E-tag positive 
clones dropped sharply after infection of the library with helper phage. This 
phenomenon has not been extensively investigated, although it was observed as 
typical for previous libraries constructed using this method (Lars Frykberg, personal 
communication). It is possible that this is a manifestation of down-regulation of 
fusion protein expression resulting from infection with the helper phage. 
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2. Production of high-titre S. Typhimurium reactive serum 
Most successful screenings of libraries displaying genomic DNA fragments 
were against a single ligand, a monoclonal antibody, or high-titre serum (Fack et al., 
1997; Jacobsson and Frykberg, 2001; Etz et al., 2002). For this reason, it was 
concluded that serum used for biopanning purposes should be highly enriched for 
anti-Salmonella antibodies. Immunisation of mice with an attenuated strain, followed 
by multiple challenges with a virulent strain, should progressively enrich the serum 
of mice for protective antibodies. Additionally, using live bacteria would be better 
than using lysates because this should mimic natural infection more closely. 
Furthermore, it would allow for the production of antibodies directed against in vivo 
expressed antigens. 
A high level of antibody was raised in the mice as a result of the 
immunisation and challenges. Although both BALB/c and CBA/Ca mice showed the 
same overall level of increase in anti-Salmonella antibodies as indicated by western 
blots and ELISA (data not shown), more emphasis was placed on CBA/Ca serum. 
This is partly due to the fact that BALB/c mice produced a stronger antibody 
response to LPS than CBA/Ca mice (Figure 3.7). The strong, quenching signal 
observed in the lanes containing LPS is not unusual for western blots with this 
molecule, with a ladder-like pattern becoming apparent in some samples. Brown and 
Hormaeche (1989) investigated immunological profiles of anti-Salmonella serum 
from mice and humans in western blots and ELISAs. The study concluded that while 
the level of antibodies directed against LPS is substantial, the majority of antigens 
are likely to be intracellular. The cytosolic fractions tested in Figures 3.8 and 3.9 
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show a variety of bands. While the study tested a variety of mice with different H-2 
haplotypes, CBA/Ca mice were not tested. It is clear in Figure 3.8 that CBA/Ca 
serum recognises a greater number of protein bands than the BALB/c serum. It is 
important to note that in this work as well as the study, the bacterial lysate could not 
contain antigens that are expressed only in vivo. Thus, many antigens may not be 
detected using these methods. 
Brown and Hormaeche (1989) also found that some protein bands were more 
consistently recognised than others. One of the consistently visible bands was 
deduced to be OmpA, which is now well-documented as antigenic (Singh et al., 
2003). Figure 3.8 shows that CBA/Ca serum recognises similar bands that are 
detected by BALB/c serum, in addition to several additional bands. Since CBA/Ca 
serum appeared to recognise more antigens and had a slightly lower LPS response 
than BALB/c serum, this serum was chosen as more suitable for biopanning. All 
biopannings using hyperimmune serum (discussed in the next chapter) were 
standardly performed with day l7pc3 CBA/Ca serum, which was the final bleed. 
Figures 3.9 and 3.10 show that the antigenic profile changed when the 
CBA/Ca immune system was exposed multiple times to virulent S. Typhimurium. 
Because the growth rates of the attenuated and virulent strains are different in vivo, 
the regulatory processes governing antigen expression must have been disparate 
(Clements et al., 2001). Thus, antigens expressed by the attenuated SL3261 strain 
were likely to have a different profile from that expressed by the virulent strain. 
However, it is not clear whether the change in profile apparent in Figures 3.9 and 
3.10 is due to differential antigen expression and/or to a dynamic host response. 
In conclusion, serum with high S. Typhimurium reactivity was produced 
(Figure 3.10), recognising a variety of antigens (Figures 3.8-3.9). Therefore, the 
CBA/Ca dayl7pc3 serum to be used in biopanning is expected to be sufficient. The 
S. Typhimurium library constructed in pG8SAET for this study exceeds the 
theoretical minimum requirements for representing 99% of the genome. Therefore, 
this library is an appropriate tool for identification of S. Typhimurium antigens. 
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CHAPTER 4 
Biopanning and Screening of Phage- 
Displayed Polypeptides for Antigenicity 
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A. Introduction 
In this chapter, the pG8SAET expression library (constructed in Chapter 3) 
displaying random S. Typhimurium fragments is probed for antigens using the high-
titre anti-S. Typhimurium serum from CBAICa mice (analysed in Chapter 3). The 
development of the library and serum is described in Chapter 3. As described in 
Chapter 1, biopanning involves the selection of phage particles from a mixture based 
on their binding affinity for the ligand, followed by propagation and additional 
rounds of selection. Jacobsson & Ftykberg (2001) used polystyrene micro-wells as 
the solid support for the ligands used in biopanning with the pG8SAET phagemid 
vector. A schematic representation of this biopanning method, which was also used 
in this thesis, is shown in Figure 4.1 below. 
C) Allow binding to 
antibodies in 
micro-wells 
D) Wash, elute 
bound phage 
CD B) Infect TG  
host cells with 




E.coli TG  cells with 
pG8SAET clones: 
Add helper phage R408 
S. Typhimurium 
protein fragments displayed 
on mosaic outer coat of phage 
Key 
helper phage DNA 
pG8SAET 
mouse antibody 
Figure 4.1. Schematic representation of biopanning method used in this thesis 
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B. Results & Discussion: Biopanning 
1. Resuts: Verification of established successful biopanning method 
In order to test the biopanning procedure itself, a "control" panning was 
performed using a pG8SAET library and ligand that have an established successful 
protocol. An S. aureus library made in the vector pG8SAET (kindly provided by Dr. 
Jacobsson) was panned against human plasma as described previously (Jacobsson 
and Frykberg, 2001). Essentially, a freshly defrosted aliquot of the phage display 
library was added to a microwell previously coated with human plasma. The well 
was washed extensively with PBS-T prior to elution of bound particles using an 
acidic pH. Eluted particles were allowed to infect E. coli host cells, which gave rise 
to ampicillin-resistant colonies on selective medium. Individual colonies were 
patched and subsequently transferred onto nitrocellulose, on which they were grown 
for immunodetection of E-tag expression (see section F2 of Chapter 2 for details). 
Colonies from the first round of biopanning were collected in a slurry of LB and 
propagated as phage particles that were used in a second round of biopanning. The S. 
Typhimurium library constructed in pG8SAET was panned against human plasma in 
parallel as a negative control. 
Approximately 6.5 x 104 phagemid were recovered after the first round of 
biopanning the S. aureus library, 35% of which expressed the E-tag. A second round 
of biopanning particles propagated from the first round yielded 1.2 x 107  phagemid 
with 89% expressing the E-tag. In comparison, only 1.6 x 103  and 1.7 x 104 
phagemid were recovered after the first and second rounds of biopanning the S. 
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Typhimurium library, respectively. E-tag expression for these was at <1% and 9%, 
respectively. Thus, approximately 40 times more S. aureus-derived phagemid bound 
in the first round compared to S. Typhimurium-derived phagemid. The difference 
between the two was 700 fold in the second round. 
2. Discussion: Verification of established biopanning method 
In order to establish a starting point for biopanning the S. Typhimurium 
pG8SAET library, it was important to reproduce the successful panning results 
obtained with another pG8SAET library (Jacobsson and Frykberg, 2001). A 
significant level of enrichment resulted from biopanning the S. aureus library against 
human plasma, as manifested by the 200-fold increase in total phagemid recovered 
and near-ubiquitous E tag expression observed after the second round. The S. 
Typhimurium pG8SAET library, whose titre and complexity were comparable to the 
S. aureus pG8SAET library, was only enriched 10-fold in parallel. Additionally, two 
rounds of panning the S. Typhimurium library could not achieve E tag expression 
levels produced after only one round of panning the S. aureus library (9% vs. 35%). 
This indicates that the first round of biopanning the S. aureus library yielded a much 
more enhanced level of enrichment compared to the other library. 
The relative lack of enrichment observed in the S. Typhimurium biopanning 
was expected because numerous serum-binding proteins are produced by S. aureus 
and not by S. Typhimurium (Zhang et al., 1999; Zhang et al., 2000a). The ten-fold 
enrichment observed from the S. Typhimurium library was similar to an enrichment 
of non-specific background binding that occurs in nearly all biopannings (Jacobsson 
and Frykberg, personal communication). Hence, although the human plasma used for 
biopanning may have contained anti-Salmonella antibodies, the concentration and/or 
affinity of such antibodies were not sufficient to produce a significant enrichment 
from the library constructed in this thesis. In summary, these experiments provide the 
reference points for positive and negative biopanning results necessary for further 
experiments in the optimisation of biopanning the S. Typhimurium pG8SAET 
library. 
3. Results & Discussion: Optimisation of biopanning conditions 
a. Overview 
Since the "control's biopanning method that was used with the S. aureus 
pG8SAET library could not provide the same quality of results when applied to the 
S. Typhimurium pG8SAET library panning against serum, some modifications were 
required. In the following series of experiments, several parameters were assessed in 
order to achieve a selective enrichment of phagemid clones expressing antigenic S. 
typhimurium epitopes. These parameters included the use of an anti-mouse IgG 
antibody to capture IgG from the mouse serum, the incubation of library particles in 
a number of wells coated with pre-immune mouse serum prior to biopanning, the 
incbation of library particles in solution with untreated or heat-treated non-immune 
mouse serum, the assessment of coating capacity and blocking agents, serum 
fractionation for enrichment of IgG, and combinations of these factors. A generalised 
scheme of the series of biopanning experiments is displayed in Figure 4.2. 
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1. SecondaryAb vs. secondaryAb + serum vs. serum: 
YY1YI 
2.-3. SecondaryAb + serum vs. serum, 
in context of pre-absorption in 4 or 12 microlls: 
Figure 4.2. Schematic representation 
of Experiments 1-9 
Pre-incubation of particles with non-immune 
mouse serum, in solution, prior to biopanning. 
Combination ofexperimerits3and4 I 
I 6. Assessment of coat ngcapacity I 
Assessment of blocking agents 
Assessment of biopanning with serum fmctions 
Combination of experiments 6-8 
b. Experiment 1: Results 
In a parallel setup of biopannings, micro-wells were coated with either goat 
anti-mouse IgG (Fc) antibody, 5 il of anti-S. Typhimurium serum, or goat anti-
mouse Fc followed by 5 il anti-S. Typhimurium serum. After elution, host cells were 
added to the micro-wells to recover any remaining phage that did not elute. Other 
biopanning parameters were according to the previously established protocol 
(Jacobsson and Frykberg, 2001). Phagemid from eluted particles were combined 
with phagemid subsequently recovered from the corresponding well. These were 
propagated and used in a second round of biopanning against the same ligand from 
the first round. The resulting phagemid recoveries and percentage expressing the E-
tag are indicated in Table 4.1. 
113 
Ligand Eluted phagemid, in 
CFUs 
(% E-tag +) 
CFUs of phagemid 
Recovered from Well 
(% E441+) 
ROUND 1 
Anti-mouse Ab 3 x 10 (1%) 600(2%) 
Anti-mouse Ab + serum 5 x 10 (1%) 200(14%) 
Serum 2 x 103 (1%) 300(8%) 
ROUND 2  
Anti-mouse Ab 5 x 10 6  (20%) 1 x iO4 (6%) 
Anti-mouse Ab + serum 1 x iO (28%) 4 x 103 (23%) 
Serum 4 x 105 (32%) 7 x 10 (23%) 
Table 4.1. Recovery of phagemid from two rounds of biopanning in Experiment 1. 
CPUs correspond to stage F) of biopanning, indicated in Figure 4.1. The pG8SAET library 
library was panned against the ligands indicated. Host cells were added to wells after elution 
in order to recover remaining bound phagemid. The two categories of phagemid obtained 
from the first round were combined for each ligand and propagated for subsequent selection 
in the second round against the corresponding ligand. Phagemid CPUs obtained after each 
round of selection, and the proportion expressing E-tag are indicated. 
c. Experiment 1: Discussion 
In Experiment 1, biopanning with serum directly coated in microwells was 
compared to biopanning with the assistance of anti-mouse antibody. In theory, wells 
pre-coated with antibodies directed against the mouse IgG molecule should promote 
the selective retention of these antibodies subsequent to addition of the serum. 
Furthermore, the Fc-specificity of the antibody should aid in orienting the mouse 
antibodies to maximise exposure of their antigen-binding regions. However, no 
significant difference was observed when biopanning was performed in wells 
containing anti-mouse antibody plus serum compared to wells containing either 
component alone. The similar level of enrichment achieved when panning against 
serum alone versus anti-mouse antibody alone indicated that the enrichment was 
unlikely to be specific for Salmonella antigens. This is an important point because 
the enrichment level indicated by the number of recovered phagemid is greater than 
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200 fold between the first and second round of biopanning. However, the number of 
phagemid recovered from the first round, as well as the frequency of E tag 
expression among these, are much lower than what was obtained in the first round of 
biopanning with the S. aureus library. Finally, sequencing of 30 different E-tag 
positive clones from the second round of biopanning for each of the three categories 
of ligand failed to reveal any clones encoding known antigens or having overlapping 
insert sequences (data not shown). Indeed, undesirable enrichment of phage binding 
to the secondary antibody was documented in another study that used a random 
peptide library (Messmer and Thaler, 2001). Iterative panning of the peptide library 
led to the development of a specific peptide for blocking unoccupied sites on the 
monoclonal secondary antibody, which solved the problem of undesirable binding of 
phage particles. However, affinity-purified or otherwise polyclonal antibody would 
require the development of a more complex blocking peptide mixture, specifically 
designed for the antibody in question. 
d. Experiments 2-3: Results 
Four (Experiment 2A) or 12 (Experiment 3A) wells were coated with pre-
immune CBA mouse serum and an additional well was coated with the dayl7pc3 
CBAICa anti-S. Typhimurium serum. Another series of wells was set up in parallel, 
but the wells were coated with anti-mouse antibody prior to addition of mouse serum 
(Experiments 2B and 313). The library was sequentially incubated in wells containing 
pre-immune CBA/Ca serum before addition to the well containing anti-S. 
Typhimurium serum. Phagemid from eluted particles were combined with phagemid 
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subsequently recovered from the corresponding well. In the second round, phage 
were not pre-incubated in wells containing pre-immune serum. Instead, phage 
derived from Experiment A were panned against ligand A in two wells: one with pre-
immune and one with anti-S. Typhimurium serum, and likewise for B. Only eluted 
phagemid were counted from the second round. The resulting phagemid recoveries 
are indicated in Tables 4.2 and 4.3. 
Round 1 CFUs  
Ligand Eluted Recovered from Well 
Serum 1.5 x iO3  400 
Anti-mouse Ab+ serum 2.5 x 10 500 
Round 2 CFUs (from eluted phagemid-containing particles) 
Pre-immune Immune 
Serum 1.2 x 104 1.2 x iO4 
Anti-mouse Ab + serum 9 x 101  7 x 10 
Table 4.2. Recovery of phagemid from Experiment 2. CFUs correspond to stage F) of 
biopanning, indicated in Figure 4.1. Phagemid CFUs obtained after elution and retrieval of 
remaining bound particles in wells are indicated. The pG8SAET library was pre-adsorbed in 
FOUR consecutive wells coated with pre-immune serum, or pre-immune serum bound to 
anti-mouse antibody, prior to biopannning against hyperimmune anti-S. Typhimurium serum 
in round 1. The two categories of phagemid obtained from the first round were combined for 
each ligand A. and B. and propagated for subsequent selection against the corresponding 
ligand in the second round. Phage were not pre-adsorbed in the second round but were 
panned against pre-immune or hyperimmune anti-S. Typhimurium serum in the second 
round. Phage originating from panning against ligand A and B were panned against the 
respective ligands A and B in the second round. 
Round 1 CFUs 
Ligand Eluted Recovered from Well 
Serum 1 x 101  270 
Anti-mouse Ab + serum 2.6 x 450 
Round 2 CFUs (from eluted phagemid-containing particles) 
Pre-immune Immune 
Serum 1.6 x 104 2.7 x iø 
Anti-mouse Ab + serum 4 x 10 3.8 x 104 
Table 4.3. Recovery of phagemid from Experiment 3. CFUs correspond to stage F) of 
biopanning, indicated in Figure 4.1. Phagemid CFUs obtained after elution and retrieval of 
remaining bound particles in wells are indicated. The pG8SAET library was pre-adsorbed in 
TWELVE consecutive wells coated with pre-immune serum, or pre-immune serum bound to 
anti-mouse antibody, prior to biopannning against hyperimmune anti-S. Typhimurium serum 
in round 1. All other conditions correspond to those in Table 4.2. 
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e. Experiments 2-3: Discussion 
In Experiments 2-3, the anti-mouse antibody/ mouse serum combination was 
compared to serum alone in the context of pre-absorption of the library in 
consecutive wells containing pre-immune serum. The goal for these experiments was 
to reduce the level of background binding to wells and serum components other than 
anti-S. Typhimurium antibodies. In a study that successfully identified four known 
antigens and one novel antigen of Brugia malczyi, a similar pre-incubation strategy 
was used (Gnanasekar et al., 2004). A 1:100 dilution of pooled serum from three 
different categories of pathology, each consisting of 10 non-immune individuals, was 
used to coat wells directly. The B. malayi cDNA phage display library was incubated 
consecutively in each well coated with a different category of non-immune serum 
prior to panning against a well coated with pooled serum from immune individuals. 
The same procedure was performed for each of four consecutive rounds of 
biopanning (Gnanasekar et al., 2004). 
Experiments 2-3 also include the recovery of phagemid particles not released 
by elution buffer through the addition of host cells to wells after elution. This method 
allowed the isolation of a clone encoding a particular binding domain of von 
Willebrand factor binding protein from a Staphylococcus lugdunensis library that 
was not obtained by elution with low pH (Nilsson et al., 2004). 
Experiments 2-3 revealed that the use of capturing antibody does not enhance 
the level of enrichment achieved by biopanning with serum alone. Additionally, 
consecutive pre-incubation of the library in 4 or even 12 wells containing pre-
immune serum does not improve enrichment levels. Finally, these experiments 
indicated that a small percentage of phage not eluted in the first round constitute a 
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significant loss of enrichment in conventional biopanning, as demonstrated by the 
very large proportion of non-eluted phagemid in the second round. 
f. Experiment 4: Results 
The subsequent trials were performed without the use of capturing antibody. 
The library was pre-incubated with 10 t1 or 20 }.tl of untreated or heat inactivated 
non-immune serum (obtained from non-immunised CBA/Ca mice other than those 
used for generation of hyperinimune S. Typhimurium serum) prior to biopanning 
against anti-S. Typhimurium serum. Non-immune serum was used instead of pre-
immune serum in order to conserve pre-immune serum for future experiments. A 
single round of biopanning yielded phagemid as indicated in Table 4.4. Phagemid 
recovered from biopanning with library having been pre-incubated with 10 pA 
untreated non-immune serum were used in a second round of biopanning in 
Experiment 4. For this and subsequent biopannings, phagemid from eluted particles 
were combined with phagemid subsequently recovered from the corresponding well. 
The phage stock was pre-incubated with non-immune serum as it had been in the 
first round, after which it was added to a well containing non-immune (A) or anti-S. 
Typhimurium (B) serum. Phagemid recovered from round 2B were panned a third 
time against non-immune (A) or anti-S. Typhimurium (B) serum. Phagemid 
recovered from round 3B were panned a fourth time against non-immune (A) or anti-
S. Typhimurium (B) serum. The resulting phagemid recoveries are indicated in Table 
4.5. 
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Table 4.4. Phagemid recovery after one round of 
biopanning with particles having been pre-
incubated in untreated or heat-treated non-
immune serum. CFUs correspond to stage F) of 
biopanning, indicated in Figure 4.1. Serum was 
added to the library and incubated for 15 mm. at RI 
prior to addition of the mixture to wells. *These 







*lOp!untreated 620, 130 
10 j.iJ heat-treated 570, 230 
20 .tl untreated 700, 130 
20 il heat-treated 640, 150 
Ligand Round 2 Round 3 Round 4 
CFUs eluted, CFUs eluted, CFUs eluted, 
recovered from well recovered from well recovered from well 
Non-immune 830,270 420, 2 x 10 2.7 x 	8 x io 
serum  
Immune serum 740,500 760, 2 x 103  5.1 x 103, 8 x 103  
Table 4.5. Recovery of phagemid from Experiment 4. CFUs correspond to stage F) of biopanning, 
indicated in Figure 4.1. Phagemid recovered from the biopanning indicated in Table 4.4 were used in 
subsequent rounds of panning. Each phage preparation was pre-incubated with 10 p.1 of untreated non-
immune serum prior to each round of panning. Propagated phage were panned sequentially against the 
same ligand. 
g. Experiment 4: Discussion 
Experiments were performed to assess differences in phagemid recovery after 
a single round of panning with library phage having been pre-incubated with 10 or 
20 .tl of untreated or heat-treated non-immune serum. Since complement is a serum 
component that may potentially damage phage particles, heat treatment was 
performed to inactivate it. However, no difference was observed among all four 
treatments. In Experiment 4, addition of non-immune serum to the library prior to 
biopanning was investigated in successive rounds of biopanning, with a parallel 
panning against pre-immune serum as a reference point. The multiple panning 
rounds revealed a strong enrichment for phagemid that could not be eluted. However, 
this enrichment was observed at the same level for both anti-S. Typhimurium serum 
119 
as well as pre-immune serum, which indicated that although the enrichment was 
strong, it was not likely to have resulted from antibodies directed against S. 
Typhimurium. In contrast, the addition of a non-immune antibody preparation to a 
random peptide phage display library prior to biopanning may have contributed to 
the successful isolation of epitopes specifically recognised by the antibodies of 
individuals exposed to Borrelia burdorferi (Kouzmitcheva et al., 2001). Notably, the 
mixture was centrifuged to remove complexes prior to biopanning. However, many 
factors could have contributed to the success, since this study used purified 
antibodies that were also pre-adsobed against wild-type phage. Another study added 
non-specific antibody in solution with a random peptide library but did not remove 
the complexes prior to successfully panning for Equine herpesvirus type I epitopes 
(Birch-Machin et al., 2000). 
h. Experiment 5: Results 
In the next several experiments (Experiment 5), the library was pre-incubated 
with non-immune serum, then was sequentially incubated in 7 wells coated with non-
immune serum, prior to biopanning against anti-S. Typhimurium serum in the first 
round. In one of these experiments, about 5 x 103  phagemid were obtained by 
elution, and a further I x 103  were recovered from the well after elution in the first 
round. The combined progeny of the phagemid from this round were panned against 
non-immune and immune serum. This resulted in I x 104 and 6.6 x 104  eluted 
phagemid from wells coated with non-immune and immune serum, respectively. A 
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further 800 and 5 x 103  phagemid were recovered from the wells after elution, 
respectively. Several repetitions of this experiment could not reproduce the result. 
Experiment 5: Discussion 
In Experiment 5, addition of non-immune serum to the library prior to 
biopanning was combined with pre-absorption in wells coated with pre-immune 
serum. Several experiments were performed, one of which potentially exhibited a 
significant and specific enrichment. However, this experiment could not be repeated 
despite multiple attempts. Therefore, goals were set for subsequent experiments to 
optimise other biopanning parameters with the aim of improving the frequency in 
which potentially successful enrichments occur. 
Experiments 6-8: Results 
Next, different amounts of serum were used to coat wells in order to assess 
background binding of phage particles in Experiment 6. The anti-S. Typhimurium 
serum used throughout biopanning experiments (the final bleed from CBA mice) was 
determined to be at a concentration of 50 mg/mi as measured by Coomassie Plus 
Protein Assay Reagent (Pierce). Biopanning was performed following the original 
protocol established for the S. aureus pG8SAET library, but particles derived from 
the pG8SAET vector without inserted foreign DNA were used instead of the library. 
In Experiment 7, different blocking solutions were tested for their ability to reduce 
the level of background binding. This time, the library itself was used owing to the 
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fact that the wells were not coated with ligand prior to blocking. For Experiment 8, 
the anti-S. Typhimurium serum was divided into two fractions by precipitation with 
saturated ammonium sulphate. Both fractions were dialysed against PBS prior to 
coating in wells for biopanning. Wells were blocked with milk prior to addition of 
the library for biopanning. Phagemid recoveries (in CFUs: see stage F of biopanning 




 from well 
10 g 1x103  160 
*2 pLI1.6x10 240 
0.2 j.tl 2.6 x 10 3 240 
0.02 gl 4.2 x 103  380 
0 l.tl 1.lx 101  920 
Table 4.6. CFU Phagemid recovery from 
Experiment 6. No-insert phage were used 
in mock panning instead of library phage. 
* Indicates quantity of serum normally used 




 from well 
Fish gelatin 8 x 7 x 
Milk 160 100 
None 1.9 x 3.8>< 
Table 4.7. CFU Phagemid recovery from 
Experiment 7. Wells were not coated prior to 
blocking in mock single-round biopanning. 
Library phage were used in this experiment. 
Ligand Eluted 
(% E-tag +) 
Recovered from Well 
(% E-tag +) 
ROUND! 
0.1 mg supernatant fraction 370 (11%) 260(12%) 




0.1 mg supernatant fraction 3 x 106  (21%) N/C (36%) 
0.1 mg IgG-enriched fraction 3 x 10 (33%) N/C (5 1%) 
Table 4.8. CFU Phagemid recovery from Experiment 8. Wells were coated with partially 
purified ligand as indicated, and were subsequently blocked with milk prior to biopanning 
with library phage. N/C: not counted. Proportion of phagemid expressing the E-tag are 
indicated in parentheses. 
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k. Experiments 6-8: Discussion 
In Experiment 6, the binding capacity of the wells was tested by coating wells 
with different amounts of the anti-S. Typhimurium serum and observing the number 
of non-recombinant phagemid particles that bound after a single round of mock 
biopanning. Since non-recombinant phagemid particles do not display any foreign 
polypeptides, any binding must be non-specific. This experiment revealed that 
coating was maximal with the highest concentration of serum (10 jil), but the number 
of bound phagemid was not significantly lower than the typically used quantity (2 .tl, 
which contains 0.1 mg protein), which was in turn not very much lower than for the 
well coated with 0.2 l of serum. 
In Experiment 7, different blocking solutions were tested for the ability to 
prevent binding of the library phage to uncoated wells. Up to this point, no blocking 
solution had been used during biopanning. This was because extensive washing with 
PBS-T had been sufficient for the positive control biopanning of the S. aureus 
library, so no blocking solution was used. Other successful studies also have not 
needed a blocking agent (Sheu et al., 2003; Wall et al., 2003). However, the total 
number of phagemid that bound in the first round of control biopanning the S. aureus 
library was much higher than had been the case for the S. Typhimurium library. 
Thus, the proportion of non-specifically binding phagemid was much lower for the S. 
aureus panning and therefore blocking was less important for that panning, and vice 
versa. Skimmed milk has been used as a blocking agent in successful biopanning 
procedures (Kjaer et al., 1998; Theisen et al., 2000). Fish gelatine has been evaluated 
among other blocking agents for quantitative detection of antigen (Kaur et al., 2002). 
Biopanning the S. Typhimurium against empty wells blocked with the different 
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solutions yielded surprising results. An empty well blocked with fish gelatin caused 
more particles to bind than an unblocked empty well, implying that fish gelatine is 
"sticky" for M13 phage. This is significant because it shows that a poorly chosen 
blocking solution could complicate the interpretation of positive results. Since 
blocking with milk was shown to significantly reduce non-specific binding of the 
library to the wells, this step was added to subsequent pannings. 
In Experiment 8, the mouse serum used in biopannings was partially purified 
by precipitation with saturated ammonium sulphate. This procedure was predicted to 
divide the serum into an IgG-enriched fraction (precipitate) and an IgG-depleted 
fraction (supernatant). Both of these fractions were dialysed against PBS prior to use 
in biopanning experiments. This is significant because some serum components 
having a very small molecular weight (<15 kDa) may have been lost during the 
procedure. Subsequent use of these two fractions for biopanning resulted in a high 
level of enrichment between the first and second rounds of biopanning for both 
fractions. Screening for E-tag expression further supported the probability that a 
successful enrichment had occurred. Importantly, this experiment did not contain a 
negative control owing to the fact that very little non-immune CBA serum was 
available, thus precluding a similar partitioning of this serum into IgG-enriched and 
IgG-depleted fractions. 
1. Experiment 9: Results 
In Experiment 9, a well was coated with 0.2 mg of the IgG-enriched fraction 
of anti-S. Typhimurium serum, blocked with milk, and used for biopanning the 
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library phage. All 2176 phagemid recovered after elution and subsequent recovery 
from the well were screened for E-tag expression. Phagemid with inconclusive E-tag 
expression were considered positive and were included in the total of 179 clones 
selected for further screening. Stationary phase cultures were made for each 
phagemid clone, and these were combined in equal volumes to form a mixed culture 
which was used for propagation of phage in soft agar on plates. Phage were extracted 
and used for a second round of biopanning, which yielded 1 x 10 eluted phagemid 
as well as a number of phagemid, recovered from the well after elution, that were not 
counted. 
m. Experiment 9: Discussion 
In Experiment 9, a well was coated with twice as much IgG-enriched fraction 
as was used for Experiment 8 (0.2 vs 0.1 mg). To ensure that no antigens were lost 
between the first and second rounds of biopanning, all 2176 colonies recovered from 
elution and after elution were screened for E-tag expression. Colonies with very 
weak and potentially negative results were included in the pool chosen for further 
analysis as a precautionary measure. Phage particles propagated on a 
stoichiometrically mixed culture of these clones were used in a second round of 
biopanning, which resulted in a strong enrichment for both eluted and non-eluted 
phage. The strong enrichments in Experiments 8 and 9 may have been due to a loss 
of one or more inhibitory components lost from the serum during dialysis. However, 
the specificity of the enrichments observed in these two experiments could not be 
ascertained due to a lack of negative control. 
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C. Results & Discussion: Screening 
1. Results 
a. Sequencing of clones and confirmation of E-tag expression 
Plasmid DNA was isolated from each of the 179 clones isolated from 
Experiment 9 using a Wizard miniprep kit (Promega). Primers "etseq" and "etag" 
were used to sequence the DNA from the 5' and 3' side of insertion site, 
respectively. The sequencing primers annealed at a distance sufficiently far from the 
junction at both the 5' and 3' end of the insert to permit accurate assessment of the 
reading frame at both ends. Most sequencing reactions yielded data sufficient for 
identification of genes, their orientation and reading frames, and insert size. A 
reading frame of (+2) was required at the 5' end of the insert to form an in-frame 
fusion with the signal peptide. In other words, the first codon of the insert was 
formed by nucleotides 3-5. An in-frame fusion with the E-tag occurred at the 3' end 
when the last three nucleotides of the insert formed the last codon of the insert 
coding sequence (CDS). Data from successful sequencing reactions were used to 
perform BLAST searches to identify the sequences contained in each clone. The 
resulting data were then consolidated into Table 4.9. Additionally, colonies were 
screened once again for E-tag expression (Figure 4.3). TG1 harbouring pG8SAET 
with no insert was the negative control, while a pG8SAET construct containing the S. 
Typhimurium rplL gene (described below) served as the positive control. 
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Clone] E-tag complete] ORF]size (bp) frame] E-tag fusion Antigen icity] Typhi 1 gene/region name of protein comments 
1 Y Y 43 (-3) Y 1.51 100% recJ ssDNA exonuclease 	. 5'-->3 speck, Mg dependent 
2 + Y Y 149 (+3) Y 1.99 100% accB acetylCoAcarboxylase, ]carrier ofbiotin 
BCCP subunit 
3 Y Y 217 N/A Y 2.46 98% dbpA  sequence region _between corA and 
4 + Y >349 (+) Y 1.81 99% I pduG putative cobalann sequence quality not good at 5'junction 
adenosyltranstorase 
5 - Y Y 31 (-2) * (-0.2) 96% STM1697 putative diguanylato (+2) contains 2 TAG's, (+1) and (+3) are ORFs 
cydase/phosp hod iestorase 
domain 2 
- 
6 ++ y' * 125 (+2) * 2.06 N/A oriF hypothetical rrobilization non-conjugative E. co/i plasmid RSF 1010; 
operon protein F base #309 (just before insert) nssing 
from vector; (+2) contains one stop codon; 
7 - V Y 374 (+3) Y 	- 1.28 N/A STM2697 putative tail protein 
(+1) &(+3) contain 1 'TAG' each 
Fels-2 prophage: similar to 
'ore protein in phage 186  
8 - Y Y 86 (+2) Y 2.27 N/A ssbB single-stranded DNA ]pSLT 
binding protein 
9 Y Y 97 (+2) Y 2.26 97'' cysA sulfate transport ATP-binding protein 
10 - Y Y 149 (+3) Y 1.95 98% dxr 1-deoxy-D-xylulose 	non-rcevalonate pathway of 
5-phosphate 	 isoprenoid biosynthesis 
11 - y * 90 (+3) * 1.15 100% ytY 
reductoisomerase  
paral putative acetyl- 	putative 3-ketoacyl-CoA 
* * 
CoA acetylfiansterase ]lhiolase in S. Typhi 
12 - Y 67 (-2) 0.06 N/A repB/nobA putative primase/ 	non-conjugative 
replication protein! IE. co/i plasrrd RSF1010 
rmbilizationproteio  
13 - N N >334 (-1) unknown 	N/A 96% avt valine-pyruvate 	] no CDS; kill of stop codons 
annotransbrase 
Table 4.9 (continued on following pages). The 179 clones selected from Experiment 9 for further analysis. Bold numbers in column I indicate clones that were chosen 
for screening. Rows with bold borders indicate clones that were chosen for sub-cloning. E-tag expression levels are relative to the positive and negative controls. Column 3 
indicates whether the entire insert sequence was obtained. Column 4 indicates whether the insert sequence constitutes a continuous open reading frame (ORF). A correct 
fusion to the signal sequence has a reading frame of (+2). * Indicates that an ORF in frame with the E-tag having one or more amber (TAG) stop codons. Column 8 contains 
the mean antigenic index (Jameson-Wolf, using Protean software from DNASTAR) of the 6 consecutive amino acids (indicated in bold in Appendix) with the highest 
antigenicity in the available sequence. Column 9 indicates amino acid identity with S. Typhi CT 18. Plasmid sequences were not compared. 
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N/A oat4; ygaP 
100% 	gipA 
99% 	ybgS 
0-antigen acetylase; fusion of 	ditterentDNA fragment 
putative rhodanese- 
related sulfur1ransrase 
anaerobic sn-glycerol-3-phosphate  
dehydrogenase, large subunit  

















cytoplasnic L asparaginase I 
anaerobic sn-glycerol- 	(+1)&(+3) frames each 
3-phosphate 	 contain one stop codon 
dehydrogenase, large subunit 
19 - Y Y 218 (-1) Y 	1.62 1 	94% 	tic phase 1 fagellin 	 tirst40 amino acids of ORE have low-level 
homology with an E, co!i flagellin subunit 


















lysine speclfc perrmase 	APC family 
DELETION MUTANT 
D alanine D alanine 	full of stop codons 
ligaseA 
24 + V V —880 (+2) V 	2.29 99% 	STM2722 1  probable terrrnase 	Fels-2 prophage: similar to gpP, 
subunit 	 ATP charging, in phage P2 
25 +++i-. Y V 157 (+2) V 	2.67 98% 1 	STM3167 putative diadenosine tetraphosphate (Ap4A) hydrolase 
26 + Y Y 587 (+3) Y 2.45 98% ticB catabolic threonine 	induced anaerobically when aa's 
dehydratase 	 are plentiful and glucose is absent 
27 + V Y 143 (+3) Y 2.08 97% 	yfuK putative periplasnt protein 
28 - poor growth; sequence not obtained 
29 - V N 496 (+1) N N/A 98% 	ddg cold shock-induced 	full of stop codons 
palmitoleoyl tanstorase 
30 - J  DELETION MUTANT  
Table 4.9 (continued from previous page). The 179 clones selected from Experiment 9 for further analysis. Bold numbers in column I indicate clones that were 
chosen for screening. Rows with bold borders indicate clones that were chosen for sub-cloning. E-tag expression levels are relative to the positive and negative controls. 
Column 3 indicates whether the entire insert sequence was obtained. Column 4 indicates whether the insert sequence constitutes a continuous open reading frame (ORF). 
A correct fusion to the signal sequence has a reading frame of (+2). * Indicates that an ORF in frame with the E-tag having one or more amber (TAG) stop codons. 
Column 8 contains the mean antigenic index (Jameson-Wolf, using Protean software from DNASTAR) of the 6 consecutive amino acids (indicated in bold in Appendix) 
with the highest antigenicity in the available sequence. Column 9 indicates amino acid identity with S. Typhi CT 18. Plasmid sequences were not compared. 
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Clone E-tag complete'ORF'Islze (bp)l frame E-tag fusioniAnitgenicity Typhi 	gene 	name of protein 	 comments 
31 - Y Y 63 (+1) Y 	1 0.59 100% trmE GTPase for IRNA nudiftation and thiophene and tran oxidation 
32 + Y Y 201 (+1) Y 2.77 N/A 	sodCl 	Cu, Zn superoxide Gitsy-2 prophage 
dismutase 
33 - Y Y 228 (-2) Y 2.35 98% 	serB 	1 3-phosphoserine phosphatase 
34 + Y 373 (+2) Y 2.37 'ATP 100% deaD -dependent RNA CDS begins halfway through 




—470 (+) Y 2.94 98% 	metG 	methionineNA sequence quality 
synthetase not good at5 junction 
36 - Y Y 669 (+1) Y 2.60 66% 	rci 	shufilon-specific CDS is preceded by 1 step codon 
recombinase & begins halfway through the insert 
sequence; poor growth 
37 - Y Y 203 (+3) V 2.14 1 	99% 	edd 	6-phosphogluconate dehydrafase 
38 - Y Y 122 (+3) V 2.60 100% nagE PTS system; N-acetyk CDS begins 2/3 of the way 


















96% 	pyrE 	i orotidine-5-phosphate decarboxylase 
59% ybeQ putative TPR repeat 	CDS is preceded by 1 step codon 
I 	
protein 	 &starts halfway through insert sequence 
41 + V Y 135 (+1) V 1.11 100% kdsA 	3-deoxy-D-manno-octulosonic acid 8-P synthetase 
42 - N V >519 (+;+3) N 2.47 N/A 	res; ylaB rest iction-rrodifcation 	insert is a fusion of 2 fragments 
enzyme; putative diguanylate 
cyclase/p hosp hod ieste rase 
43 - V V 143 (-1) V 2.64 98% 	yjiY 	putative carbon starvation protein 
44 + V N 79 (-1) N N/A 100% i 1N essential cell division 	each of the 3 possible reading frames 
I  protein contains 1 step codon 
45 ++ -  - 	DELETION MUTANT 
Table 4.9 (continued from previous page). The 179 clones selected from Experiment 9 for further analysis. Bold numbers in column 1 indicate clones that were 
chosen for screening. Rows with bold borders indicate clones that were chosen for sub-cloning. E-tag expression levels are relative to the positive and negative controls. 
Column 3 indicates whether the entire insert sequence was obtained. Column 4 indicates whether the insert sequence constitutes a continuous open reading frame (ORF). 
A correct fusion to the signal sequence has a reading frame of (+2). * Indicates that an ORF in frame with the E-tag having one or more amber (TAG) stop codons. 
Column 8 contains the mean antigenic index (Jameson-Wolf, using Protean software from DNASTAR) of the 6 consecutive amino acids (indicated in bold in Appendix) 
with the highest antigenicity in the available sequence. Column 9 indicates amino acid identity with S. Typhi CTI8. Plasmid sequences were not compared. 
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Clone' E-tag compIeteORFsize (bp) frameE-tag fusionAnitgenicity Typhi 	gene 	name of protein comments 
46 N N >541 (-2) N 	1 N/A 	97% yqgA putative inner membrane full of stop codons 
transport protein 
47 - Y N 128 (-3) N N/A 	N/A 	orf46 	I Putative  inlegrase S. Choleraesuis 50k virulence plasnd; 
protein each reading tame contains 1 stop codon 
48 - Y Y 200 (+3) Y 2.59 	100% 	ybeX 	Mg and Co efflux protein CDS is preceded by 1 stop codon & 
begins 27 bases into the insert haenolysin- 
related protein; contains CBS domain 
49 - Y N 303 (-3;+1) Y N/A 	N/A 	yliP; adiY 	believed to be involved in I contains 1 stop codon; 
assembly of Fe-S 	insert is 	fusion of 2 DNA fragments 
clusters; transcriptional activator of adiA 
50 + Y N 506 (+1+3) V N/A 	99% 	yiaN; yiaO 	putative DedAfamily; putative dicarboxylate-binding protein - 	- 
51 - V N 205 (+1;+2) V N/A 97% STM0610; putative component of anaerobic dehydrogenases; 
STM061 1 	putative oxidoreductase protein 
52 - V V 390 (+1) Y 2.30 	100% 	lonH putative ATP-dependent 	005 is preceded by 2 stop codons & 
protease 	 starts 1/3 way through insert sequence 
53 Y 127 (+2) Y 2.38 	1 	99% 	ytlE 	putative cell rmrphogenesis protein 
54 - V Y 35 (-2) Y 1.68 N/A STM4489 putative superfunily I DNA helicase 
55 + V N 405 (+1;-2) V N/A 	99% 	hp gcd 	hypoxanthine phosphor ibosyttransfurase; glucose dehydrogenase 
56 ++ Y N 267 N/A N N/A 97% RSA repetitive element full of stop codons 
57 - N Y >145 (-1) unknown 
- 
2.15 	95% 	ybjF'putative 	NA(uracil-5-)-methyllransterase 
58 - Y N 328 (+2) N N/A N/A t PSLT036 	putative transposase, 	pSLT; full of stop codons 
lS200-like 
59 - V N 151 (-3) N N/A 	N/A 	9 	'tailspike protein P22; full of stop codons 
60 + V * 182 (-2) * 2.56 96% sciP putative outer ompA family; contains 2 TAGs 
membrane protein 
+ N N >250 (-1) N N/A 	95% 	STM2010 	putative cytoplasmic full of stop codons  
protein 
62 +++ Y Y 131 (-1) V 0.88 	97% 	nrdD 	anaerobic ribonucleoside-triphosphate reduclase 
Table 4.9 (continued from previous page). The 179 clones selected from Experiment 9 for further analysis. Bold numbers in column I indicate clones that were 
chosen for screening. Rows with bold borders indicate clones that were chosen for sub-cloning. E-tag expression levels are relative to the positive and negative controls. 
Column 3 indicates whether the entire insert sequence was obtained. Column 4 indicates whether the insert sequence constitutes a continuous open reading frame (ORF). 
A correct fusion to the signal sequence has a reading frame of (+2). * Indicates that an ORF in frame with the E-tag having one or more amber (TAG) stop codons. 
Column 8 contains the mean antigenic index (Jameson-Wolf, using Protean software from DNASTAR) of the 6 consecutive amino acids (indicated in bold in Appendix) 
with the highest antigenicity in the available sequence. Column 9 indicates amino acid identity with S. Typhi CT18. Plasmid sequences were not compared. 
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Clone E-tag complete ORFsize_(bp) frame E-tagfusionlAnitgenicityl Typhi I 	gene 	name of protein I 	 comments 
63 + Y Y 464 (+3) Y2.21 98% las putative aldo/kelo reductase 
64 - Y Y 233 (+3) Y 2.53 	99% 	deaD 	ATP-dependent RNA helicase/ cyslaine sutfinala desutfinase 
65 -  N N >304 (-2) unknown N/A N/A STM1O4I probable minor tail Gihy-2 prophage 
66 - Y V 687 (1-1) V 2.22 	<65% 	STM0351 	putative cation efilux 
i.prolain 	 ________________________________________________— 
Paralog of E. coil integral transrnembrane 
system protein !protein; acridine resistance 
67 - Y V 206 (+3) V 0.83 	100% 	dnaX 	DNA polyrmrase Ill CDS is preceded by 1 slap codon & 
garriria subunit star 	2/3 way through insert sequence  
68 + V V 540 (+1) V 2.62 	98% 	STM4305 	E  putative anaerobic dimethyl suttixide reductase, subunit A 
69 + Y N 363 (+1) Y N/A N/A C 	stbA iE. coil plasrrd pCoo 
70 - N N >450 (-3) unknown N/A 	99% engA 	putative GTP-binding tijil of slap codons 
protein 
71 + V V 483 I 	(+1) Y 2.3 	99% 1 	kdsB 	CTP:CMP-3-deoxy-D-manno-octi.osonate transtirase 
72 - N N >157 I (-3) unknown N/A 98% mtiA PTS family, mannilakpecific enzyme 
IIABC components; contains 1 slap codon  
73 - N N >454 (-1) unknown N/A 	98% 	phoH PhoB-dependent, ATP-binding pho regulon 
component; till of slap codons 
74 - Y N 415 (-3) N N/A 	N/A 	traA 	Imbrial subunit i conjugative transfer; contains 1 slap codon 
75 - V Y 86 (-1) V 2.73 1 98% cgs cystathione gamma-synthase  
76 - Y Y 515 (+l;-3)1 N 1.92 	1 	N/A 	STM1537; 	putative Ni/Fe-hydro- 	insertsequence is a fusion of 
. mt genase 1 b-type cyla- 2 DNA fragments  
chrorrE subunit; P22 inlagrase 
77 - V Y 44 (+1) N 
-- 
1.38 	100% 	hoiB 	DNA polynrase III, delta prime subunit 
78 - V N 133 (-2) * 2.49 100% tuB dihydroneoplarin 	'also has dihydoneoplarin triphosphala 
aldolase 	 2'-epinrase activity; contains 1 TAG  
79 - N Y >107 (-1) unknown 2.33 	98% 	. eutG 	paral putative transport protein in ethanolariine utilization 
80 - N N >247 (-1) unknown N/A 98% blaB outer membrane 	contains 1 slap codon 
receptor for transport of vitamin B12, E coticins, and baclariophage BF23 
Table 4.9 (continued from previous page). The 179 clones selected from Experiment 9 for further analysis. Bold numbers in column I indicate clones that were 
chosen for screening. Rows with bold borders indicate clones that were chosen for sub-cloning. E-tag expression levels are relative to the positive and negative controls. 
Column 3 indicates whether the entire insert sequence was obtained. Column 4 indicates whether the insert sequence constitutes a continuous open reading frame (ORF). 
A correct fusion to the signal sequence has a reading frame of (+2). * Indicates that an ORF in frame with the E-tag having one or more amber (TAG) stop codons. 
Column 8 contains the mean antigenic index (Jameson-Wolf, using Protean software from DNASTAR) of the 6 consecutive amino acids (indicated in bold in Appendix) 
with the highest antigenicity in the available sequence. Column 9 indicates amino acid identity with S. Typhi CT 18. Plasmid sequences were not compared. 
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Clone" E-tag complete ORF size (bp)l frame E-tag fusionlAnitgenicityl Typhi 1 	gene 	name of protein I 	comments 
81 + NN >268 N/A N N/A 100% sohBlyciK intergenic region; till of step codons 
82 - Y Y 369 (+1) Y 2.62 99% 	STM4551 	putative diguanylatecyclase/phosp hod ieste rase domain 1 
83 - N Y >105 (-2) unknown 	i 2.67 100% orf2 proline/tireonine-rich S. Typhi; 3 of smpB 
84 - N >383  N/A 
protein  
N/A 	STM1 025 	Giy-2 prophage contains several step codons N 	
.....  
putative lipoprotein in all forward tames 
85 ++ DELETION MUTANT Bases 283-309 (inclusive) deleted 
86- Y N 89 (+1) N N/A N/A 	or6  very small P22 protein; contains 1 step codan  
87 + V N 160 (+2) Y 0.74 N/A traR 	 1 step codon precedes the CDS; 
overlaps with clone 101 insert 
88 - N V >125 (+) N 2.10 1 	Z1868 	putative replication protein 0 of prophage CP-933X 
in enterohemnoragic E. co/i 01 57:H7 
89 - V V 242 (+3) V 2.60 100% 	ycdX 	putative histidinol 	hydrolase of the PHP family 
90 ++ V V 143 (+3) V 2.54 
phosphatase 
97% 	nrfl 	part ofbrmate-dependentnitrite- reductase ______ 
complex; involved in attachment ofhaemc 













99% 	i fihA 	tagellar biosynthesis; possible export of fagellar proteins 
	
?gpsA dehydrogenase (NAD+) glycerol-3-phosphate 
93 
+++++ 
- N V >282 
(-2) 
(+) V 2.72 98% 	STM4306 	putative anaerobic dirmlhyl sultixide reductase, subunit B 
94 + Y N 175 (+2) V N/A 100% nusA :rwPti0n  pausing; 	RBS and frst6 amino acids 
N utilization 


















96% 	yL; engA 	putative se rine/threo nine protein kinase; putative GTP-binding protein 
98% 1 ccmE jperiplasmichaerm-de pendent peroxidase; 
cybchrorm c-type biogenesis protein 
98] Y V 28 (-3) 1 0.10 100% 	yijD 	putative inner membrane protein 
Table 4.9 (continued from previous page). The 179 clones selected from Experiment 9 for further analysis. Bold numbers in column 1 indicate clones that were 
chosen for screening. Rows with bold borders indicate clones that were chosen for sub-cloning. E-tag expression levels are relative to the positive and negative controls. 
Column 3 indicates whether the entire insert sequence was obtained. Column 4 indicates whether the insert sequence constitutes a continuous open reading frame (ORF). 
A correct fusion to the signal sequence has a reading frame of (+2). * Indicates that an ORF in frame with the E-tag having one or more amber (TAG) stop codons. 
Column 8 contains the mean antigenic index (Jameson-Wolf, using Protean software from DNASTAR) of the 6 consecutive amino acids (indicated in bold in Appendix) 
with the highest antigenicity in the available sequence. Column 9 indicates amino acid identity with S. Typhi CT 18. Plasmid sequences were not compared. 
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Clone! E-tagIcomplete ORF!size (bp) frame! E-tag fusion' Anitgenicity! Typhi 	gene 	name of protein comments 
99 +N N >429 (-3) unknown N/A 	99% nIpI cell division lipoprotein contains 1 stop codon; 
located immediately alter deaD gene 
100 + Y Y 128  Y 2.49 	75% 	1 pilV 	shufiton protein A; plasmid R64; Incll plasmid 
101 ++++ Y Y 181 (+2) Y 	7 
jpeiVprepihin 
0.74, 	j N/A 	traR 2 stop codons precede the CDS; 
overlaps with clone 87 insert 
102 - Y N 220 (+1) N N/A 	99% 	1gM 	1 ant-sigma 28 factor negative regulator offlagellin synthesis; 
103 - N Y >384 (+1) unknown 
___ 
 
2.52 	98% 	or2 	proline/threonine-rich 
contains istop codon near end ofinsert 
3 of smpB in S. Typhi clinical isolate 
protein 

































2.44 I 97% eutE ialdehyde oxidoreductase 
DELETION MUTANT 
N/A 	90% 	yafS 
0.46 j97% ybgJ 	putativecarboxyse 
0.78 	100% 	fucA 	probable formate transporter 
ethanolamine utilization protein 
putative SAM-dependent rruthyltransterase 
(sequence not available) 
111 - N N >380(-1) unknown N/A 100% STM2475 putative cytoplasmic very small protein 
112 - V N 215 N/A N 
__ 'protein  
N/A 	i 98% 	pagO noCDS:intergenicregionfullof stop codons 
113 + V Y 70 (+2) 4 Y 0.77 98% ptsN 	_sugar specific PTS family, enzyme _IA, also regulates Nmetabolism 
114 ++++ V Y 124 (+2) Y 1.30 	97% 	oat _putative acetylornithineaminotransfurase 
115 ++ V 
I 
331 (+2) V 2.18 99% 1 rsmC 	1 16S rRNA m2G 1207 
mathylase 
contains 1 stop codon at beginning of insert 
116 - V Y 192 (+1) Y 1.27 	N/A 	1 1 	P22 portal protein similar to phage APSE-i P19 
117 + V * 89 (-2) * 2.52 N/A 9I  bifunctional P22protein: 
tailspike_&_endorhamnidase  
(+1) tame contains one _TAG 
118 V Y 118  _V _2,24 	98% 	_yhjJ 	_putative Zn-dependentpeptidase 
Table 4.9 (continued from previous page). The 179 clones selected from Experiment 9 for further analysis. Bold numbers in column I indicate clones that were 
chosen for screening. Rows with bold borders indicate clones that were chosen for sub-cloning. E-tag expression levels are relative to the positive and negative controls. 
Column 3 indicates whether the entire insert sequence was obtained. Column 4 indicates whether the insert sequence constitutes a continuous open reading frame (ORF). 
A correct fusion to the signal sequence has a reading frame of (+2). * Indicates that an ORF in frame with the E-tag having one or more amber (TAG) stop codons. 
Column 8 contains the mean antigenic index (Jameson-Wolf, using Protean software from DNASTAR) of the 6 consecutive amino acids (indicated in bold in Appendix) 
with the highest antigenicity in the available sequence. Column 9 indicates amino acid identity with S. Typhi CT 18. Plasmid sequences were not compared. 
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Clone! E-tag compIeteORFsize (bp)l frame E-tag fusioniAnitgenicity. Typhi 	gene 	I name of protein comments 
119 - Y N 251 (+3) Y 1.96 98% ydcP putative collagenase CDS begins 90 bases into insert 
120 + N Y >107 (+) Y 1.22 100% 1 	lpxK 	t&raacyldisaccharide Lipid A4-kinase 
4-kinase 
121 + N ? >277 (+1;+) Y 1.65 N/A 	so667; mgs 	putative collagenase; may be a fusion of 2 fragments; _____________ 
muthyiglyoxal syntiase central junction unsequenced 
122 + Y Y 244 (+2) Y 2.58 N/A 	16 	P22 DNA transfer similar to phage APSE-1 P35 
protein (injection protein) 
123 + N Y >122 (+) Y 0.73 	1 99% 	IgN export chaperone involved in 
flagellar biosynthesis 
124 - Y Y 74 (-2) Y 0.41 71% 	S1M4534 	putative NIrC family Paralog of E. co/i psp operon 
transcriptional transcriptional activator 
regulators, ATPase domain 
125 - Y Y 165 (+1) Y 1.52 98% 	pykA 	:pyruvate  kinase II, glucose stimulated 
126 ++ Y V 109 (+2) V 0.93 99% yijO hypothetical transcrip- AraC/XylS family 
tonal regulator 
127 + N V >296 (+) Y 2.09 N/A 	STM1055 	hypothetical protein 	Giy-2prophage 
128 + N - V >75 (+) unknown unknown ? ratS putative outer membrane protein  
129 ++ N N >87 N/A N N/A <66% 	STM4422/ 	no CDS: intergenic region 
STM4423  
130 ++ Y Y 276 (+1) V 0.91 100% 	art 	arginine-binding protein 	ABC superfamily 
131 + N  sequence not obtained 
132 - N N >154 (-3) N N/A 1 	99% 	rlbG 	CDP glucose 4,6-dehydratase; LPS side chain defect 
133 - Y N 278 (N/A; N N/A N/A STM2769/ repressor of phase I 	insert is a fusion of 	fragments  
+3) tijA; entS 	agellin; 2,341ydro- 
2,3-dihydroxybenzoate synthetase, isochorismatase 
134 +++ Y V 
- 
88 (+2) V 2.23 J98% 	i ydiY 	putative salt-induced and acid-induced OMP 
135 - T 	Y V 336 (+1) Y 2.13 99% yheT putalivehydrolase 
136 -L Y V 72 (+1) V (-0.01) 97% 	yhhS 	putative MFS family tansportprotein 
Table 4.9 (continued from previous page). The 179 clones selected from Experiment 9 for further analysis. Bold numbers in column 1 indicate clones that were 
chosen for screening. Rows with bold borders indicate clones that were chosen for sub-cloning. E-tag expression levels are relative to the positive and negative controls. 
Column 3 indicates whether the entire insert sequence was obtained. Column 4 indicates whether the insert sequence constitutes a continuous open reading frame (ORF). 
A correct fusion to the signal sequence has a reading frame of (+2). * Indicates that an ORF in frame with the E-tag having one or more amber (TAG) stop codons. 
Column 8 contains the mean antigenic index (Jameson-Wolf, using Protean software from DNASTAR) of the 6 consecutive amino acids (indicated in bold in Appendix) 
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ClonelE-tag complete. lORF isize (bp)} frame  E-tag fusion An itgenicitylTyphi gene 	i 	name of protein L 	comments 
137 - Y V 218 (+1) Y 1.98 	1 100% 	ydfG putative oxidoreductase 


















? 	shdA 	similar to the C-terminal 
98% STM3356 putative cation transporter  
very large protein; subspecies I specitic; 
region of AIDA; IcsA; Peyers patch colonization & shedding factor 
putative cation transporter 
141 - N Y >115 (-2) unknown - 210 	1 98% 	- pta 	p hosp hotransacety lase 
142 - N Y >96 (+2) unknown (-0.175) 97% yccF putative inner membrane prote +1 is an ORF, but +2 has 
protein 3 step codons before the CDS begins 
143 + N N >210 N/A unknown N/A 98% 	yjlR/sgaT intergenic region; till of slop codons 
144 + N V >119 (+3) unknown unknown ? miaB methyithiolation of isopentenylated 
145 - N N >39 (-1) unknown unknown ? 	ydbHj putativeperiplasnicprotein  
A37 derivatives in rRNA 
146 - sequence not obtained 
147 +++ N V >124 (+3) unknown 1.51 99% 	proX 	glycine/betaine/proline ABC superfamily 
transport protein 
intergenic region; till of step codons 
148 i ++++ V Y 133 (+2) Y 2.25 N/A 	STM2235 	_!putative phageprotein 
149 ++++ N >63 N/A unknown N/A 100% rotl 
150 - 
LN 
N >186 N/A unknown N/A 98% 	niU/ynaF 	_intergenic region _ adjacenttodbpA geneonS.Typhimuruim 
genorce; opposite direction of clone 3 
151 - N V >78 (+1) unknown (45) 100% 	wzxflippase LPS biosynthesis 
152 - V V 99 (+3) N 0.73 96% mrcA 	transpeptidase of peptidoglycan synthetase 






91% 	STM2527 putative polyrredoxin of E. co/i hydrogenase 4 Fe-S subunit paralog 
154 - N Y >86 (+1) unknown unknown N/A traJ 	nucleotide-binding plasmid R64 
protein 
Table 4.9 (continued from previous page). The 179 clones selected from Experiment 9 for further analysis. Bold numbers in column I indicate clones that were 
chosen for screening. Rows with bold borders indicate clones that were chosen for sub-cloning. E-tag expression levels are relative to the positive and negative controls. 
Column 3 indicates whether the entire insert sequence was obtained. Column 4 indicates whether the insert sequence constitutes a continuous open reading frame (ORF). 
A correct fusion to the signal sequence has a reading frame of (+2). * Indicates that an ORF in frame with the E-tag having one or more amber (TAG) stop codons. 
Column 8 contains the mean antigenic index (Jameson-Wolf, using Protean software from DNASTAR) of the 6 consecutive amino acids (indicated in bold in Appendix) 
with the highest antigenicity in the available sequence. Column 9 indicates amino acid identity with S. Typhi CT 18. Plasmid sequences were not compared. 
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Clone E-tag IcompIeteORFsize (bp) frame E-tag fusion! Anitgenicityl Typhi 	gene 	name of protein comments 
155 - N Y >54 (+3) unknown unknown 	I ? pmrF putative glycosyl Iransterase LPS nuditcation protein 
156 ++ N Y >82 (+1) unknown 0.78 <60% 	STM4497 	putative cytep!asntprotein 
157 ++ sequence notobtained 
158 +++ N N >319 N/A unknown N/A 	98% 	pduB 	________ 	________ intergenic region; lii of step codons 	_______ 
159 ++++ N Y >56 (+1) unknown unknown ? ycgNyddA/yciA 	 plasmid CoIIb-P9; plasmid F 
160 ++ N Y >71 (-1) unknown 2.20 	N/A 	PSLT047 putative cytoplasmic 	pSLT 
protein 
161 +++ Y Y 79 (-2) Y 2.23 	100% 	ydeY 	putative sugar transport 	ABC superbmiy  
protein 
162 - N Y >76 (-2) unknown 0.12 	97% 	yjiN 	I putative inner membrane protein  







sequence not obtained 
sequence not obtained  
166 ++ N sequence not obtained 
167- N - !sequence not obtained  ________ 
168 - N ] sequence not obtained 
169 - N Y >150 (+1) unknown 0.18 	100% 	gIpG 
170 DELETION MUTANT 
171 +++++ Y Y 118 (-1) Y 0.90 	97% 	wcaL 	1 putative glycosyltransterase 	colanic acidbiosynthesis 
172 +++ 
----------------- 
sequence not obtained 
173 1 Y N 45 (+) N N/A 	93% 	STM0081 	 ribosomal binding site for STM0081 
174 +++++ Y N 329 (+1) N N/A 1 99% ybbO putative oxidoreductase 	4 step codons Wow the CDS 
175 - Y N 167 (-2) N N/A 	11 	98% 	STM2357 	putative anno acid 	lijIl of step codons 
transporter 	 I 
176 - N Y >70 (+3) unknown 2.17 	98% 	STM1493 	putative periplasmic protein; transporter; insert includes gene's stop codon 
177 - sequence not obtained 
178 + sequence not obtained 
179 + N Y >201 (+3) _unknown 2.30 	95% 	STM0033 	_putative secreted 5-nucleobdase 
Table 4.9 (continued from previous page). The 179 clones selected from Experiment 9 for further analysis. Bold numbers in column 1 indicate clones that were 
chosen for screening. Rows with bold borders indicate clones that were chosen for sub-cloning. E-tag expression levels are relative to the positive and negative controls. 
Column 3 indicates whether the entire insert sequence was obtained. Column 4 indicates whether the insert sequence constitutes a continuous open reading frame (ORF). 
A correct fusion to the signal sequence has a reading frame of (+2). * Indicates that an ORF in frame with the E-tag having one or more amber (TAG) stop codons. 
Column 8 contains the mean antigenic index (Jameson-Wolf, using Protean software from DNASTAR) of the 6 consecutive amino acids (indicated in bold in Appendix) 
with the highest antigenicity in the available sequence. Column 9 indicates amino acid identity with S. Typhi CT 18. Plasmid sequences were not compared. 
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Figure 4.3. Re-screening of 179 clones from Experiment 9 for E-tag expression. Colonies ofTGl 
cells with pG8SAET constructs were grown on nitrocellulose, lysed, and probed with a monoclonal 
anti-E tag antibody. HRP-labelled secondary antibody was detected by chemi luminescence and 
exposed to X-ray film. The location of the positive control clone is marked with X, while the negative 
control is marked with 0. All other numbers correspond to the number assigned to the clone tested. 
b. Construction of positive control for screening 
The S. Typhimurium rplL gene encodes the L7/L12 ribosomal subunit 
protein. This protein was identified as an antigen by the proteomic method (M. 
Mogensen, personal communication). Briefly, S. Typhimurium whole cell lysate was 
subjected to 2-D gel electrophoresis and subsequently analysed by Western blot 
using the final bleed BALB/c serum described in Chapter 3. Antigenic spots were 
excised from corresponding positions in a parallel 2-D gel and analysed by mass-
spectrometry (data not shown). The protein having the smallest molecular weight, 
L7/L12, was chosen as the positive control for screening antigens in this thesis. 
The S. Typhimurium rpIL gene was cloned into pG8SAET, in frame with the 
signal sequence at the 5' end and with the E-tag at the 3' end. Briefly, primers 
"ribfor" and "ribrev" were used to amplify the rplL gene from S. Typhimurium 
SL1344 DNA. For blunt-end ligation, the PCR product was phosphorylated with T4 
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polynucleotide kinase and combined with vector DNA having been digested with 
SnaBI and dephosphorylated. The ligated DNA was then transformed into competent 
TGI host cells, after which colony PCR was performed using primers "sasekv" and 
"etag." After analysis of PCR products by agarose gel electrophoresis (Figure 4.4), 
colonies were screened for E-tag expression. Plasmid DNA from an E-tag positive 
clone was then purified and sequenced using the primer "etag" to confirm that the 
rplL gene had been cloned correctly and that it contained no mutations. 
2 	3 	4 	5 
Figure 4.4. PCR of colonies resulting 
from transformation of the rpJL/pG8SAET 
ligation. Primers "sasekv" and "etag" produce a 
band of approximately 150 bp (lane 4) when 
used to amplify pG8SAET with no insert. Lanes 
1-3 are PCR products from independent colonies 
likely containing the rplL gene in pG8SAET. 
Lane 5 is the 100 bp ladder used to estimate DNA 





c. Screening of selected clones for antigenicity 
All clones having a + orientation of the inserted DNA sequence (regardless of 
reading frame), as well as clones having no sequence data, were screened for 
antigenicity. Each of the clones to be screened, as well as the positive control and no-
insert negative control, were grown in 1.5 ml tubes as 0.5 ml liquid cultures infected 
with helper phage to generate phage particles. The cultures were then centrifuged to 
remove cells and debris, and the supernatants were spotted onto nitrocellulose in 1 j.tl 
portions. The membranes were then blocked and subsequently probed with the same 
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serum used for biopanning (dayl7pc3) or with mouse monoclonal anti-E tag 
antibody. HRP-labelled secondary antibody was detected by chemi luminescence. 
Different blocking solutions were compared during screening for antigens. 
All membranes were blocked in (A) 5% milk for an hour, and some were blocked in 
(B) 5% milk + 20% foetal bovine serum or (C) 5% milk with 10 % bovine serum for 
an additional hour. After testing the different blocking procedures, (B) was 
considered most suitable and was used for the majority of antigenicity screening. 
Phage lysates used in these experiments were tested for consistency of titre and were 
found to generate approximately 10 particles per ml. Each clone was screened at 
least twice from independent lysates, and the final 10 clones chosen for further 
analysis were screened four times. Dot blots of the final 10 clones (indicated in bold) 
are shown after three different blocking procedures in Figure 4.5. 
A 	 B 
Figure 4.5. Dot blots of phage lysates. Dot blots were probed with anti-S. Typhimurium serum (A-C) 
or with anti-E tag antibody (D). (A) and (D) were blocked with milk alone, while (B) was further 
blocked with foetal bovine serum and (C) was blocked with bovine serum. Positions of the negative 
and positive controls, as well as specific clones from Table 4.9, are indicated in (E). "X" indicates an 
error and should be disregarded. Numbers in bold indicate the 10 clones chosen for further analysis in 




In order to select candidate S. Typhimurium antigens from the pG8SAET 
library, it was panned against hyperimmune anti-S. Typhimurium serum obtained 
from CBA/Ca mice. Several parameters of biopanning were assessed, including the 
use of capturing antibody, depletion of the library with non-immune serum, blocking, 
multiple rounds, post-elution harvesting of phagemid from wells, and fractionation of 
ligand from the serum. After an inferred successful biopanning result, individual 
phage lysates were screened at least twice for possible binding of antibody from the 
hyperimmune serum. During this screening process, three different blocking 
protocols were compared for reduction of the signal-to-noise ratio between the 
constructed positive control clone and the negative having no displayed peptides. 
The screening process identified ten possible antigens displayed on the surface of 
phage, encoded by fragments of cysA, 5TM3167, ytJE, ptsN, oat, gp16, y/O, 
STM2235, ydiY, and yhjJ. 
Analysis of Table 4.9 
Phagemid DNA from all 179 clones chosen for further analysis was isolated 
and used to perform sequencing reactions. Data from successful sequencing reactions 
was used to perform BLAST searches, and results were compiled in Table 4.9. The 
results for re-screening for E-tag expression are shown in Figure 4.3 and included in 
Table 4.9. Since colonies with potentially negative results were included, it is not 
surprising that some clones are actually negative for E-tag expression. 
Interestingly, some of the clones are deletion mutants that contain no insert 
DNA but correct the disparity in reading frames between the signal peptide and E-
tag. It is not clear at which stage these deletions occurred. However, clone 30 was 
identified as having the entire E-tag sequence deleted as shown by sequencing with 
the 5' primer. Since this clone was initially positive for E-tag expression (weakly to 
moderately so; data not shown), the deletion must have occurred during propagation 
after the first screening. It is possible that some unsuccessful sequencing reactions 
may be due to mutations in the regions of pG8SAET to which the sequencing 
primers anneal. A few clones contain insert fragments that are the result of the fusion 
of two different segments of DNA from S. Typhimrium DNA. This indicates that the 
ligation ratio of insert to vector should not be higher than what was used in the 
construction of this library in order to avoid this phenomenon. 
For the clones in Table 4.9 with sufficient sequence data available, about 
60% contain an insert in the plus orientation, which is only slightly higher than 
would be expected from a random screen. The average insert size of these clones is 
difficult to ascertain since the sequence data are incomplete. However, the clones for 
which some data are available have an average insert size of about 200 bases, which 
is slightly smaller than the average of 350 bases for the library. This is consistent 
with the observation that most biopannings result in an enrichment of clones having 
smaller inserts (Wilson and Finlay, 1998). 
Table 4.9 includes a comparison of specific chromosomal S. Typhimurium 
sequences with those of the highly virulent human pathogen, S. Typhi CT1 8. The 
vast majority of sequences have a high identity with the S. Typhi chromosomal 
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sequences, as would be expected since the two strains are members of the same 
species. This fact supports the use of S. Typhimurium for the initial screening and 
identification of antigens that may be suitable for use in human vaccinations against 
S. Typhi. 
Many peptide sequences possibly expressed by the clones in Table 4.9 are 
predicted to contain potentially antigenic regions, according to the Jameson-Wolf 
calculation for antigenicity prediction (Jameson and Wolf, 1988) performed with 
Protean software from DNASTAR. This calculation combines predictions of 
hydrophilicity, surface probability, flexibility, and secondary structure to produce an 
antigenic index. The corresponding specific regions, composed of six consecutive 
amino acids, are represented in bold type for each clone in the Appendix. The mean 
antigenicity for each specific region is represented in Table 4.9. Values greater than 
zero indicate possibly antigenic regions. Since an antigenic peptide can be very short 
in length, the possibility exists that short sequences from otherwise "missense" 
polypeptides encoded by many of the 179 clones could cross-react with antigenic 
sequences of Salmonella proteins. This possibility could explain the broad range of 
genes isolated after biopanning. Furthermore, peptide mimics of carbohydrate 
antigens may be selected through biopanning. Indeed, a peptide phage library was 
used to identify S. Typhi Vi polysaccharide epitope mimics through biopanning 
(Tang et al., 2003). 
Four loci are represented by more than one clone in table 4.9. An intergenic 
region adjacent to the dbpA gene is contained in clones 3 and 150, in opposite 
orientations. Although this region does not appear to encode any protein, the ORF in 
clone 3 is well expressed in the TG  host cells, as evidenced by the strong level of E-
tag expression. The deaD gene is present in the plus orientation in the insert of 
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clones 34 and 64, and clone 99 contains an insert from the chromosomal region 
immediately adjacent to deaD. However, none of the sequences overlap. The gipA 
gene is present in the inserts of clones 15 and 18. However, both are in the minus 
orientation and do not express the E-tag, which means this is likely to be a 
coincidence. On the other hand, the traR gene is present in the plus orientation in 
clones 87 and 101, whose insert sequences overlap. Interestingly, although both 
contain non-amber stop codons in the 5' region of the insert, both express the E-tag. 
This indicates that translation occurs by a non-conventional mechanism in these 
clones. Independently isolated clones with insert sequences that overlap have been 
characterised as containing a ligand binding region (Jacobsson and Frykberg, 2001). 
However, the traR gene is plasmid-borne; hence it is present in multiple copies 
(McClelland et al., 2001). Therefore, it is possible that these two clones have been 
isolated by chance and not because of specific enrichment. 
The insert of clone 8 is an uninterrupted ORF that is fused in the correct 
orientation and correct reading frames at both ends. Yet E-tag expression from this 
clone was not detected by screening with the monoclonal antibody. In contrast, clone 
174 has an unexpectedly high level of E-tag expression, despite the fact that the ORF 
of the insert is followed by several non-amber stop codons and is in a different 
reading frame from the E-tag sequence. The mechanism governing translation in this 
clone cannot be explained at present. 
Interestingly, clone 36, which grows poorly, encodes a shufflon-specific 
recombinase. The function of this protein has been described in Chapter 1 as 
regulating the expression of pili mediating self-association of S. Typhi. If the portion 
encoded within clone 36 produces enough active enzyme to disrupt E. coli cellular 
processes, it could explain the clone's poor growth. This clone was able to grow well 
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enough to obtain a sufficient amount of plasmid DNA for sequencing, which was not 
the case for clone 28. This highlights an inherent problem, the need for the host cell 
to survive and reproduce while expressing the recombinant fusions introduced. 
Therefore, any antigens that interfere strongly with host cell homeostasis or 
reproduction will not be recovered from this type of screening. 
The only known Salmonella antigen among the 179 clones is the flagellin 
subunit encoded byfliC (de Vries et al., 1998). However, this gene has been inserted 
into clone 19 in the minus orientation and therefore flagellin is not produced. 
Interestingly, the minus orientation of this insert forms an uninterrupted ORF that is 
fused in the correct frame at the 3' (but not 5') end. E-tag expression was negative, 
and this is possibly due to the incorrect fusion to the signal peptide. The gene 
products of edd and accB encode antigens in H pylori and Francisella tularensis, 
respectively (Lazowska ci al., 2000; Havlasova ci al., 2002). The shdA gene (clone 
140) encodes a fibronectin-binding protein that is induced in vivo and is essential for 
colonisation of PP (Kingsley ci al., 2002), but since the biopanning serum was 
obtained from mice that were inoculated i.p. rather than orally, it is unlikely that 
antibodies were produced to this protein. 
c. Dot blots 
Since no known Salmonella antigens were expressed by the clones in Table 
4.9, a positive control was constructed in pG8SAET for the purpose of screening for 
new antigens from phage lysates of individual clones. M. Mogensen identified rplL, 
which encodes the L7/L12 ribosomal subunit protein, as an antigen recognised by 
anti-S. Typhimurium serum from the final bleed of BALB/c mice having been 
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immunised and subsequently challenged three times with live bacteria (see Chapter 3 
for details). The antigenicity of L7/L12 was verified by Western blot of the purified 
recombinant His-tagged protein, using the same BALB/c serum (M. Mogensen, 
2004, unpublished data). The L7/L12 proteins of Brucella abortus, Brucella 
melitensis, Mycobacterium bovis, and H. pylon L7/L12 are strongly antigenic 
(Bachrach et al., 1994a; Bachrach et al., 1994b; Kitaura et al., 1999; Kimmel et al., 
2000). This antigenicity is not unexpected given the fact that ribosomes are highly 
expressed, form large molecular complexes, and constitute target antigens. Indeed, 
ribosomal vaccines have been prepared from over 28 different species of bacteria, 
conferring a high degree of protection, although the basis of the protective response 
has not been established clearly (Gregory, 1986). L7/L12 was therefore an attractive 
positive control for screening phage lysates. Its small size was ideal since the average 
insert size of the phagemid clones to be screened was also small. 
Phage lysates were made of each clone with an insert having a plus 
orientation, in addition to clones for which no sequence data was available. These 
clones, screened as dot blots, are identified in Table 4.9 with bold type. Repeated 
screening with independently produced lysates ensured that any candidate antigens 
would give reproducible positive results prior to further analysis. Figure 4.5 (D), 
which shows the relative E-tag expression levels of each clone in phage lysates of 
similar titre, can be used to estimate the relative expression levels of the displayed 
polypeptide to which the tag is fused. Thus, the different expression levels of 
polypeptide in dot blots are likely to affect the sensitivity of the dot blot screening 
procedure. However, there is no feasible way to control for varying expression levels 
of individual clones. Additional blocking steps designed to lower any non-specific 
binding were used in order to enhance discrimination between the positive and 
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negative controls. Additional blocking with foetal bovine serum/ bovine serum in 
milk solution was compared to milk alone. To avoid the possible loss of unknown 
antigens, foetal bovine serum was favoured over bovine serum for inclusion in the 
second blocking step. This procedure was adopted for screening all dot blots. Figure 
4.4 shows the intensity and level of consistency with which the 10 chosen clones 
were positive, compared to the positive control. For this reason, these 10 were sub-
cloned for verification of antigenicity (see Chapter 5). 
The cysA gene encodes a sulphate!thiosulphate import ATP-binding protein. 
This protein is part of the sole sulphate transporter complex of the macrophage-tropic 
intracellular pathogen, Mycobacterium tuberculosis, and is needed for in vivo 
acquisition of sulphur (Wooffel al., 2002). The prospect of this protein's antigenicity 
is tantalising since it may be induced during Salmonella pathogenesis. STM3167 
encodes a putative diadenosine tetraphosphate (Ap4A) hydrolase. This type of 
enzyme catalyzes the conversion of diadenosine tetraphosphate to adenosine 
diphosphate (ADP). While the function of this protein has not been investigated, 
another Ap4A hydrolase, ApaH, is involved in the regulation of dinucleoside 
polyphosphate pools. This regulation, which is also controlled by a second hydrolase 
YgdP, affects the ability of S. Typhimurium to invade cells in vitro (Ismail et al., 
2003). 
The ytJE gene encodes a putative cell morphogenesis protein, which may or 
may be a part of the normal cell cycle since its function has not been elucidated 
(McClelland et al., 2001). The protein encoded by ptsN is a phosphotransferase 
system enzyme hA that plays a role in linking carbon and nitrogen assimilation 
(Tchieu et al., 2001). The oat gene, also called argD, encodes a putative 
acetylornithine!succinyldiaminopimelate aminotransferase that is involved in the 
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fourth step of the arginine and lysine biosynthetic pathways (McClelland et al., 
2001). The P22 bacteriophage gene gpl6 encodes a protein that is required for 
injection of the phage genome into the host cell (Umlauf and Dreiseikelmann, 1992). 
The yUO  gene encodes a hypothetical transcriptional regulator of the AraC/XyIS 
family. This family of proteins is characterised by having a helix-turn-helix motif, 
typically activating transcriptional activity in response to environmental signals 
(Gallegos etal., 1997). STM2235 encodes an uncharacterised putative phage protein, 
while yhjJ encodes a putative periplasmic peptidase (McClelland et al., 2001). The 
protein encoded by ydiY is a putative outer membrane protein that is induced by salt/ 
low pH, making it a possible candidate for in vivo induction of expression 
(McClelland et al., 2001; Stancik et al., 2002). Sub-cloning and subsequent 
purification of these ten fragments containing possible epitopes will allow 
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A. Introduction 
In Chapter 4, ten phagemid clones displaying putative antigens were 
identified after biopanning the pG8SAET library and screening individual clones 
with hyperimmune anti-S. Typhimurium serum. This chapter focuses on verifying 
whether the protein fragments displayed by these clones are truly antigens. In order 
to do this, the corresponding sequences need to be sub-cloned, expressed, purified, 
and tested by immunoblot and ELISA. The experiments performed and results 
obtained are discussed below. 
1. TOPO and Gateway Cloning 
In this chapter, TOPO® and Gateway® cloning are used to construct 
expression vectors encoding his-tagged protein fragments for subsequent purification 
on nickel resin. This cloning is achieved using the vectors pENTR/SD/D-TOPO and 
pET-DEST 42, respectively, supplied by Invitrogen. Selection markers for these two 
vectors are kanamycin resistance (Kan R)  and ampicillin resistance (Amp R),  
respectively. Unmodified pET-DEST 42 also contains chioramphen icol resistance 
(CmR) for counter-selection. 
TOPO® cloning exploits the properties of topoisomerase I, which catalyzes 
the cleavage of the DNA phosphodiester backbone and covalently attaches to the 3' 
phosphate. The vector pENTR/SD/D-TOPO is supplied as a linearised plasmid with 
topoisomerase I covalently attached at each end. Topoisomerase I is released when 
the 5' hydroxyl group of a DNA strand attacks the phospho-tyrosyl bond to re-form 
the DNA backbone. The energy conserved by the formation of the double bond 
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between the DNA and enzyme thus confers a kinetic advantage that can be used to 
design rapid ligation reactions. Directional cloning is made possible by a 4-base 
single-stranded 3' overhang that is designed to invade the end of a double-stranded 
DNA molecule containing the complementary sequence. In this vector, the overhang 
is positioned to invade the beginning of the sequence to be cloned (Figure 5.1) 
(Invitrogen, 2003b). 
----CCCTT 	 AAGGG---- 
-- --GGGAP1GTGG 	 TTCCC---- 
H 
---- CCCTTATG GENE AGGG---- 
---- GGGAAGTG TAC of interest FTCCC---- 
Ii 
----CCCTT9ATG 	GENE 	AGGG---- 
----GGGAAGTGTAC of interest fTTCCC---- 
Figure 5.1. Schematic representation of directional TOPO® cloning. A 3' 
overhang in the linearised vector invades the end of a double-stranded DNA molecule 
containing the complementary CACC sequence, and the displaced GTGG is then 
cleaved off in E. coli host cells. 
Gateway® cloning utilises the site-specific integration and excision reactions 
that are part of the bacteriophage ? lysogenic and lytic pathways. Recombination 
between site-specific attachment sites attP (from X phage) and E. co/i attB gives rise 
to the hybrid sites attL and attR. This reaction is catalysed by X integrase and the E. 
co/i integration host factor (IHF) protein and is part of the lysogenic pathway. The 
reverse of this reaction is catalysed by X integrase, ? excisionase, and E. co/i IHF to 
produce atiP and attB (Invitrogen, 2003a). 
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The cloning site of pENTRISD/D-TOPO is flanked by a pair of 
recombination sites, attLl and attL2. The vector pET-DEST 42 contains ccdB and 
CmR flanked by attRl and attR2, followed by a sequence encoding a VS epitope and 
6x histidine tag. The modifications that produced attLl and attL2 confer specificity 
for attRl and attR2, respectively, resulting in directional recombination. The ccdB 
gene encodes a protein that interferes with E. coli DNA gyrase and therefore inhibits 
the growth of the cell that expresses it. Recombination between pENTR/SD/D-TOPO 
and pET-DEST 42 results in an exchange of ccdB and Cm   for the gene having been 
cloned into pENTRISD/D-TOPO (Figure 5.2). Transformation of this reaction into 
most E. coli strains (which are unable to grow if they express ccdB from unmodified 
pET-DEST 42) and subsequent propagation on ampicillin-containing medium 
(eliminating the entry vector) favours the growth of the expression clone (Invitrogen, 
2003a). 
aitLi 	attL2 	 attRI ccdB  attR2 
I 1iIgeneI 
	7pET-DEST42 enone  
(KanR) 	 (Amp') 
Li 
attB.1 	attB2 	 attPl ecdB attP2 
7e,  + 	by-prod ict 
___7) 
(AmpR) 	 (Kan°) 
Figure 5.2. Generation of an expression clone from an entry vector using the 
Gateway® recombination reaction. The product of the ccdB gene (present in 
parental pET-DEST42 and the reaction by-product) are toxic when transformed 
into certain E. coli strains, such as DH5a. 
151 
2. Purification 
Protein purification was traditionally based on the sequential partitioning of a 
protein mixture on the basis of size, hydrophobicity, isoelectric point and/or affinity. 
Recombinant DNA technology allowed for the manipulation of sequences to produce 
proteins fused to peptides and polypeptides that function as tags for one-step affinity 
purification. These tags include maltose-binding protein, glutathione S-transferase, 
and the polyhistidine tag. The affinity tag makes the recombinant protein unique in a 
bacterial lysate and allows binding to its target ligand with a high degree of 
specificity. Selection of the affinity tag depends on the nature of the intended 
purification and the application to follow. The 6x polyhistidine tag is small, soluble, 
and uncharged at physiological pH, making it less likely to interfere with the 
structure of the protein to which it is fused. Additionally, this tag can be used under 
native as well as denaturing conditions since its interaction with the target ligand is 
not conformation-dependent. The ligand used for purification of polyhistidine-tagged 
proteins is the nickel ion. The purifications described in this chapter use Ni-NTA 
agarose beads (Qiagen). Nitrilotriacetic acid (NTA) is a tetradentate chelating agent 
that occupies four of the six available binding sites of nickel. A nitrogen atom from 
each of two adjacent histidines of the tag interacts with the two free sites of the 
nickel ion, thus tethering the fusion protein to the Ni-NTA agarose beads. The 
interaction between fusion protein and Ni-NTA agarose beads can be disrupted with 
a high concentration of imidazole or low pH, thus eluting the protein (Qiagen, 2003). 
Although affinity tags greatly reduce the number of purification steps needed, 
an additional purification step may be necessary to ensure the purity of the protein in 
some cases. In this chapter, an additional purification step involving ion exchange 
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chromatography (lEG) is used. IEC separates proteins according to isoelectric point 
(p1) and is dependent on the pH and salt concentration of the fluid phase. The overall 
charge on a protein depends on the pH of the buffer in which it is dissolved. 
Adjusting the pH of the protein solution can favour binding of the target protein to 
the charged groups of the column, while simultaneously limiting the binding of other 
proteins. Subsequent application of a buffer with increasing salt concentration 
provides ions that compete with the target protein for binding to the column until it is 
eluted. As the ionic strength increases, each bound protein elutes at a specific salt 
concentration until all proteins are eluted (Amersham, 2004). Mono Q beads 
(Amersham Biosciences) are positively charged and thus exchange anions; Mono S 
beads (Amersham Biosciences) are negatively charged and thus exchange cations. 
B. Results 
1. Cloning and expression of His-tagged protein fragments 
The insert sequences of the ten phagemid clones isolated after biopanning and 
screening were the basis for sub-cloning the corresponding gene fragments. All 
forward primers began with CACC at the 5' terminus for directional cloning of the 
PCR product into the pENTRISD/D-TOPO vector, followed by an ATG for 
translation initiation of the gene fragment. Some sub-cloned fragments included extra 
coding sequence from the corresponding genes due to minor adjustments during 
primer design for improved DNA amplification. The amino acid sequence of each 
gene, the portions identified in phagemid clones, and the portions chosen for sub-
cloning are indicated in Table 5.1. 
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Using the primers listed in Table 2.4 (see Chapter 2), the ten gene fragments 
were amplified with Pfu polymerase (Promega) from S. Typhimurium SL1344 DNA 
and cloned into pENTR/SD/D-TOPO. Subsequently, purified plasmid DNA of all ten 
clones was digested with BsrGI (which cleaves DNA at attLi, attL2, attBl, attB2) 
and analysed by agarose gel electrophoresis (Figure 5.3A). After confirming that the 
entry vectors contained inserts of the correct size, the cloned sequences were 
transferred to pET-DEST 42 by recombination as described above for Gateway 
cloning. After BsrGI digestion of the resulting expression clones (Figure 5.313), each 
was sequenced with "oligol" to confirm that the cloned DNA was correctly fused to 
the vector at both ends and contained no mutations. 
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AAL21335 CysA (clone 9) 
MSIEIARIKK SFGRTQVLND ISLDIPSGQM VALLGPSGSG KTTLLRIIAG LEHQSSGHIR FHGTDVSRLH 
ARER'GFVF QHYALFRHMT VFDNIAFGLT VLPRRDRPTA AAIKTKVTQL LEMVQLAHLA DRFPAQLSGG 
QKQRVALARA LAVEPQILLL DEPFGALDAQ VRKELRRWLR QLHEELKFTS VFVTHDQEEA TEVADRVVVM 
SQGNIEQADA PDRVWREPAT RFVLEF'MGEV NRLTGTVRGG QFHVGAHRWP LGYTPAYQGP VDLFLRPWEV 
DISRRTSLDS PLPVQVIEAS PKGHYTQLVV QPLGWYHDPL TVVMAGEDVP VRGERLEVGL QKARLYNGDQ 
RIETREEELA LAQSA 
AAL22041 STM3 167 (clone 25) 
MTCIFCQIVE GKAPCHKVWE DEHHLAFLSI FPNTDGFTVV IPKKHYPSYA FDLPPQALAD LMLATQKVAK 
KLDKAFPDVS RTGMFFEGFG VDHVHSKLSP MGTGDLTHW KPIESRQNKF FEQYEGYLSS HDHEPADDEK 
LAALAARIRE A 
AAL23219 YtfE (clone 53) 
MAYRDQPLGE LALSIPRASA LFRQYDMDYC CGGKQTLARA AARHDVDIDI IEAQLAQLAE QPIEKDWRAV 
PLADIIDHIV VRYHDRHREQ LPELILQATK VERVHADKPN VPRGLTKYLT ALHEELSSF4 MKEEQILFPM 
IKQGMGRQAT GPISVMESEH DEAGELVDVI KHVTKNVTPP PEACTTWKAM YNGINENIDD LMEHISLENN 
VLFPRALAGE 
AAL22191 PtsN (clone 113) 
MINNDTTLQL SSVLNQECTR SGVHCQSKKR ALEIISELAA KQLSLPPQVV FEAILTREKM GSTGIGNGIA 
IPHGKLEEDT LRAVGVFVQL ETPIAFDAID NQPVDLLFAL LVPADQTKTH LHTLSLVAKR LADKTICRRL 
RAALNDEELY QIITDTEGEQ NEA 
AAL22091 Oat (clone 114) 
MKALNREVID YFKEHVNPGF LEYRKSVTAG GDYGAVEWQA GSLNTLVDTQ GQEPIDCLGG FGIFNVGHRN 
PVVVSAVQNQ LAKQPLHSQE LLDPLRAMLA KTLAALTPGK LKYSFFCNSG TESVEAALKL AKAYQSPRGK 
FTFIATSGAF HGKSLGALSA TAKSTFRRPF NPLLPGFRHV PFGNIDPNSM AFSEGKKTGD EIAAVILEPI 
QGEGGVILPP QGYLTEVRKL CDEFGALMIL DEVQTGMGRT GKMFACEHEN VQPDILCLAK ALGGGVMPIG 
ATIATEEVFS VLFDNPFLHT TTFGGNPLAC AAALATINVL LEQNLPAQAE QKGDTLLDGF RQLAREYPNL 
VHDARGKGML MAIEFVDNET GYRFASEMFR QRVLVAGTLN NAKTIRIEPP LTLTIELCEQ VLKSARNALA 
ANQVSVEEV 
AAN87103 Gp16 of P22 phage (clone 122) 
MKVTANGKTF NFPDGTSTED IGAAVDEYFA GQASPAETQP AEQQEEPQQP EQSLMQRAGD LLTGGQSAGQ 
IAEQAGRGLV NIPFDVLQGG ASLINAISQG LGGPKVLDDV YRPVDRPTDP YAQAGESIGG YLIPGAGVAG 
NNAIGSVAEA ANQQGDFAGN VAKNAAVNLG AQGLLSGAAK LVGRGITAAR GEIAPEARQL IDTAESMGVK 
PMTSDMIKPG NAFTRSLMQG GEGALLGTGG KRAEQYAIRS KLLGDYFDRV GGYNPDDIVK SMTSTVGGRK 
NAAGAVRDEI VNRMGSAPVG TTNSINAIDT NIARLEKLGT SADQRLLTAL KNLKGELNSG NVDFDLLQQH 
RTAFRTNVQG DANVFPNQAK AATNMVENN TBDLBNAVGK SLGPQPMKY LKSNSDF?NI YNKVLNKRIS 
NTLNKARSEY TPELINTVVF SRKPSDII WSSLDNKGKD ANRAAYISKI AEKTGDSPAK FITEVNKLKA 
QSGGEIYNTI FSGRHMKELD ALHDVLRQTA RSDSANVVTQ TGQALANPVR LGAAIPTLGI< SLAAEAGYGL 
AMRVYESKPI RNMLLRLANT KPGTPAYERA LNQAATAVRP LLANEATRQ 
Table 5.1. Amino acid sequence of genes chosen for sub-cloning. The phagemid clones associated 
with the encoded proteins are indicated in parentheses. Amino acids encoded by the phagemid clones 
are underlined, and the portions to be expressed by sub-clones are in bold type. The sequence of clone 
122 contains two point mutations relative to the published P22 sequence that produce A—*D and S---+A 
substitutions. These amino acids are doubly underlined. Constructs in pET-DEST 42 are predicted to 
have KGGRPDPAFLYKVVINSKLEGKPIPNPLLGLDSTRTGHHHHHH attached to the C-terminus of protein 
fragments. 
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AAL 22956 YijO (clone 126) 
MYHDVSHLLS RLINGPLPLR QIYFASASGP APELAYQVDF PRLEIVLEGE LTDMSITAPL IPCDVLYVPA 
GGWNIPQWQT PVTTLSILFG KQQLGFSVVH WDGQQHQNLT KQHVARRGPR IGSFLLQTLN EMQMQPQEQQ 
TARLIVASLL SHCRDLLGSQ IQTASRSRAL FEAIREYIDE 
RYAAPLTRES VAQAFYISPN YLSHLFQKTG AIGFNEYLNU TRLEHAKTLL KGYDLKVKEV AHRCGFVDSN 
YFCRLFRKNT ERSPSEYRRQ YHSQLTEKQI TPG 
AAL21 137 STM2235 (clone 148) 
MHRIDTPTAQ KDKFGQGKNG FTNGDPATGR RATDLNSDMW DAVQEEVCTV IEAAGIPLSK GEHTQLHAAI 
GRLIYEQVKT RLEKNQNGAD IPNKPLFLQN VGLVDVLFKG DGRFLAGTFV SDAIDRTSIG ARAATGCQFM 
RAHQAPDAPD QVSFWQIITL SEVVSPTTVV DVLAVSGNNV LFGHGTGTGI TSWRQVAMLE GGAFTGGISA 
PNMRGDTLVT VGDGTGGMAK GDVDGAGFNG 
NNLNIKSWNG IGFQNSEDLA IRAYISTRLG VIAAAENLQA GSAIFNKNGD VYGDIWGGGS GPGWLSAFVA 
SKPARQYITM VGVYQNDKTK PFMLHDDGSG VFLATTDMLS GYVQSIRFGA VEHGNLYRSP GFADQLGYVI 
TGVENGDSND TPDRIQRRLL QLKVNGQWYT VGA 
AAL20252 YdiY (clone 134) 
MKLLKAVPAV VMLAGGVFAS LYAAADDSVF TVMDDPSTAK KPFEGNLNPG YLAQSGNTKS SSLTJ.DTANT 
WYGQRTAWSL WGNASNTSSN DERSSEKYAV GARNRFNMTD YDYTFGQASW LTDRFNGYRQ RDVLTAGYGR 
QFLNGPVHSF RFEFGPGVRY DEHTDDTTET QPLGYASGSY AWQLTDNAKE' TQGVSVFGAE DTTLNSETAL 
NVAINEHFGL KVGYNLTWNS QPPESAPEHT DRRTTVTLGY KM 
AAL22473 YhjJ (clone 118) 
MQGTKIRLLA GSLLMLASAG YVQADALQPD PAWQQGTLAN GLQWQVLATP QRPSDRIEVR LQVNTGSLTE 
STQQSGFSHA IPRIALTQSG GLDAAQARSL WQQGFDPKRP MPPVIVSYDS TLYNLSLPNN RNDLLKEALT 
YLANVSGKLT ITPETVNHAL SSEDMVATWP ADTKEGWWRY RLKGSALLGH DPAEPLKQPV DAAKIQAFYE 
KWYTPDATL IVVGNIDARS VAEQINKTFG TLKGKRETPA PVPTLSLRA ESVSIMTDAV RQDRLSIMWD 
TPWQPIRESA ALLRYWQADL AREALFWHIQ QELTKNNAKD IGLGFDCRVL FLRAQCAINI ESPNDKLNTN 
LSLVANELAK VRDKGLSEEE FTALVAQKNL ELQKLFATYA RTDTDILTGQ RMRSLQNQVV DIAPEQYQKL 
RQNFLNSLTV DMLNQNLRQQ LSQEMALILL QPQGEPEE'NM KALKATWDEI MVPTTAAVE ADEAHPEVTE 
TPAAQ 
Table 5.1 (continued). Amino acid sequence of genes chosen for sub-cloning. The phagemid 
clones associated with the encoded proteins are indicated in parentheses. Amino acids encoded by the 
phagemid clones are underlined, and the portions to be expressed by sub-clones are in bold type. 
Constructs in pET-DEST 42 are predicted to have 
KGGRADPAFLYKVVINSKLEGKPI PNPLLGLDSTRTGHHHHHH attached to the C-terminus of protein 
fragments. 
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Figure 5.3. Restriction analysis of (A) entry and (B) destination clones. Digestion of 
plasmid DNA with BsrGI released fragments from entry (-2600 bp) and destination (-7400 
bp) vectors. These fragments correspond in size to the cloned DNA plus approximately 80 
nucleotides from the vector. BsrGT-released fragments are identical for corresponding entry 
and destination clones because the restriction sites are located within the all sites that flank 
the cloned DNA. Sizes (in bp) represented by bands of the molecular weight marker (lane 6) 
are indicated on the right. Lanes 1-5 are digested plasmids containing sequences from cysA, 
STi'v13167,ytJE,ptsN, and oat, respectively. Lanes 7-11 are digested plasmids containing 
sequences from gpl6, yijO, STM2235, ydiY, and yhji, respectively. 
Sequencing of all pET-DEST 42 expression clones verified that the inserted 
sequence of each was correct. The two point mutations in gp16 that identified the 
difference between the phagemid clone 122 insert and the published P22 
bacteriophage sequence for this gene, were also present in the independently 
produced expression clone. After confirmation of sequence accuracy, optimal 
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conditions for induction of protein expression were experimentally assessed for all 
ten clones in E. co/i BL21 (DE3) cells. The vectors pVCN2 and pMOG3 (see Table 
2.3 of Chapter 2), encoding 6x His-tagged green fluorescent protein (GFP) and 6x 
His-tagged L7/L12 ribosomal subunit protein, respectively, were used as negative 
and positive controls for expression, purification, and testing of potential antigens. 
Test inductions were performed in 10 ml cultures with 1 mM IPTG for 2-18 hrs at 
18-37°C, and sonicated samples were analysed by SDS-PAGE. Moderate induction 
was observed for the positive control. Low-level induction was achieved for the 
negative control, as well as for constructs of cysA, gp16, S7-M2235, and yhjJ (Figure 
5.4). Induction in the six other constructs could not be detected by SDS-PAGE for 
any length of time at any temperature tested (data not shown). A western blot of cell 
lysates with anti-His antibody could not detect the affinity tag in lysates from these 









Figure 5.4. Sonicated E. coil with IPTG-
induced expression of His-tagged proteins 
and protein fragments. Lane 1: uninduced; 
Lane 2: CysA frag at 4 hrs, Lane 3: Gp16 at 2 
hrs; Lane 4: STM2235 at 2 hrs; Lane 5: YhjJ 
frag at 2hrs; Lane 6: L7/L12 at 20 hrs; Lane 7: 
GFP at 18 hrs; Lane 8: Molecular weight 
marker, with band sizes (in kDa) indicated on 
the right. Induced bands are indicated with 
arrows. GFP and L7/L12 were induced at 18°C; 
all others were induced at 37°C. 
3.5 
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Figure 5.5. ECL of Western Hot of IPTG-treated, sonicated E. coil carrying constructs encoding 
His-tagged protein fragments. Lane I: uninduced; Lanes 2, 3: STM3 167 frag at 2 hrs, 4 hrs; Lanes 
4, 5: YtfE frag at 2 hrs, 4 hrs; Lanes 6, 7: PtsN frag at 2 hrs, 4 hrs; Lane 8: molecular weight marker 
(drawn in after staining with Ponceau S and not visible during ECL detection procedure), Lanes 9, 10: 
Oat frag at 2 hrs, 4 hrs; Lanes 11, 12: YijO frag at 2 hrs, 4 hrs; Lane 13: STM2235 frag at 2 hrs, Lanes 
14, 15: YdiY frag at 2 hrs, 4 hrs. All inductions for this figure were performed at 37°C with 1 mM 
IPTG. 
2. Purification 
a. Affinity purification on Ni-NTA agarose in native conditions 
After assessment of results from small-scale inductions, expression of His-
tagged proteins and protein fragments was induced in 500 mL cultures. These 
cultures were induced with 1 mM IPTG for 2 hrs at 37°C (Gp16 frag, STM2235 frag, 
and YhjJ frag), 4 hrs at 37°C (CysA frag), or 18 hrs at 18°C (STM3167 frag, YtfE 
frag, PtsN frag, Oat frag, YijO frag, YdiY frag, L7/L12, and GFP). Cells from all 
cultures were then pelleted, resuspended in Lysis Buffer, and lysed with a French 
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press. The lysates were combined with Ni-NTA agarose beads and mixed for 3 hrs at 
4°C to allow binding of the His-tagged fusions, after which the beads were washed 
several times to remove unbound protein. The beads from CysA frag, Gp16 frag, 
STM2235 frag, and YhjJ frag lysates were then washed several times and 
subsequently eluted sequentially with buffer containing 0.05 M, 0.1 M, 0.15 M, and 
0.2 M imidazole. Sequential elutions were analysed by SDS-PAGE to assess relative 
purity (Figure 5.6). All other fusions were eluted with 0.2 M imidazole. No bands 
corresponding to the expected molecular weight for STM3 167 frag, YtfE frag, PtsN 
frag, Oat frag, YijO frag, or YdiY frag were apparent in the elutions from these 
lysates (data not shown). Elutions of L7/L12 and GFP were of a much higher degree 
of purity than all other elutions (Figure 5.7). The sequential elutions with different 
imidazole concentrations were combined for each of the four successfully induced 
protein fragment constructs. These, as well as the positive and negative controls, 
were then prepared for further purification by ion exchange chromatography. Table 
5.2 summarizes calculated data and results for the ten constructs and two controls. 
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Figure 5.6. Elution of His-tagged protein fragments from Ni-NTA agarose 
with different concentrations of imidazole. Lanes 1-4: CysA frag eluted with 0.05 M, 
0.1 M, 0.15 M, and 0.2 M imidazole; Lanes 5-7: Gp16 frag eluted with 0.1 M, 0.15 M, 
and 0.2 M imidazole; Lane 8: Molecular weight marker, with corresponding band sizes 
(in kDa) on the right; Lanes 9-11: STM2235 frag eluted with 0.1 M, 0.15 M, and 0.2 M 
imidazole; Lanes 12-15: YdiY frag eluted with 0.05 M, 0.1 M, 0.15 M, and 0.2 M imidazole. 
"an, 
Figure 5.7. Elutions of His-tagged L7/L12 
and GFP from Ni-NTA with 0.2 M imidazole. 
L7/L12 (left) and GFP (right) are indicated with 
arrows. 
A 
Vector name Ref. Length Cale. Detectable Ni-NTA Cale. Cale. Cale. 
pG8SAET (aa) MW induction? Partial p1 p1 p1 
clone  (Da)  Purification? _______ (+His) (+Etag) 
pET-DEST42 9 76 8,444 Y Y 5.13 8.33 4.91 
cysA_frag  
pET-DEST42 25 97 10,988 N N 5.76 8.29 5.39 
STM3167 frag 
pET-DEST42 53 91 10,322 N N 6.18 9.57 5.66 
ytfE_frag  
pET-DEST42 113 75 8,306 N N 5.57 7.28 5.09 
ptsN_frag  
pET-DEST42 114 88 9,629 N N 8.40 10.00 6.31 
oat frag  
pET-DEST42 122 129 14,404 Y Y 9.85 10.14 9.25 
gpI6_frag  
pET-DEST42 126 80 8,993 N N 5.77 9.40 5.19 
yijO_frag  
pET-DEST42 148 100 10,752 Y Y 5.33 9.30 4.96 
STM2235 frag  
pET-DEST42 134 73 7,940 N N 5.99 9.78 5.13 
ydiY_frag  
pET-DEST42 118 83 9,316 Y Y 5.08 9.06 4.92 
yhjJ_frag  
pMOG3 positive 164 17,027 Y Y 4.55 5.70 4.60 
(see methods) control 
pVCN2 -- 278 31,450 Y Y N/A 6.24 N/A 
(see _method s)  
Table 5.2. Summary of fusion constructs, relevant properties, and expression/purification 
results. The predicted isoelectric point (CaIc. p1) of the relevant product is represented as it would be 
without extra sequence, with added pET-DEST42 sequence including polyhistidine tag (+His), and as 
an E-tag and phage protein GP8 fusion (+Etag). 
b. Purification of positive and negative controls using ion exchange 
To further purify the fusion protein fragments and controls, the buffers of Ni-
NTA eluates for each fusion were exchanged for the buffers to be used in IEC. 
L7/L12 and GFP were dialysed in 20 mM Tris-C1 (pH 8.0) in preparation for anion 
exchange on a Mono Q column (Amersham). Following this, the two proteins were 
purified consecutively on the same column. Briefly, the sample was loaded in 2 x 5 
ml volumes, after which the column was washed with 10 ml of the same Tris buffer. 
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Following this, a gradient of the same Tris buffer with increasing ionic strength was 
applied over 20 ml (L7/L12) or 30 ml (GFP) until the maximum NaCl concentration 
of 1 M was reached. A further 10 ml of buffered I M NaCl was passed through the 
column to elute any remaining bound protein. Consecutive fractions of 1 ml were 
collected starting just before and ending just after the gradient was applied. Green 
fractions were collected from the GFP purification and analysed by SDS-PAGE 
(Figure 5.8). The UV absorbance value of L7/L12 elution fractions was monitored, 
and fractions with relatively high absorbance values were subsequently analysed by 
SDS-PAGE (Figure 5.9). Lanes containing fractions that were subsequently used for 
immunodetection are indicated in bold type. 
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Figure 5.8. SDS-PAGE analysis of 	Figure 5.9. SDS-PAGE analysis of IEC eluted 
JEC eluted fractions of His-tagged fractions of His-tagged L7/L12. Fractions (1 ml) 
GFP. Fractions (1 ml) were collected 	were collected during application of a salt gradient 
during application of a salt gradient to to a Mono Q column with bound L7/L12 fusion 
a Mono Q column with bound GFP 	protein. Lanes 1-5, 7-11: samples of consecutive 
fusion protein. Lanes 2-7: samples of fractions that exhibited the highest liv absorbance 
green fractions; Lane 1: Molecular 	readings. Lane 6: Molecular weight marker,with 
weight marker, with corresponding corresponding sizes (in kDa) on the right. Fractions 
sizes (in kDa) on the left. The 	 in lanes 2 and 3 were combined and subsequently 
fraction in Lane 4 was subsequently 	used in immunodetection. 
used in immunodetection. 
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c. Purification ofYhjJ frag and CysA frag fusions using ion exchange 
Buffers of Ni-NTA eluates containing YhjJ frag and CysA frag were 
transferred to 50 mM sodium phosphate (pH 7.0) for cation exchange on a Mono S 
column (Amershani). Due to their low molecular weights, the buffer exchange was 
performed using 1 kDa cutoff spin columns. Otherwise, the IEC purification 
procedure for these two fusions were as described for the control fusion proteins in 
the previous section. UV absorbance of eluate was observed, and fractions 
corresponding to an absorbance peak (Figure 5.10) were analysed by SDS-PAGE 
(Figures 5.11). Lane 4 of Figure 5.11 contains the fraction of YhjJ frag that was 










Figure 5.10. UV absorbance peakof fractions 
collected during the application of a salt gradient to 
Mono S beads to elute bound YhJJ frag. Ni-NTA 
purified YhjJ frag was bound to Mono S beads in buffer 
with no salt, and subsequently eluted with increasing salt 
concentrations. Fractions (indicated by red lines) 
corresponding to the major UV absorbance peak were 
subsequently analysed by SDS-PAGE in Figure 5.11. 
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Figure 5.11. SDS-PAGE analysis of IEC eluted 
fractions corresponding to a major UV absorbance 
peak indicating the presence of protein. Elution 
fractions were analysed by SDS-PAGE to assess purity 
and molecular weight of the protein detected by the 
major absorbance peak in Figure 5.10. Lane 1: Molecular 
weight marker with corresponding band sizes (in kDa) 
indicated on the left. Lanes 2-4: Samples of fractions 
corresponding to the major UV absorbance peak 
measured during IEC purification of YhjJ frag. Lane 4 
contains the fraction used subsequently for 
immunodetection experiments. 
14.2—. 40  
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The CysA frag Ni-NTA was similarly subjected to further purification by IEC 
on a Mono S column. Fractions corresponding to Peak A in the CysA frag IEC 
elution contained two bands, the lower of which matched the expected MW for the 
protein fragment fusion. The Peak A fractions were combined and re-purified by IEC 
using the same procedure as was used for the first IEC purification of CysA frag. 
This second purification produced a single, barely detectable absorbance peak that 
was analysed by SDS-PAGE and found to consist of only the upper contaminating 
band from the Peak A fractions (data not shown). Therefore, a new purification was 
performed from a fresh 500 ml culture, under denaturing conditions. This and the 
following purifications under denaturing conditions were performed, due in part to 
limited time availability for experimental work. 
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Figure 5.12. UV absorbance peaks 
of fractions collected during the 
application of a salt gradient to 
Mono S beads to elute bound CysA 
frag. Ni-NTA purified CysA frag was 
bound to Mono S beads in buffer with 
no salt, and subsequently eluted with 
increasing salt concentrations. 
Fractions (indicated by red lines) 
corresponding to IJV absorbance peaks 
A and 13 were subsequently analysed 
by SDS-PAGE in Figure 5.13. 
1 2 34567 
Figure 5.13. SDS-PAGE analysis of LEC eluted 
aw 26.6 
fractions corresponding to UV absorbance peaks 
indicating the presence of protein. Lanes 1-5: 
17 samples of fractions corresponding to Peak A in 
Figure 5.12. Lane 6: Sample of a fraction corresponding 
at 14.2 to Peak B. Lane 7: Molecular weight marker, with - 6.5 corresponding sizes (m kDa) on the right. 
3.5 
Cells were pelleted and lysed with Denaturing Lysis Buffer, washed with 
Denaturing Wash Buffer and then with Refolding Buffer, and eluted again in 
Refolding Buffer with added 0.2 M imidazole. The eluate was analysed by SDS-
PAGE (Figure 5.14). To remove the contaminating protein bands that co-purified, 
IM 
this elution was re-purified by IEC using the same procedure as was used for the first 
JEC purification. Elution fractions of 0.5 ml were collected, and SDS-PAGE was 
performed on samples of fractions with increased UV absorbance (Figures 5.15, 
5.16). Although the concentration was quite low, a single band of the correct size 
was isolated. The three indicated fractions were combined and subsequently 
concentrated by lyophilisation followed by resuspension in water. This preparation 
was subsequently used for immunodetection. 
26.6- Figure 5.14. SDS-PAGE analysis of CysA frag 
Ni-NTA affinity purification under denaturing 
conditions. CysA frag was affinity purified from 
1 7 	- bacterial culture using denaturing and refolding 
14.2 
buffers. Left lane: Molecular weight marker, with 
band sizes (in kDa) indicated on the left. Right lane: 
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Figure 5.15. WC separation of 
Mono S-bound proteins obtained 
by elution of His-tagged protein 
originally bound to Ni-NTA from 
bacterial lysate in denaturing 
conditions. Ni-NTA purified CysA 
frag was bound to Mono S beads in 
buffer with no salt, and subsequently 
eluted with increasing salt 
concentrations. Fractions (indicated by 
red lines) corresponding to Peak B 
were subsequently analysed by SDS-
PAGE in Figure 5.16. 
Figure 5.16. SDS-PAGE analysis of 
IEC elution fractions from Peak B of 
Figure 5.15. Lane 1: Molecular weight 
marker with corresponding banc sizes 
(in kDa) indicated on the left. Lanes 2-7: 
Samples from fractions associated with 
Peak B in Figure 5.15. The position of 
CysA frag is indicated with an arrow on 
the right. Fractions reperesented in 
Lanes 5-7 were combined, concentrated, 
and subsequently used in immunodetection. 
d. Purification of Gp16 frag and STM2235 frag 
Ni-NTA elutions of Gp16 frag and STM2235 frag (purified in native 
conditions) were dialysed in 50 mM sodium phosphate (pH 7.0) using a 3.5 kDa 
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cutoff membrane in preparation for cation exchange on a Mono S column. Gp 16 frag 
and STM2235 frag precipitated during dialysis. SDS-PAGE analysis confirmed that 
the protein fragment fusions were contained only in the precipitate and not in the 
remaining soluble fraction (Figure 5.17). 
Figure 5.17. SDS-PAGE analysis of precipitates 
that developed during dialysis of Cp16 frag and 
STM2235 frag. Lane 1: Molecular weight marker, 
with corresponding sizes (in kDa) indicated to the 
left; Lanes 2, 3: remaining soluble fractions of Gp16 
frag, STM2235 frag; Lanes 4, 5: precipitates of Gp16 
frag, STM2235 frag. The protein fragment fusions are 
indicated with arrows. 
Precipitates were dissolved in Denaturing Lysis Buffer containing urea, and 
subsequently incubated with Ni-NTA beads for a second affinity purification. Beads 
were washed with denaturing buffer and subsequently with refolding buffer. Elutions 
whith 0.2 M imidazole in refolding buffer were analysed by SDS-PAGE. No 
detectable protein was present in the Gp16 frag eluate; however, STM2235 frag was 






Figure 5.18. Elutions of Gp16 frag and STM2235 frag 
after a second affinity purification with Ni-NTA. 
Precipitates in Figure 5.17 were dissolved in Denaturing 
Lysis Buffer, and subsequently washed with Denaturing 
Wash Buffer followed by Refolding Buffer. Ni-NTA beads 
were then eluted using the same Refolding Buffer with 
added 0.2 M imidazole. Lane 1: Molecular weight marker 
with corresponding band sizes (in kDa) on the left; 
Lane 2: Gp16 frag elution; Lane 3: STM2235 frag elution. 
Since the STM2235 frag eluate from the re-purification on Ni-NTA still 
contained contaminating E. coli proteins, the eluate was prepared once again for IEC. 
Instead of dialysis, the eluate was diluted tenfold in cation exchange buffer and 
subsequently concentrated again by polyethylene glycol (PEG)-induced extraction of 
the buffer through the dialysis membrane. The STM2235 frag solution was then used 
for IEC. STM2235 frag did not bind to the Mono S column (data not shown). Since 
the unbound protein solution had become very dilute, a new purification of this 
construct was performed from a 500 ml IPTG-induced culture. The same denaturing 
and refolding buffers were used in the same purification protocol. The resulting 
elution was analysed by SDS-PAGE (Figure 5.19). 
Gp16 frag was similarly re-purified from a new culture using denaturing and 
re-folding conditions. Because three bands of equal intensity were present in the 
eluate (data not shown), this protein was prepared for further purification on the 
Mono S cation exchange column. The eluate was diluted in cation exchange buffer 
and concentrated with PEG-induced extraction through dialysis membrane in a 
similar manner as was done for STM2235 frag. Like STM2235, this protein did not 
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bind to the Mono S column (data not shown). A new round of Ni-NTA purification 
using denaturing and re-folding conditions was then performed from fresh culture. 
The resulting elution was analysed by SDS-PAGE (Figure 5.19). The same three 
protein bands were present in this purification as in the previous purification. 
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26.6 Figure 5.19. Gp16 frag and STM2235 frag affinity purified 
on Ni-NTA from new 500 mL cultures in denaturing 
1  
followed by re-folding conditions. Elutions in Refolding 
Buffer with added 0.2 M imidazole are shown. Lane I: 
14 2 Molecular weight marker with corresponding band sizes on 
$ the left; Lane 2: Gp16 frag; Lane 3: STM2235 frag. 6.5 
3.5 	* 
k44I3' 
Since the quantity of Gp16 frag isolated from the latest purification was very 
low, the same purification was repeated but with overnight binding to Ni-NTA 
instead of 3 hrs. The two independently obtained Gp 16 frag purifications were 
combined into one solution and concentrated by PEG extraction of buffer through 
dialysis membrane. The STM2235 frag elution was used in a second, identical round 
of affinity purification on Ni-NTA in an attempt to remove the higher molecular 
weight contaminant. The resulting eluate was less pure than the original eluate 
(compare Gpl 6 frag in Figure 5.19 and Figure 5.20). Additionally, the concentrated, 
combined Gp 16 frag purification was dominated by a protein band of approximately 
25 kDa which was larger than bands seen in previous purifications (Figure 5.20). 




Figure 5.20. SDS-PAGE showing all purified 
His-tagged constructs to be used subsequently in 
LU.0 Immunodetection. Samples (0.2 gig) of each 
preparation were subjected to electrophoresis, after 
maw 17 which the gel was stained with GelCode Blue 
(Pierece) and imaged. Lane 1: CysA frag; Lane 2: 
14.2 op16  frag; Lane 3: STM2235 frag; Lane 4: YhjJ frag; 
OW Lane 5: Moleuclar weight marker, with corresponding 
6.5 band sizes (in kDa) on the right; Lane 6: L7/L12; Lane 7: 
GFP. 
3.5 
3. Immuno detection 
a. ELISA 
Each well of an Immu!on-2 plate was coated with 0.1 i.g of purified fusion 
protein. Pooled pre-immune and dayl7pc3 CBA/Ca sera were titrated against the 
fusion proteins, starting at a dilution of 1:40. The reaction of HRP-conjugated anti-
mouse IgG with H202 and the OPD substrate caused the development of a coloured 
by-product for which the absorbance was measured at ?.=492 nm. The absorbance 
values for all samples (including that of L7/L12, intended to be the positive control) 
were quite low; for this reason, cutoff values were not used. Absorbance values, less 
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Figure 5.21. Relative absorbance values representing antigenicity of different 6x His-tagged 
constructs after testing by ELISA. Purified 6x His-tagged fragments of CysA, YhjJ, SMT2235, and 
Gp 16 identified as potential antigens were tested with pre-immune (dO) and hyperimmune anti-S. 
Typhimurium (dl7pc3) sera at the dilutions indicated. Positive and negative control antigens were 
L7/L 12 and GFP, respectively. 
To ensure that the low absorbance values obtained in the ELISA were not due 
to experimental error, a new positive control was added. GroEL is a well 
characterised Salmonella antigen (Panchanathan et al., 1998; Dera-Tomaszewska et 
at., 2003). For this reason, purified S. Typhimurium SL1344 GroEL (courtesy of P. 
Taylor: purified untagged protein (Taylor, 1997)) was likewise tested by ELISA in 
parallel with the potential antigens. Absorbance values, less the average value of 
secondary antibody control wells, are represented in Figure 5.22. Very high 
absorbance readings were produced by very dilute amounts of anti-S. Typhimurium 
serum in wells coated with GroEL. This occurred in parallel with very low readings 
produced by much higher preimmune serum concentrations in GroEL-coated wells. 
It was also in parallel with very low readings produced by high concentrations of 
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Figure 5.22. Relative absorbance values representing antigenicity of purified proteins after 
testing by ELISA. Purified 6x His-tagged L7/L 12, GFP, and a fragment of Gpl 6 identified as 
potentially antigenic were tested with pre-immune (dO) and hyperimmune anti-S. Typhimurium 
(dl7pc3) sera at the dilutions indicated. Untagged GroEL and 6x Flis-tagged GFP were positive and 
negative control antigens, respectively. 
b. Western blots 
Western blots were performed for comparison with the ELISA results. An 
SDS-PAGE gel was prepared, with the purified His-tagged constructs (0.2 ji,g per 
lane) alongside GroEL in duplicate, separated by a pre-stained molecular weight 
marker (New England Biolabs). After electrophoresis, proteins were transferred to 
PVDF membrane, after which the membrane was divided along the centre of the pre-
stained marker. The two pieces of membrane were then blocked and subsequently 
probed with either HRP-conjugated His-probe H-3 mouse monoclonal antibody 
(Santa Cruz Biotechnology) at 1:1000 or hyperimmune anti-S. Typhimurium 
(dIl7pc3 CBAICa) serum at 1:4000, which was the same serum concentration used in 
the screening process. Protein bands were detected by ECL and photographed. The 
ECL detection and normally photographed PVDF membrane are shown (Figure 
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5.23). Figure 5.23(A) shows that GroEL (indicated with an arrow) reacts strongly 
with anti-S. Typhimurium serum and is accompanied by a weakly reactive 
contaminating band of approximately 16 kDa. L7/L12 (Figure 5.23(A), Lane 5) is 
weakly reactive with the same serum. The clearly transferred prestain marker, as well 
as the strongly reactive anti-histidine bands in Figure 5.23(C) confirm that an ample 
quantity of protein was transferred to the membrane for immunodetection purposes. 
Indeed, the three anti-histidine reactive bands present in the Gp16 frag preparation 
are present in very small quantities as seen in Lane 2 of Figure 5.20., with the 
smallest anti-histidine reactive band not being visible at all. The lack of anti-histidine 
reactivity of GroEL confirms that the antibody binding is specific. The major protein 
band present in the Gpl 6 frag preparation does not have the predicted molecular 
weight for this construct and is extremely faint in Figure 5.23(B). Thus, the major 
component of this preparation is likely to be a contaminant. The reason for multiple 
bands in Lanes 2 and 3 of Figure 5.23(B) is not clear but will be examined in the 
following discussion section of this chapter. 
CysA frag is not included in Figure 5.23 because it had been completely 
consumed when this blot was performed. However, it was immunoblotted previously 
with anti-His antibody and also with hyperimmune anti-S. Typhimurium serum. ECL 
detected a single band, corresponding precisely to the band in Lane 1 of Figure 5.20, 
when the anti-his antibody was used. No bands were detected by ECL when the 














Figure 5.23. ECL detection of purified proteins, probed with (A) hyperimmune anti-S. 
Typhimurium serum or (B) anti-3xHis antibody. (C) Divided PVDF membrane, after ECL, 
corresponding to the images directly above it. (0.2 jig each lane) Lane 1: GroEL; Lane 2: Gp16 frag-
6xHis; Lane 3: STM2235 frag-6xHis; Lane 4: YhjJ frag-6xHis; Lane 5: L7/L12-6xHis; Lane 6: GFP-
6xHis; H: BenchMark His-tagged protein standard (Invitrogen). P: Broad-range prestained protein 
marker (New England Biolabs), with corresponding band sizes (in kDa) alongside the marker. Other 
protein bands visible in (C) appeared as a result of strongly reacting ECL components. The GroEL 
protein band is identified with an arrow. 
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C. Discussion 
Following the identification of phagemid clones encoding potentially 
antigenic protein fragments in the previous chapter, the corresponding sequences 
were sub-cloned into expression vectors. IPTG-induced expression was detectable 
from positive (L7/L1 2) and negative (GFP) controls and from four of the ten clones 
in the conditions tested. Purification by affinity chromatography followed by IEC 
allowed the immunodetection of these protein fragment fusions by ELISA and 
western blot. The antigenicity of the four purified fusions was comparable to that of 
the negative control. Furthermore, the positive control was very weakly antigenic, as 
verified by a second positive control that was subsequently introduced. 
1. Cloning 
In order to match the chosen phagemid clones' sequences as closely as 
possible, protein fragments were cloned rather than entire proteins. This would 
reduce the possibility of an antigen being identified coincidentally with a phagemid 
clone. Ultimately, a phagemid clone isolated on the basis of antigenicity must encode 
an antigenic epitope. If a whole protein is tested for antigenicity, it may happen to be 
antigenic due to the presence of an epitope that is entirely absent from the phage-
displayed portion. This would be no different than randomly testing proteins for 
antigenicity. The likelihood of coincidentally identifying an antigen should not be 
underestimated, as immunoblots in Chapter 3 suggested that the CBA/Ca mouse 
serum reacts with a variety of S. Typhimunum antigens. Additionally, coincidental 
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isolation of phagemid clones was highlighted in Chapter 4. The isolation of Clone 19 
containing a portion of the gene encoding a well-known antigen, flagellin, was 
coincidental. The only evidence to prove its random presence was the minus 
orientation of the insert. If it had a plus orientation, it would not necessarily contain 
an antigenic epitope. 
For sub-cloning the sequences encoding the protein fragments, TOPO and 
Gateway cloning were used for greater convenience. Cloning into the TOPO entry 
vector allows the flexibility to recombine the same insert sequence into different 
destination vectors to produce expression clones with different affinity tags 
(Invitrogen, 2003a). When choosing an affinity tag for purification of the target 
recombinant protein fragments, the polyhistidine tag was chosen primarily on the 
basis of its small size. Larger molecules such as GST could potentially mask the 
antigenicity of a small protein fragment. Cleavable affinity tags are also available. 
However, the efficiency of cleavage varies according to the recombinant protein to 
which the tag is fused (J. Bjerketorp, 2001, unpublished results). In the phagemid 
vector pG8SAET, phage-displayed protein fragments are fused to the small B-tag at 
the C-terminus. In order to more closely match the structure of phage-displayed 
protein fragments, a C-terminal His-tag fusion was chosen. 
The nucleotide sequence of all constructs was checked to confirm that they 
did not contain mutations affecting the correct translation of the insert sequence. 
None of the constructs were mutated in any way. The gpl6 sequence obtained from 
Clone 122 deviated from the published sequence for the corresponding gene at two 
nucleotide positions, creating a difference at the amino acid level. The fact that the 
gpl6 expression clone had the identical sequence deviation from independently 
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amplified DNA indicates that this difference is related to the S. Typhimurium strain 
from which the DNA is amplified. 
2. Expression 
After extensive testing of induction conditions, only four of the ten protein 
fragment constructs showed detectable expression. It is possible that the other six 
expressed the recombinant fusion in the insoluble fraction, since the supernatant of 
cell sonicates were used for SDS-PAGE analysis. However, expression could not be 
detected in the lysates even with a monoclonal anti-3xHis antibody for these six 
clones. This was despite the strongly detected expression of the STM2235 construct, 
which is predicted to have a 95% chance of insolubility when overexpressed in E. 
coli (www.biotech.ou.edu). Among all the constructs, this one had the highest 
probability of insolubility as predicted by the amino acid sequence. Thus, if 
expression had occurred in the other constructs, it should have been detectable in the 
supernatant after sonication with the anti-3xHis antibody. The failed attempt to 
enrich for possibly expressed fusions from the six by performing Ni-NTA affinity 
chromatography on whole cell lysates supported the conclusion that there was no 
expressed fusion to purify from these six. However, a better assessment could be 
performed on denatured lysates in which inclusion bodies are disrupted by guanidine 
or urea (Kuliopulos, 1994). 
Additionally, the 5TM2235 construct is predicted to be the least stable protein 
among all the constructs according to the "N-end rule" because it is the only one 
encoding Met followed by Leu in positions one and two of the amino acid sequence. 
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Processing of the N-formyl methionine exposes leucine at the N-terminus, leading to 
a significantly decreased half-life. This instability is dependent on the activity of the 
CIp protease in E. coil (Tobias et al., 1991). Although E. co/i BL2I is naturally 
deficient in Lon and OmpT proteases, Up deficiency has not been described for this 
strain. If instability played a role in the lack of expression for the six clones, it was 
not instability related to the N-end rule. 
Many other degradation pathways exist in E. co/i, including a protease that 
specifically targets small (<15 kDa) proteins (Kim et al., 1995). Instability of small 
proteins can be counteracted by reducing growth temperature, inducing for a shorter 
time, and/or using a dihydrofolate reductase (DHFR) tag (Qiagen, 2003). Expression 
levels were not investigated at 1 hr after addition of IPTG with growth at 30°C, and 
this could be a reason for the lack of observable expression from the six constructs. 
An alternative system for the expression of recombinant peptides is by N-
terminal fusion to ketosteroid isomerase (KS!) in conjunction with C-terminal fusion 
to a polyhistidine tag. KSI is highly insoluble and is rapidly directed to inclusion 
bodies when produced. This protects fused peptides from degradation and improves 
the yield. After affinity purification of inclusion bodies under denaturing conditions, 
the recombinant peptide is released from KSI and the polyhistidine tag by CNBr 
cleavage of junctional methionines (Kuliopulos and Walsh, 1994). Protein fragments 
may be expressed more stably when fused to larger affinity tags. Native-purified 
protein fragments fused to maltose-binding protein (MBP) have been successfully 
used in the analysis of domain interactions of the fusion-active complex of SARS 
virus (Ingallinella et al., 2004). A GST tag fused to antigenic fragments of 
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Chiamydia abortus outer membrane proteins enabled affinity purification and also 
did not interfere with antibody binding (Vretou et al., 2003). 
3. Purification 
The purity of a tagged fusion protein after affinity chromatography is in part 
dependent on expression levels (Ramage et al., 2002). Thus, it is not surprising that 
the purest eluted protein after affinity chromatography in native conditions was the 
L7/1,12 construct, which expressed the most fusion protein relative to other cellular 
proteins. Conversely, native Ni-NTA affinity chromatography performed on lysates 
of the four sub-clones with very low expression levels yielded fusion proteins of very 
low purity. A second step in purification was thus introduced. 
IEC, which is frequently used as the last step to yield highly pure protein 
preparations for crystallography (Ramage et al., 2002), greatly enhanced the purity 
of all eluted proteins. Additionally, successful purification of biologically active 
polyhistidine-tagged fragments of fibronectin by IEC following Ni-NTA affinity 
chromatography has been described (Klein et al., 2003). Except in the case of 
STM2235 frag, IEC eluted protein fractions containing the target protein were 
sufficiently pure to use for immunodetection. Except in the case ofGpl6 frag and the 
second attempted STM2235 frag IEC purification, all of the target proteins bound to 
the column. A lack of binding to the IEC column was accompanied by an attempt to 
concentrate the sample, using PEG and dialysis tubing, prior to loading it onto the 
column. Significantly, it was assumed that the molecular weight cutoff of 3.5 kDa 
would guarantee that the fusions would not pass through it. This was not verified, 
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and drew further suspicion after the final Gp16 frag preparation was concentrated 
using this method. The protein band corresponding to Gp16 frag his was extremely 
faint after PEG.-induced extraction of buffer through dialysis membrane, and a larger 
contaminating band became very concentrated. 
Due to a shortage of time to perform further experiments, denaturing 
conditions were used when fusion protein had to be newly purified from cell lysate. 
Native conditions should be used whenever possible to ensure the correct folding of a 
protein, which is important for detecting some antigenic epitopes (Somner et al., 
999). Although the conformation of polyhistidine-tagged protein fragments may be 
different from the corresponding E-tagged fragments displayed on the phage surface, 
it is prudent to retain native conformation whenever possible since it is also possible 
that the conformations may be the same. However, a refolding buffer can be used in 
conjunction with denaturing conditions to partially compensate for a loss of 
conformation (Tsumoto et al., 2003). This was a convenient solution since binding to 
Ni-NTA in denaturing conditions yielded much purer fusion protein after elution 
with the refolding buffer. This phenomenon is likely due to E. co/i metalloproteins 
which co-purify on Ni-NTA in native conditions (Pasquinelli et al., 2000) that lose 
the metal-binding site due to disrupted protein structure in denaturing conditions. 
Since high purity was important for minimising the possibility of the polyclonal anti-
S. Typhimurium serum reacting with impurities originating from the closely related 
E. coli, and shorter amino acid sequences are more flexible in conformation, this was 
considered the best strategy to complete the purification scheme. 
GFP, L7/L12, CysA frag, and YhjJ frag fusions were highly pure after Ni-
NTA and lEG separation from host cell proteins, characterised by a single band 
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observed in SDS-PAGE analysis (Figure 5.20) that correlated with a single anti-
polyhistidine reactive band in western blots (Figure 5.23(C), data not shown). Only 
Gp16 frag and STM2235 frag preparations contained multiple, anti -polyhistidine 
reactive bands. The band of highest molecular weight in the STM2235 frag 
preparation corresponds in size to a possible dimer. Although the sample was 
prepared with DTT prior to electrophoresis, oxidation caused by presence of leached 
nickel ions from the Ni-NTA could counteract its effect. Indeed, leaching of nickel 
ions during affinity purification has led to oxidation of the purified polyhistidine-
tagged construct in other studies (Ramage et al., 2002). However, this explanation 
cannot be applied to the other bands in the two protein fragment preparations. 
Significantly, both of these constructs are derived from bacteriophage genes. 
Multifunctional proteins are not uncommon among phages and viruses (Ray and 
Ray, 2001; Zhao et al., 2001; Toth et al., 2003). Furthermore, multiple distinct 
polypeptides may be produced by a single viral gene, according to different 
translation mechanisms (Vassilaki and Mavromara, 2003; Zimmer et al., 2003). New 
polypeptide forms of a viral gene may be detectable by expression of C-terminal 
fusion tags (N. Vassilaki, personal communication). The production of multiple 
proteins from a single sequence, and multifunctional characteristics of some viral and 
phage proteins, may be the product of evolutionary pressure to maintain a small 
genome size (Yewdell and Hill, 2002). 
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4. Immunodetection 
Only four of the ten constructs could be tested for antigen icity. ELISA and 
western blots failed to identify any of these as antigens. Surprisingly, the intended 
positive control, L7/L12, was an extremely weak antigen for the CBA/Ca mice in 
which the hyperimmune serum was produced. It was barely detectable in all ELISAs 
and western blots, although the serum strongly reacted with a known antigen, GroEL, 
in parallel. This is in contrast to hyperimmune anti-S. Typhirnurium serum prepared 
in the same manner in BALB/c mice (M. Mogensen, 2004, unpublished results). 
Since these two strains of inbred mice have different H-2 haplotypes (H2d  for 
BALB/c and H2k  for CBA/Ca) they recognise different antigenic peptides. This 
could explain why L7/L12 is strongly antigenic for BALB/c mice but not for 
CBA/Ca mice. Indeed, genetic differences may explain why immunoblots detected 
L7/1,12 as an antigen recognised by serum from some Chiamydia trachomatis-
infected individuals but not others (Sanchez-Campillo et al., 1999). 
None of the subcloned constructs could be demonstrated as antigenic. A 
sufficiently pure and detectable amount of the expressed fusion constructs was used 
for antigenicity testing, except in the case of Gp16 frag. The three polyhistidine-
tagged forms visible in Figure 5.23(C), Lane 2, may not be present in a high enough 
concentration for reliable ELISA testing. An ELISA test using the anti-polyhistidine 
antibody would clarify the detectability of all the fusion proteins bound to the plate. 
Furthermore, the possibility of conformational antigenic epitopes being present 
among the sub-cloned fragments cannot be ruled out, since denaturing conditions 
were employed in the purification of three out of four. If Gp16 frag is antigenic, the 
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different forms would have to be isolated by other purification methods so that each 
can be independently tested for antigenicity. The possibility of this protein's 
antigenicity draws attention to its possible expression during the course of murine 
infection and how this may be related to pathogenesis. As pointed out in Chapter 1, 
bacteriophage production during the course of pathogenesis has been documented, 
although not yet in the case of Salmonella. 
The magnitude of difference in antigenicity between GroEL and L7/L12, as 
well as the lack of antigenicity exhibited by the other fusions, was consistent 
between the immunoblot and ELISA results. The antigenic potential of any of the 
constructs cannot be ruled out; however, the intensity with which the phage-
displayed fragments give a positive result in a dot blot (Figure 4.5, Chapter 4), 
relative to phage-displayed L7/Ll2 --now established as very weakly antigenic--, 
does not support the likelihood of strong antigenicity among any of the ten selected 
clones. 
Since the protein fragments could not be proven as antigenic, it is possible 
that the fragments displayed by the ten clones attracted the binding of E. coli 
chaperone proteins. GroEL, shown above as strongly recognised by anti-S. 
Typhimurium serum, is part of the HSP60 family of proteins that are involved in the 
folding and refolding of polypeptides (Craig et al., 1993). This protein is highly 
conserved, being nearly identical for E. co/i and Salmonella (Lillicrap et al., 2004). 
GroEL binds to a large variety of sequences that it recognises as being in an 
abnormal conformation (Chatellier et al., 1999; Kandror et al., 1999). Since the ten 
clones are clearly distinguishable from the negative control in Figure 4.5 (Chapter 4), 
GroEL could be binding, in small quantities, to protein fragments on the surface of 
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the particles produced by the ten phagemid clones. Since the negative control is not 
expected to display any protein fragments, it would not attract the binding of this 
chaperone. To assess whether host GroEL is binding to the phage particles, the same 
dot blots could be performed using commercially available anti-GroEL antibody. 
Purification of the protein fragments was important for clarifying the reasons 
for the positive results observed in Chapter 4. Thus, the results obtained in this 
chapter not only reveal that a different positive control antigen is necessary, but also 
that the screening procedure should be modified to reduce the likelihood of 
misleading results arising from possible binding of host GroEL or other proteins. 
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A. Summary 
Emerging antibiotic resistance has drawn new attention to vaccine 
development (Graham, 2002). Two vaccines are currently licensed for typhoid fever 
in humans: a live attenuated strain that is not suitable for immunocompromised 
individuals, and a polysaccharide subunit vaccine whose antigen is produced by a 
segment of the S. Typhi genome that is unstable (Ivanoffet al., 1994; Plotkin and 
Bouveret-Le Cam, 1995; Nair et al., 2004). Vaccination with multiple antigenic 
subunits offers an ideal solution to this problem. S. Typhimurium infection of mice 
has been a useful model for the study of typhoid fever (Carter and Collins, 1974; 
Jones and Falkow, 1996). Furthermore, immunoblot patterns of mouse serum against 
S. Typhimurium lysate closely resemble those of human serum against S. Typhi 
lysate (Brown and Hormaeche, 1989). 
Using the mouse model, the viability of multiple subunit vaccination was 
recently shown. Briefly, a promoter trap library derived from S. Typhimurium DNA 
was constructed upstream of plasmid-encoded GFP-ovalbumin. BALB/c mice were 
infected with S. Typhimurium bearing the library, after which genes associated with 
increased promoter activity were identified. Corresponding proteins were purified 
and used in conjunction with Freund's complete and incomplete adjuvant in primary 
and secondary immunisations, respectively (Rollenhagen et al., 2004). The method 
used to identify the antigens was laborious and time-consuming, with the antigenicity 
of the proteins being inferred from in vivo expression levels. Freund's adjuvant is 
standardly used in animals, but its side effects are unacceptably severe for use in 
humans. The protection level achieved was high and comparable to that conferred by 
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a whole-cell lysate of the pathogen. However, the protective subunit vaccine 
consisted of only two antigens, which may not produce the same result if used to 
immunise mouse strains other than BALB/c. This is significant in light of the need 
for a vaccine suitable for a genetically diverse population with varied responses to 
specific antigens. Moreover, the use of multiple antigens will reduce the likelihood 
of antigenic drift, such as may be happening for the currently used Vi subunit 
vaccine (Nair et al., 2004). 
The objective of this thesis was to identify S. Typhirnurium antigens by phage 
display technology. A phagemid library was constructed using S. Typhirnurium DNA 
and hyperimmune S. Typhirnurium-reactive serum was raised in mice. With these 
tools, a series of selection protocols (biopannings) were tested and modified until a 
successful biopanning was inferred. A number of clones were screened for possible 
antigenicity against a constructed phagemid clone that was considered as the positive 
control. This screening process led to the selection of a final ten phagemid clones 
encoding protein fragments. The corresponding gene fragments were amplified from 
S. Typhimurium DNA and cloned into an expression vector encoding an affinity tag 
for purification. Expression and purification was achieved for four of these, which 
were subsequently tested for antigenicity. Antigenicity could not be demonstrated for 
any of the four, and the protein that was thought to be antigenic was demonstrated as 
very weakly antigenic. Hence, while it is possible that the purified protein fragments 
did not display the same epitopes as when bound to the phage, it is more likely that 
the biopanning was not successful and an inappropriate protein was chosen as the 
positive control for screening. Although the main aim of this work was not achieved, 
much can be learnt from the present study to allow the successful use of this 
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technology in the future. The phagemid library and serum used for biopanning were 
demonstrated to be of a high quality and are the most important tools, for future 
experiments, which are discussed below. 
B. New biopanning strategies 
1. New control biopannings 
The majority of biopanning studies are performed with ligands of maximal 
homogeneity, such as a single protein, a monoclonal antibody, or purified fractions 
of serum (Theisen etal., 2000; Kouzmitcheva etal., 2001; Robben etal., 2002). It is 
for this reason that IgG was partially purified from the hyperimmune anti-S. 
Typhimurium serum by ammonium sulphate precipitation. However, there was no 
test to confirm whether the level of purification was sufficient for successful 
biopanning. In order to prove that a successful biopanning is achievable with the 
pG8SAET S. Typhimurium library, a homogenous ligand should be used in an initial 
control biopanning. The recent analyses of the S. Typhimurium ShdA protein as a 
fibronectin-binding protein (Kingsley et al., 2002; Kingsley et al., 2004) make this 
interaction a convenient tool for biopanning experiments. Since the target protein is 
already known, a successful biopanning of the phagemid library against fibronectin 
will be obvious. Therefore, the conditions of this experiment could be more easily 
adjusted to achieve optimisation, which would provide useful information for 
subsequent biopannings against other targets. Ideally, the next ligand should be a 
monoclonal antibody directed against the same protein, since its detectability from 
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the library will have been established. Biopanning against this ligand could be 
optimised in turn, and the monoclonal antibody could be diluted in increasing 
proportions of mouse antibody preparations, until a limit of detection is reached. The 
optimal conditions for a successful biopanning at this limit would then be used for 
biopanning against successive purifications of hyperimmune anti-S. typhimurium 
serum. This sequence of experiments will provide a stronger foundation for inferring 
a positive result, thus meriting the further screening of clones and the testing of 
candidate antigens. 
A second option for a new biopanning strategy would be to raise new 
hyperimmune serum directed against a single antigen, such as OmpC, flagellin, or 
AhpC. Samples of successive purifications could be used as ligands for biopanning, 
beginning with the most pure and optimising for each step of decreasing ligand 
purity. This would have the advantage of mimicking a hyperimmune anti-S. 
Typhimurium serum biopanning more closely. However, the most pure form of this 
antibody preparation is likely to be less pure as a ligand in comparison to fibronectin. 
Alternatively, monoclonal antibodies could be raised against these proteins and used 
for biopanning trials. The epitope to which monoclonal antibody binds within the 
OmpA protein has been defined, so this antigen-antibody pair could be exploited for 
trial biopannings (Singh et al., 2003). 
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2. Suggested modifications for improved selection and screening 
As mentioned above, a successful biopanning has yet to be demonstrated 
using the phagemid library prepared in Chapter 3. If trial biopannings are performed 
against a homogenous ligand such as fibronectin, it may become clear whether 
proteolytic degradation of displayed fragments has caused a decrease in the 
efficiency of ligand binding. While this is a more crucial point for gene Ill-based 
systems than for geneVIll due to the difference in copy number (Baek et al., 2002), it 
may be a contributing factor and thus should be investigated for this library. 
Jacobsson et al. (2001) and many others did not need to use protease inhibitors for 
successful enrichment, but this could have been compensated by the homogeneity of 
ligand. If proteolysis is suspected to interfere with biopanning, the phagemid library 
could be re-infected with R408, and particles could be extracted in the presence of 
protease inhibitors. To further enhance the stability of displayed protein fragments, 
glycerol also could be included in the biopanning solutions. This has been 
demonstrated to enhance binding specificity during selection (Kjaer et al., 1998). 
One possibility that has not been assessed is whether interactions between phage 
particles could interfere with binding. Tween 20 was used in the washing solution for 
removal of non-specifically binding phage. The same component could be added to 
the library prior to panning, to reduce the frequency of any phage-phage complexes 
that could be masking antigenic epitiopes. 
Since successive purification of antibody from serum is somewhat difficult 
when very small quantities are available, such as from mice, a capture method may 
be used in combination with purification. An anti-mouse antibody was used during 
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initial pannings, which led to enrichment of phage binding to the anti-mouse 
antibody. A more appropriate capture method may be to use a non-antibody protein 
such as protein G. This protein binds to the Fc and Fab regions of the antibody 
molecule, as well as to albumin. However, a mutant form lacking the Fab and 
albumin binding regions could be used (Goward et al., 1990). Mutant protein G 
could be coated onto microwells in order to capture the mouse IgG at the Fe 
terminus, increasing the efficiency of selection by ensuring that the antigen-binding 
region is exposed to the phage library. If background binding to protein G interferes 
with enrichment of phage encoding antigens, protein G and anti-mouse antibody 
could be used in the first and second rounds of biopanning, respectively. 
The possibility of the hyperimmune anti-S. Typhimuriurn serum reacting with 
host components, such as GroEL, highlights the need for elimination of antibodies 
with undesirable binding from the serum. Kouzmitcheva et al. (2001) depleted their 
IgG preparation of antibodies that may bind phage non-specifically by pre-adsorbing 
the ligand with inactivated wild-type phage several times. This could be combined 
with pre-adsorption of the serum with a lysate of host cells. Indeed, the elimination 
of human antibodies binding to host cell and phage components was found to be 
crucial to the identification of tumor antigens (Chen, 2004). 
Another way to reduce the proportion of undesirable phage recovered from a 
round of selection involves a stepwise reduction in pH during elution (D'Mello and 
Howard, 2001). This is reminiscent of the salt gradient used to elute target proteins 
during lEG purification (Chapter 5). In fact, the use of 2 M NaCl in one study 
enabled the isolation of a clone that was not recovered by elution with low pH 
(Jacobsson et al., 2003). This study tested mild and harsh elution conditions: 5% 
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Tween, 2 M NaCl, S M urea, 40% ethanol, 80% methanol, 5% Tween, and 40% 
ethylene glycol. Low pH, not 2 M NaCl, was determined as the most efficient eluting 
agent. Thus, the specific nature of binding between a particle and the ligand 
determine which conditions are necessary for disrupting that interaction. Indeed, 
chemical elution is highly dependent on the specific antigen-antibody pair in 
question (Schier et at., 1996; de Bruin et al., 1999). More recently, an affinity-
independent method for elution was tested. Streptavidin, attached to a solid support 
by a DNA linker, can be detached by the addition of nuclease in the Cellection Biotin 
Binder Kit (Dynal). After panning the biotinylated ligand complexed with 
streptavidin, the phage-ligand complexes are eluted from the solid support by 
degradation of the DNA linker. This method solves the problem of poor recovery of 
clones with very high binding affinity (Santala and Saviranta, 2004). Thus, 
biotinylated mutant protein G could be used for biopanning in this manner. 
For subsequent screening of clones recovered from biopanning against 
hyperimmune anti-S. Typhimurium serum, a suitable positive control will be needed. 
A fragment of OmpC containing a known antigenic region could be cloned into the 
vector (Singh et al., 1995). Clearly, antigenicity of the fragment should not be 
assumed under any circumstances and should be verified prior to its use as a positive 
control with serum from any given mouse strain. The strikingly weak antigenicity of 
L7/L12 in CBA/Ca mice, compared to BALB/c, highlighted an important point. The 
variability between mouse strains in the antigens they recognise should be addressed 
when biopanning, as it is relevant for eventual vaccine development. Hyperimmune 
serum from more than one strain of mouse should be used to compensate for the 
variability of antigen recognition associated with differing H-2 haplotypes. A study 
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that successfully identified mimotopes for diagnosis of infection with Borrelia 
burgdorferi (Kouzmitcheva et al., 2001) used antibody from one individual for the 
first round of biopanning, antibody from another individual in the second round, and 
a mixture of both for a third round. A similar strategy could be used for BALB/c and 
CBA/Ca antibody preparations. Alternatively, serum could be raised in heterozygote 
and/or outbred mice to more closely mimic a heterozygous population. 
C. Immunisation Strategies: Direct Immunisation With Phage 
There are even greater benefits to be gained from phage display than the 
identification of antigenic epitopes. Animals have been directly immunised with 
recombinant phage which elicited antibodies against the antigen that was mimicked 
by the displayed peptide (Zuercher et al., 2000). Since the viral particles themselves 
are highly immunogenic, adjuvant is not needed (Greenwood et al., 1991). In 
addition, recombinant phage can elicit both humoral and cell-mediated immunity 
(Heal et al., 1999; Manoutcharian et al., 1999). An immune response can be 
generated by peptides fused to the coat proteins encoded by gene VIII or gene III 
(Yip et al., 2001), and recombinant phage have been used as part of sucessful 
intradermal anti-cysticercosis and oral anti-IgE immunisations in mice 
(Manoutcharian etal., 1999; Zuercher etal., 2000). 
A vaccine consisting of a defined set of several epitopes could elicit 
protection without the risk of causing disease. It is important that several epitopes be 
used because the specificity of antibodies elicited to a particular disease will vary 
from one individual to the next (Germaschewski and Murray, 1996). Vaccinating 
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with recombinant phage would be better than with protein plus adjuvant for several 
reasons. Firstly, adjuvant would not be needed if phage are used. Secondly, a phage 
vaccine would be cheaper and easier to produce. Thirdly, phage elicit both humoral 
and cell-mediated immunity, which is particularly relevant for Salmonella infection 
due to its intracellular localisation. Such recombinant phage can be used to directly 
immunise against the antigen of choice. A major disadvantage would arise from the 
induction of antibodies to the phage itself, and this might interfere with future 
vaccinations for a different disease where the same phage is used as the vector for 
imm unisation. 
D. Phage Display and S. Typhimurium: Concluding Remarks 
Phage display offers many advantages for identifying antigens and serving as 
a carrier for these antigens in immunisation. Many parameters affect the copy 
number and stability of displayed protein fragments, and non-specific binding can 
interfere with the isolation of specifically binding particles. However, optimisation of 
selection procedures can overcome these problems to generate valuable results for 
the future design of multiple subunit vaccines. Following the selection of appropriate 
antigens for use in such vaccines, different immunisation protocols should be tested 
in order to determine efficacy of protection. Furthermore, different strains of mice 
should be used in these protocols to infer how broadly useful the antigens may be in 
a genetically diverse population. 
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APPENDIX: 
5-3' Nucleotide Sequences of Clones 
Represented in Table 4.9 
with Corresponding Predicted Amino Acid Sequences 
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THE SIX CONSECUTIVE AMINO ACIDS WITH THE HIGHEST 





































(AAAATRTGSVLRLLI SGPLALLRVALFAVGSLLGALLSPvGLvvAALAGVALVIWKyWQpI SAFLGG 














































C GAT GAGTAT GAC GGTTTT GTThTT CT GCAC GGCACC GACAC GATGGCGTTTAC C GCATC GGC GCTCT 
CTTTCATGCTGGAAAATCTGGGTAAACCGGTCATTGTGACAGGGTCACAAATTCCGCTGGCTGAGCTG 
























GTTGTC CTGCG CCAG GACTTTCACGCC GTT GAAC T GAGTCTGGC CGGATACACG GTC GATTT C OTT CA 
GGCGCTGGGTGATTTCAGCCTGGATGGAGTCGAGGTCAGACTGGGAGTTGGTGCTGTTAGCAGACTGA 
ACCGCCAGTTCACG 
(VDLLQI DI DS FTVVGTNLDGQGVVLRQDFHAVELSLAGYTVDFVQALGDFSLDGVEVRLGVGAVSRL 
NRQF'T) 
 
AAAAC CGGGTACCAAACAGCAGTTCCCGTAAT C GGTTC C GCATT CCCAGCTTCAC CAGTAAC C GGTAT 
TTGTCCTGCCAGATTTGCTTCTCCTGTGTATTCAGCCTTCCACACAACGCTGACAACCTTCCTCGTCC 





























































































(APKSKVAATCDYSAEVVLHGDNFNDTIAKVSE IVETEGRI FT PPYDDPKVIAGQGTIGLE IMEDLYD 




AT GAAAAAGGAT TTTAC CAT GAAGAAAATT G TTT GC GC C GTCGTT GCGCTCCT GCTGACC CTACCC GC 
CTGGGCG 
(RNNHTRSATYYPANGLRCSDYCMKKDFTMKKIVCAVVALLLTLPAWA) 
26. SEQUENCE NOT OBTAINED 
 





























ATCAAT TT CAT GATGAGT TAT GTAGAC TGGCC GCCATTAATTTT GAGGCACAC GTAC TACAT GGCT GA 
































































TT GO CAGCAGC GGTAACCTT GACCC C GCTAT TCTT C C GCT CAT TCACCATGAGAC GCCC CTGCGGCTG 
GAAAACCGAGGCATTCAGTATGCTATCCACCCCTTTCCGGAAATGGGCATTACTATCGTAAGCTGGGC 
ACCGACCGCTOCGCTGGAAAGGAGCTGGTATCGACAGGCGTTTATCTGGCTACCGGCGGGCATCGTAA 






































































T TTC CAGC CATAT OAT GAAAGAAGAACAGAT COT GTT C CCCAT OAT CAAACAGGGTAT G 


































































































































































































































































































































































































































































































































C OAT GA 
(NO ORF) 
(SEQUENCE NOT AVAILABLE) 
(SEQUENCE NOT AVAILABLE) 
SEQUENCE NOT OBTAINED 
 
CCATAATTAAAGGAACAACGATGCGACATACCGTGATATTTGCCTCAGCGTTTGCCACCCTTGTCACC 























(SEQUENCE NOT AVAILABLE) 






SEQUENCE NOT OBTAINED 
 






















(LASSRKVPS I SVTTTLTVI LKLLAVTA) 
SEQUENCE NOT OBTAINED 
SEQUENCE NOT OBTAINED 
SEQUENCE NOT OBTAINED 
SEQUENCE NOT OBTAINED 





















(FOUR STOP CODONS FOLLOW THE CDS) 
 
GATATAAATAAAATTGCTGTGCGGGAATATAGCGGGTCAGCAACGACACTAACGCCAACAAGGCCGTG 












SEQUENCE NOT OBTAINED 
SEQUENCE NOT OBTAINED 
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